Temperature-compensated analyte monitoring devices, systems, and methods thereof

Information

  • Patent Grant
  • 12290354
  • Patent Number
    12,290,354
  • Date Filed
    Tuesday, January 10, 2023
    2 years ago
  • Date Issued
    Tuesday, May 6, 2025
    11 days ago
Abstract
Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
Description
BACKGROUND

In vivo analyte monitoring systems include an in vivo analyte sensor. At least a portion of the sensor is positioned beneath the skin surface of a user to contact bodily fluid to monitor one or more analytes in the fluid over a period of time. This is also referred to as continuous analyte monitoring in that the sensor remains positioned in the user for a continuous period of time.


Analyte sensors may have temperature dependencies and the sensor signals produced by the sensors are may then be affected by temperature changes. An error caused by temperature measurement may lead to an associated error in analyte measurements, such as blood glucose measurements.


SUMMARY

Aspects of the present disclosure relate to analyte monitoring systems, devices, and methods thereof related to temperature compensation, such as temperature compensated glucose values. Included are devices, computer-implemented methods, and systems that determine temperature of an environment surrounding an in vivo glucose sensor, and whether the temperature adversely affects the in vivo analyte sensor glucose data, e.g., the temperature is too high and/or too low. If the temperature may adversely affect the glucose data, the system may be responsive to the temperature information so that erroneous glucose information is not presented to the user. Determined glucose values may be modified or not depending on the temperature and/or glucose values may be displayed to a user or not depending on the temperature. Temperature data may be in vivo temperature data (e.g., obtained at the location of a working electrode of an in vivo analyte sensor during a sensing process such as on or near the body-inserted sensor portion) and/or may be ambient temperature, and/or may be temperature of a processor of a sensor electronics unit such as a sensor control unit and/or may be skin surface temperature.


In certain embodiments, a processor of a glucose monitoring system may always compensate in vivo glucose sensor data based on temperature, but a display device will not display the temperature-compensated glucose values if the temperature is determined to exceed a predetermined threshold, or a processor of a glucose monitoring system will only compensate in vivo glucose sensor data based on temperature if temperature is determined to be within a predetermined range, and a display device will display temperature un-compensated glucose values if the temperature is determined to be within a first range predetermined range and will display temperature-compensated glucose values if temperature is determined to be in a second range.


Embodiments include obtaining glucose data from an in vivo glucose sensor, obtaining temperature data from one or more temperature sensors, comparing the temperature data to a predetermined temperature threshold, and determining a temperature-compensated glucose value if the temperature data does not exceed the predetermined threshold, and not determining a temperature-compensated glucose value if the temperature data does exceed the predetermined threshold. Certain embodiments may include not compensating for temperature if the temperature data is within a predetermined range. In other words, glucose values may be adjusted or not based on temperature data obtained at the same or substantially same time as the glucose data.


Embodiments include methods that include displaying information responsive to obtained temperature data. Embodiments include obtaining glucose data from an in vivo glucose sensor, obtaining temperature data from one or more temperature sensors, comparing the temperature data to a predetermined temperature threshold, and displaying on a user interface device a temperature-compensated glucose value if the temperature data does not exceed the predetermined threshold, and not displaying a temperature-compensated glucose value if the temperature data does exceed the predetermined threshold. In such embodiments, glucose values may be determined or not, but in any event are not communicated to a user if a temperature threshold is exceeded.


Embodiments include computer systems that analyze temperature data for its affects to a glucose sensor. Certain embodiments include an in vivo glucose sensor, at least one temperature sensor, a sensor electronics unit that receives glucose data from the in vivo analyte sensor, and a receiver unit that receives glucose data from the electronics unit. A display may be included with the sensor electronics unit or receiver unit. At least one processor of the electronics unit and/or the receiver unit includes instructions to process temperature data of the at least one temperature sensor and in vivo analyte sensor data of the in vivo analyte sensor, and compare the temperature data to a predetermined temperature threshold, and determine a temperature-compensated glucose value if the temperature data does not exceed the predetermined threshold, and not determine a temperature-compensated glucose value if the temperature data does exceed the predetermined threshold. The at least one processor may include instructions to not compensate for temperature if the temperature data is within a predetermined range. In other words, it may cause glucose values to be adjusted or not based on temperature data obtained at the same or substantially same time as the glucose data. In display embodiments, the one or more processors may include instructions to cause the display to display or not to display information responsive to obtained temperature data. At least one processor includes instructions to process temperature data of the at least one temperature sensor and in vivo analyte sensor data of the in vivo glucose sensor in include obtaining glucose data from an in vivo glucose sensor, and compare the temperature data to a predetermined temperature threshold, and display on the display a temperature-compensated glucose value if the temperature data does not exceed the predetermined threshold, and not display a temperature-compensated glucose value if the temperature data does exceed the predetermined threshold. In such embodiments, the one or more processors may cause glucose values to be determined or not, but in any event are not communicated to a user on a display device if a temperature threshold is exceeded.


In some aspects of the present disclosure, methods of detecting and/or determining an analyte level by compensating for ambient temperature using a temperature sensor (e.g., coupled to an in vivo analyte sensor) are provided. The methods includes receiving a sensor signal (e.g., sensor information, such as current, voltage, etc.) derived from an in vivo analyte sensor; detecting a temperature measurement from a temperature sensor; determining, with a processor, whether a temperature threshold requirement is exceeded based on the temperature measurement; and determining, with the processor, a temperature-compensated analyte sensor signal. When the threshold requirement is not exceeded, the temperature-compensated analyte sensor signal is determined using the temperature measurement. Only when the threshold requirement is exceeded, the temperature-compensated analyte sensor signal is determined using an ambient-compensated temperature that is derived by compensating the temperature measurement for ambient temperature.


In some aspects of the present disclosure, analyte monitoring devices are provided that include a housing; a processor coupled to the housing; and memory communicably coupled to the processor. An in vivo analyte sensor is communicably coupled to the processor, and a temperature sensor is communicably coupled to the processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to receive a sensor signal from the in vivo analyte sensor; detecting a temperature measurement from the temperature sensor; determine whether a threshold requirement is exceeded based on the temperature measurement; and determine a temperature-compensated analyte sensor signal. When the threshold requirement is not exceeded, the temperature-compensated analyte sensor signal is determined using the temperature measurement. Only when the threshold requirement is exceeded, the temperature-compensated analyte sensor signal is determined using an ambient-compensated temperature that is derived by compensating the temperature measurement for ambient temperature.


In some aspects of the present disclosure, methods of compensating for ambient temperature using a single temperature sensor are provided that include detecting a temperature measurement from a temperature sensor; and determining, with a processor, an ambient-compensated temperature from the temperature measurement using an offset term.


In some aspects of the present disclosure, analyte monitoring devices are provided that include a housing; a processor coupled to the housing; and memory communicably coupled to the processor. An in vivo analyte sensor is communicably coupled to the processor, and a temperature sensor is communicably coupled to the processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to detect a temperature measurement from the temperature sensor; and determine an ambient-compensated temperature from the temperature measurement using an offset term.


In some aspects of the present disclosure, methods of compensating for ambient temperature using temperature sensors are provided that include sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor; determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. The correction gain or factor changes value at a slower rate than the sampling rate.


In some aspects of the present disclosure analyte monitoring device are provided that include a housing; a processor coupled to the housing; and memory communicably coupled to the processor. An in vivo analyte sensor is communicably coupled to the processor, and a first temperature sensor and second temperature sensor are communicably coupled to the processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to sample at a first sampling rate, with a processor, first temperatures measured from a first temperature sensor on the housing; determine first ambient-compensated temperatures from the first temperature measurements; and determine final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. The correction gain or factor changes value at a slower rate than the sampling rate.


In some aspects of the present disclosure, in vivo analyte sensors are provided that include a substrate layer; an electrode layer disposed on the substrate layer, and a temperature sensing element disposed on the substrate layer. The electrode layer includes a sensing area, and the temperature sensing element providing a signal for determining temperature adjacent the sensing area.


In some aspects of the present disclosure, analyte monitoring devices are provided that include a housing; electronic circuitry coupled to the housing, the electronic circuitry including a processor; and an in vivo analyte sensor electrically coupled to the electronic circuitry and extending from the housing. The in vivo analyte sensor include a substrate layer; an electrode layer disposed on the substrate layer; and a temperature sensing element disposed on the substrate layer, the temperature sensing element providing a signal for determining temperature adjacent a sensing area.


In some aspects of the present disclosure, analyte sensor devices are provided that include a body including an elongated member having a central tunnel that inserts into skin of a subject, electrodes disposed on the body, and a temperature sensor coupled to the body. The body is adapted to couple to the skin of the subject.


In some aspects of the present disclosure, methods are provided that include coupling an analyte sensor device to a skin of a subject and inserting a temperature sensor within the skin of the subject. The temperature sensor is disposed within the central tunnel. The sensor coupling device includes a body including an elongated member having a central tunnel that inserts into the skin of a subject, and electrodes disposed on the body. The body is adapted to couple to the skin of the subject.


In some aspects of the present disclosure, methods are provided that include receiving a first sensor signal from a first electrode on an in vivo analyte sensor on an on-body sensor; receiving a second sensor signal from a second electrode on the in vivo analyte sensor, and determining, with a processor, a compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes. The first electrode and second electrode include different sensing chemistries with different temperature dependencies.


In some aspects of the present disclosure, analyte monitoring devices are provided that include a housing; a processor coupled to the housing; and memory communicably coupled to the processor. An in vivo analyte sensor is communicably coupled to the processor, and the in vivo analyte sensor includes two working electrodes. The memory includes instructions stored therein that, when executed by the processor, cause the processor to detect a first sensor signal from a first electrode on the in vivo analyte sensor; detect a second sensor signal from a second electrode on the in vivo analyte sensor; and determine a compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes. The first electrode and second electrode include different sensing chemistries with different temperature dependencies.





BRIEF DESCRIPTION OF DRAWINGS


FIG. 1 shows a block diagram of an embodiment of an analyte monitoring system, according to certain embodiments;



FIG. 2 shows a block diagram of an embodiment of a data processing unit of the analyte monitoring system shown in FIG. 1, according to certain embodiments;



FIG. 3 shows a block diagram of an embodiment of the primary receiver unit of the analyte monitoring system of FIG. 1, according to certain embodiments;



FIG. 4 shows a schematic diagram of an embodiment of an analyte sensor, according to certain embodiments;



FIG. 5 illustrates a flowchart for a method of determining an analyte level by compensating for ambient temperature using a single temperature sensor on an on-body sensor, according to certain embodiments;



FIG. 6 illustrates a flowchart for a method of compensating for ambient temperature using a single temperature sensor on an on-body sensor, according to certain embodiments;



FIG. 7 illustrates a circuit diagram representation of an example two-thermistor model, according to certain embodiments;



FIG. 8 illustrates a circuit diagram representation of an example one-thermistor model, according to certain embodiments;



FIG. 9 illustrates method of compensating for ambient temperature using temperature sensors on an on-body sensor, according to certain embodiments;



FIG. 10 illustrates an electrode arrangement for a typical three-terminal sensor, according to certain embodiments;



FIG. 11 illustrates an electrode arrangement for a three-terminal analyte sensor wherein one of the electrodes is also an embedded RTD, according to certain embodiments;



FIG. 12 illustrates a partial circuit diagram for an example analog front-end circuit for a three-terminal analyte sensor with one of the electrodes as an embedded RTD, according to certain embodiments;



FIG. 13 illustrates a front-side view of an analyte sensor having thermocouple temperature sensor, according to certain embodiments;



FIG. 14 illustrates a back-side view of an analyte sensor having thermocouple temperature sensor, according to certain embodiments;



FIG. 15 illustrates a system block diagram of an on-body sensor having a thermocouple temperature sensor, according to certain embodiments;



FIG. 16 illustrates a cross-sectional view of an analyte sensor substrate having a thermocouple junction, according to certain embodiments;



FIG. 17 illustrates an on-body sensor having a thermistor located in a thermally conductive structure such that it protrudes from the bottom of the on-body sensor, according to certain embodiments; and



FIG. 18 illustrates a top view of multiple sensing elements disposed on a sensing surface, according to certain embodiments.





DETAILED DESCRIPTION

Before the present disclosure is described in additional detail, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.


Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges is also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.


It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.


The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.


As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.


The figures shown herein are not necessarily drawn to scale, with some components and features being exaggerated for clarity.


The analyte sensor may be configured so that at least a portion thereof is placed under the skin of the patient to detect the analyte levels of the patient, and another portion of the analyte sensor—which may be above the skin—is coupled to electronics within a housing that is positioned externally on the skin of the subject. The electronics may include various components, such as communication element(s) for communication with a remote receiving unit. The analyte monitoring device that is coupled to the subject's body and includes the in vivo positioned analyte sensor, housing, and electronics (e.g., data processing, storage, and/or communication components) is also referred to herein as an “on-body unit”, “OBU”, “on-body sensor”, “on body patch”, or “patch”.


Analyte sensors may have temperature dependencies and the sensor signals produced by the sensors may then be affected by temperature changes. An error caused by temperature may lead to an associated error in analyte measurements, such as glucose measurements.


It should be appreciated the subject matter of the disclosure is not limited to transcutaneous analyte sensor, but is also applicable to in vivo analyte sensors in general.


Temperature Compensation


As summarized above, aspects of the present disclosure relate to analyte monitoring systems, devices, and methods thereof related to temperature compensation. It should be appreciated that while the devices and methods may be described in terms of a subcutaneous sensor, other in vivo analyte sensors may also be applicable and the subject matter not limited to specifically subcutaneous analyte sensors.


It should also be appreciated that the embodiments described herein are exemplary and should not be viewed as limiting. For example, it should be appreciated that the methods described herein may be implemented in an on-body unit, the receiver, or mixed between the on-body unit and the receiver. Thus, various combinations of the steps performed on the on-body unit or receiver are contemplated. For example, an on-body unit may perform some steps such as temperature measurement and transmit the measurement to a receiver, where a processor on the receiver performs subsequent processing, such as determining ambient temperature compensation, determining temperature-compensated analyte sensor signals, determining analyte levels, etc. Or, as another example, the on-body unit may perform the steps of measuring the temperature, determining ambient temperature compensation, and determining temperature-compensated analyte sensor signals. For instance, the on-body unit may transmit the results to a receiver wherein the results are provided on a user interface.


It is noted that the combinations of steps between the on-body unit and receiver are appreciated for the one temperature sensor and two temperature sensor embodiments. Thus, for example, steps in the two temperature sensor embodiments may also be performed on the on-body unit or the receiver in other embodiments—e.g., sampling of temperature sensors, and/or correction factor or gain determination, determining ambient temperature compensation, determining temperature-compensated analyte sensor signals, etc.


It is also appreciated that temperatures may be measured by a processor on the on-body unit and/or receiver. For example, a processor may receive temperature data from a temperature sensor and calculate a temperature from the temperature data. The temperature may be, for example, an analog or digital signal derived by the temperature sensor. For example, in certain embodiments, a processor on the on-body unit may be coupled to the temperature sensor and provide a temperature measurement to the receiver, wherein the receiver detects the temperature measurement communicated and then performs additional processing steps based on the temperature measurement. It is appreciated that in another embodiment, the temperature data from the temperature sensor is sent to the receiver and the processor on the receiver calculates the temperature from the temperature data. The processor may then use this detected temperature for additional processing steps.


Compensating Sensor Signals


Temperature measurements are important for obtaining accurate analyte measurements (e.g., glucose measurements) with on-body sensors that are part of in vivo analyte monitoring systems—e.g., continuous glucose monitor (CGM) systems or intermittent or periodic glucose monitoring systems. The analyte-sensing chemistry on a subcutaneously positionable analyte sensor, or other in vivo analyte sensor, of the on-body sensor is temperature dependent and the sensor signal produced by the in vivo analyte sensor is thus affected by temperature.


Subcutaneously inserted glucose sensors, for example, may measure glucose by correlating the sensor signal output with glucose concentration. The signal response of analyte sensor may be linear across the operating range of glucose concentrations. However, the slope of this response may vary as temperature around the analyte sensor tip changes.


In order to compensate for this thermal effect, knowledge of temperature around the sensor sensing area is needed. The term “sensing area” is used herein to mean the area of the analyte sensor where the sensing chemistries are located. For example, in certain embodiments, the sensing area is disposed at the sensor tip, and thus the temperature at the sensor tip is estimated.


Therefore, the effect of temperature may be taken into account in order to calculate an accurate value for glucose concentration.


On-body sensors may utilize a temperature sensor disposed near the in vivo analyte sensor to estimate the sensor temperature. This temperature measurement is used to compensate the analyte sensor signal for temperature effects. For example, temperature-compensated analyte sensor signal may be determined by:

ITC=I*1.07{circumflex over ( )}(32.5−T),


where I is the raw sensor current, T is the measured temperature in degrees Celsius (C), and ITC is the temperature compensated signal that is proportional to glucose concentration.


Ambient temperature impinging on the on-body housing may influence temperature measurements, and in effect, create a temperature measurement error that will lead to a glucose calculation error. For example, in some instances, experiments have shown that in an ambient temperature environment of 20 degrees C., the resulting glucose error due to ambient temperature effects can be about 10%.


In some aspects of the present disclosure, on-body sensors employ a second temperature sensor used to compensate for errors in the sensor temperature measurement due to the influence of ambient temperature on the first temperature sensor. For example, one temperature sensor (T1) may be located close to the skin surface Tskin, and another temperatures sensor (T2) located close to the transmitter (TX) processor or on the printed circuit board (PCB).


The temperature which compensates for ambient temperature influence using two temperature sensors is determined by, for example:

T=T1+K*(T1−T2)


where K is related to the thermal resistances between the first temperature sensor and the second temperature sensor, and is a constant (e.g., 0.5, 0.2, or other constant) that may be derived empirically; T1 is the measured temperature at the temperature sensor near the sensor; T2 is the measured ambient temperature from the second temperature sensor; and T is the temperature which is compensated for ambient temperature influence. Other more complex models may be contemplated; for instance, K may not be constant but rather a function of T1 and/or T2, for instance.


Ambient Temperature Compensation Using a Single Temperature Sensor


To estimate the temperature at the sensing area of the in vivo analyte sensor, ambient compensation may be performed. In some aspects of the present disclosure, ambient temperature compensation is provided using a single temperature sensor on the on-body sensor. Thus, a second temperature is not required to compensate for ambient effects. Having a single temperature instead of multiple temperature sensors may provide one or more benefits, such as a reduction in cost, a reduction in complexity, etc.



FIG. 5 illustrates a flowchart for a method of determining an analyte level by compensating for ambient temperature using a single temperature sensor (e.g., a temperatures sensor that approximates skin temperature) on an on-body sensor, according to certain embodiments.


At block 601, a sensor signal is received from an in vivo analyte sensor that is transcutaneously positioned with the skin of a subject. For example, the on-body sensor may include a processor that is electrically coupled to the analyte sensor and receives the sensor signal.


At block 605, the processor receives a temperature signal from a temperature sensor coupled to the on-body sensor. The temperature sensor may be, for example, positioned at or near a skin contacting surface to represent skin temperature. Since skin temperature may be affected by ambient temperature, a change in skin temperature may be correlated to a change in ambient temperature. When the ambient temperature is low, skin temperature will decrease, and when the ambient temperature is high, skin temperature will increase. Thus, deviations from “normal” skin temperature may be used to represent how strong the ambient temperature effects are.


At block 610, the processor determines if the measured temperature has reached a predetermined threshold value. For instance, a normal temperature or normal temperature range may be established and any deviation past the established threshold or thresholds (e.g., outside the normal temperature range) will trigger the ambient temperature correction. It should be appreciated that the term “predetermined threshold” is used broadly herein, and may include an upper and lower threshold. For example, an upper threshold and lower threshold may be implemented in some instances to establish a range. In some instances, only an upper or lower threshold may be implemented.


If the skin temperature does not deviate beyond the threshold, then it can be assumed that the ambient temperature effects are minimal, and no ambient temperature compensation is required, as represented by block 615. The temperature measurement may then be used to determine the temperature compensated analyte sensor signal, ITC, as represented by block 625, and transmitted or displayed as a corresponding analyte (e.g., glucose) level, as represented by block 630.


If the skin temperature deviates beyond the predetermined threshold, then it can be assumed that the ambient temperature effects are significant, and ambient temperature compensation is performed (e.g., a correction factor applied) to compensate for the effects of ambient temperature, as represented by block 620. The resulting ambient-compensated temperature is then used to determine the temperature-compensated analyte sensor signal, ITC, as represented by block 625, for a more accurate analyte (e.g., glucose) level determination that is transmitted or displayed, as represented by block 630.


For example, skin temperature for most people may normally range between 30 and 35° C. in ambient temperature environments that people are comfortable in. In certain embodiments, ambient temperature compensation is applied when “extreme” skin temperatures are detected (e.g., when the skin temperatures deviate beyond the predetermined threshold or thresholds). For instance, when the skin temperature measurement from the temperature sensor drops below 30 degrees C., then a correction factor can be added to the temperature measurement.


It should be appreciated that the predetermined threshold or thresholds (e.g., the “normal” range) may vary, and further, that the actual compensation algorithm (e.g., correction factor) implemented may also vary. As an example, ambient temperature compensation may be provided by the correction factor:

If T<30, then Tcorrected=T+1
AND
IF T>35, then Tcorrected=T−1


As another example, the ambient temperature compensation may be provided by a slightly more complex correction factor, such as:

If T<30, then Tcorrected=T+(30−T)/5
AND
If T>35, then Tcorrected=T−(T−35)/5


Tcorrected is then used to determine the temperature-compensated analyte sensor signal. In this way, the temperature-compensated analyte sensor signal accounts for ambient temperature influence. It should be appreciated that correction factors of varying complexities may be implemented in other embodiments.


It should be appreciated that illness may also affect the skin temperature of a subject—e.g., to make the skin temperature elevate outside the normal range. In certain embodiments, the ambient temperature compensation is applied only if the temperature error causes a high reading. In this way, only low temperature measurements are compensated.


In certain embodiments, changes in skin temperature are used to detect and correct for ambient temperature influences. For example, an ambient correction factor may be applied after a change in skin temperature is detected. It should be appreciated that the magnitude of the change may vary in different implementations as desired. For example, in some instances, a “normal” temperature could be detected at the start of a sensor wear, and when the temperature deviates by some predetermined amount (or, for example, by an amount detected by monitoring the changes during a period at the start of a sensor wear), then the ambient temperature compensation can be performed, such as described above.


In certain embodiments, temperature changes above a certain absolute value over a predetermined period of time initiates the ambient temperature compensation. For instance,

T(t=0)−T(t=−10)>5, then Tcorrected=T+1
T(t=0)−T(t=−10)<−5, then Tcorrected=T−1


In certain embodiments, the ambient temperature compensation is based on the rate of change of skin temperature. In other embodiments, a combination of absolute temperature checks and temperature rate of change could be used in both the detection and correction.


It should be appreciated that the embodiment shown in FIG. 5 is exemplary, and that one or more steps may be performed by a processor on the on-body unit and/or a receiver in communication with the on-body unit in other embodiments. For example, in certain embodiments, the temperature sensor is coupled to the on-body unit and a processor on the on-body unit is detecting the temperature measurement, determining whether the threshold requirement is met, performing the ambient temperature compensation, and determining the temperature-compensated signal. Then, for example, the temperature-compensated signal is sent to a receiver wherein the temperature-compensated analyte level is displayed on a user-interface of the receiver for instance. In another embodiment, for example, the temperature sensor is coupled to the on-body unit and a processor on the on-body unit transmits the temperature measurements to the receiver where a processor coupled to the receiver determines whether the threshold requirement is met, performs the ambient temperature compensation, and determines the temperature-compensated signal. Then, for example, the temperature-compensated analyte level is displayed on a user-interface of the receiver for instance. It should be appreciated that the steps may be split up in other combinations between the on-body unit and the receiver.


It should be appreciated that, in certain embodiments, the ambient temperature compensation may, for the most, always or continuously be performed on the received analyte sensor signal. For example, the processor may continuously perform the ambient temperature compensation on the analyte sensor signal in addition to determining if the threshold temperature has been exceeded. When the temperature measurement does not exceed the temperature threshold, the temperature-compensated analyte sensor signal is based off the uncompensated signal, resulting in uncompensated analyte levels. When the temperature measurement exceeds the temperature threshold, the temperature-compensated analyte sensor signal is based off the ambient-compensated signal, resulting in ambient-compensated analyte levels. Thus, the temperature-compensated analyte sensor signal results in a mixed signal of the uncompensated analyte levels and ambient-compensated analyte levels. The temperature-compensated analyte sensor signal may be transmitted (e.g., communicated to a receiver) or presented on a user interface (e.g., displayed on a display for the user).


In other embodiments, the ambient-temperature compensation is not always or continuously performed on the received analyte sensor signal, but rather, only when the temperature threshold is exceeded. When the temperature measurement does not exceed the temperature threshold, the temperature-compensated analyte sensor signal is based off the uncompensated signal, resulting in uncompensated analyte levels presented on a user interface (e.g., displayed on a display). When the temperature measurement exceeds the temperature threshold, ambient-compensation is performed and the temperature-compensated analyte sensor signal is based off the ambient-compensated signal, resulting in ambient-compensated analyte levels presented on the user interface. Again, the temperature-compensated analyte sensor signal results in a mixed signal of the uncompensated analyte levels and ambient-compensated analyte levels.


It is also appreciated that in certain embodiments, the ambient compensation may be based off predetermined temperature ranges rather than predetermined thresholds. For example, the uncompensated analyte sensor signal may be used when the temperature measurement falls within a predetermined range or ranges, and the ambient compensated signal is used when the temperature measurement falls within another predetermined range or ranges.


It should be appreciated that in certain embodiments the temperature compensation may be applied to an analyte sensor signal that is not yet calibrated or converted (e.g., scaled by a scaling factor) to a corresponding analyte level, and thereafter converted to the corresponding analyte level. In yet other embodiments, the temperature compensation is applied to an analyte sensor signal that already represents the analyte level (e.g., is already calibrated or converted to the corresponding analyte level), and the temperature-compensated analyte sensor signal is the temperature compensated analyte level.


Ambient Temperature Compensation Based on Core Body Temperature


As previously noted, some on-body units may include a correction algorithm that utilizes two temperatures sensors to compensate for ambient temperature influence on the temperature sensor. For example, one temperature sensor is located close to the skin in a can that protrudes from the bottom of the transmitter. The other temperature sensor is located on the printed circuit board (PCB) in the transmitter and is a feature provided by the controller chip. Again, the correction method employed is:

T=T1+K*(T1−T2)


This method can be considered an “extrapolation” method, since two temperature measurements are made at points where the temperature for each is lower than the sensing area temperature, and the sensing area temperature is estimated by extrapolating from these two measured temperatures. In this transmitter configuration, the two temperature sensors are generally well separated, which results in a stable K value that is robust over different transmitter locations on the body and for different body types. As transmitter designs become physically smaller, however, it becomes more difficult to separate the two temperature sensors thermally. Without adequate thermal separation, the K value becomes significantly less stable, and furthermore, becomes significantly larger, with the effect of amplifying the noise in the temperature measurement.


Utilizing a single temperature sensor instead of two may provide many advantages, such as cost savings. In some aspects of the present disclosure, ambient temperature compensation is based on a predetermined core body temperature and temperature measurements from a single temperature sensor.



FIG. 6 illustrates a flowchart for a method of compensating for ambient temperature using a single temperature sensor on an on-body unit, according to certain embodiments.


At block 701, a sensor signal is received from an analyte sensor that is transcutaneously positioned within the skin of a subject, or otherwise implanted in vivo. For example, the on-body unit may include a processor that is electrically coupled to the analyte sensor and receives the analyte sensor signal.


At block 705, the processor receives temperature data from a temperature sensor coupled to the on-body unit. For example, in certain embodiments, the temperature sensor may be positioned at or near a skin contacting surface to represent skin temperature.


At block 710, the processor determines an ambient-compensated temperature from the measured temperature using an offset term (e.g., an offset term based on a predetermined core body temperature). For example, a correction factor is applied to the measured temperature to correct for ambient temperature effects. The correction factor may have an offset term that is based on a predetermined core body temperature value—e.g., 37° C. since a user's core body temperature is relatively stable at approximately 37° C. For example, ambient temperature compensation may be provided by the following correction factor:

Test=Bcorebody+K*T1


where Bcorebody is a predetermined core body temperature (e.g., approximately 37 degrees C.); K is a constant that may be empirically derived; and T1 is the measured temperature by the temperature sensor; and Test is the estimated sensing area temperature that is compensated for ambient temperature influence.


The resulting sensing area (e.g., sensor tip) temperature estimate is compensated for ambient effects and may then be used to determine the temperature-compensated analyte sensor signal, ITC, as represented by block 715, for a more accurate glucose level determination that is transmitted or displayed, as represented by block 720.


The sensing area temperature estimate is an “interpolation” method since the sensing area temperature estimate is in between the core body temperature and the temperature measured at the transmitter. Measurement noise is not amplified using the interpolation method.


As similarly stated above, it should be appreciated that the embodiment shown in FIG. 6 is exemplary, and that one or more steps may be performed by a processor on the on-body unit and/or a receiver in communication with the on-body unit in other embodiments. For example, in certain embodiments, the temperature sensor is coupled to the on-body unit and a processor on the on-body unit detects the temperature measurement, determines an ambient-compensated temperature from the measured temperature using an offset term, and determines the temperature-compensated signal. Then, for example, the temperature-compensated signal is sent to a receiver wherein the temperature-compensated analyte level is displayed on a user-interface of the receiver for instance. In another embodiment, for example, the temperature sensor is coupled to the on-body unit and a processor on the on-body unit transmits the temperature measurements to the receiver where a processor coupled to the receiver determines an ambient-compensated temperature from the measured temperature using an offset term, and determines the temperature-compensated signal. Then, for example, the temperature-compensated analyte level is displayed on a user-interface of the receiver for instance. It should be appreciated that the steps may be split up in other combinations between the on-body unit and the receiver.


Using One-Temperature Sensor Models and Two-Temperature Sensor Models


Subcutaneously inserted glucose sensors measure glucose by correlating the sensor signal output with glucose concentration. As stated above, this signal output is affected by temperature. As stated above, in some instances, temperature is estimated using two temperature sensors.


For example, in certain embodiments, one thermistor is disposed close to the skin surface to provide a skin temperature measurement, Tskin. Another thermistor is disposed away from the skin surface to provide a temperature measurement, Tcpu, that may be near the on-body processor that is has more influence from the ambient temperature and less influence from the sensor tip temperature than Tskin.



FIG. 7 illustrates a circuit diagram representation of an example two-thermistor model, according to certain embodiments. It should be appreciated that in other embodiments a different type of temperature sensor may be implemented.


As shown, temperature 805 is ambient air temperature; temperature Tcpu 810 is the temperature at the circuitry (e.g., processor); temperature Tskin 815 is the temperature at the skin surface; and temperature Ttip 820 is estimated temperature at the sensing area (e.g., at the sensor tip). Resistance Rx 825 represents thermal resistance between the ambient air and circuitry; Rcpu-skin 830 represents thermal resistance between the circuitry and the skin; and Rskin-tip 835 represents thermal resistance between the skin and sensing area.


K=Rskin-tip/Rcpu-skin is a fixed constant, which acts as a scaling factor to extrapolate the difference Ttip−Tskin as a function of the difference Tskin−Tcpu.

Ttip−Tskin=K*(Tskin−Tcpu)


This relationship is used to calculate the temperature at the sensing area, Ttip:

Ttip=Tskin+K*(Tskin−Tcpu)


In some aspects, the two-thermistor model has relative insensitivity to changes in ambient temperature, core body temperature, and site-to-site thermal impedance variability. The two-sensor model may also possess minute-to-minute variability in the temperature sensor (e.g., thermistor) readings Tcpu and Tskin that can degrade the smoothness of the temperature corrected glucose signal. This is especially a concern when plasma-to-interstitial glucose lag compensation is required.


In certain embodiments, the one-sensor model described above assumes that the core body temperature is the dominant heat source, and that the thermal resistance between the core body and the sensing element is universally constant.



FIG. 8 illustrates a circuit diagram representation of an example one-thermistor model, according to certain embodiments. As shown, temperature Ttherm 905 is the temperature at the thermistor; sensing area temperature (e.g., sensor tip temperature) Ttip 910 is the estimated temperature at the sensing area, and body core temperature Tcore 915 is the predetermined body core temperature. Rtherm-tip 925 represents thermal resistance between the thermistor and the sensing area. Rtip-core 930 represents thermal resistance between the sensing area and the core body.


Where K1TM=Rtip-core/Rtherm-tip, such that Ttip can be calculated as follows:

Ttip=(Ttherm*K1TM+Tcore)/(1+K1TM)


where K1TM is an empirically derived constant for the one-thermistor model.


Since the model does not extrapolate between two measurement channels, improved minute-to-minute smoothness occurs. Experimental data suggests that while the one-thermistor model has a very consistent minute-to-minute estimate, the site-to-site variability results in a poorer overall Ttip estimate compared to the two-thermistor model. Rtip-core in the one-thermistor model assumes knowledge of a constant thermal resistance between the body's core temperature and the sensing area (e.g., sensor tip). The value of this resistance might vary between the arm and abdomen sites because of different proximities to the body core.


The minute-to-minute variability that is caused by the extrapolation operation of the two-thermistor model measurements directly affects the minute-to-minute variability of the glucose measurement. In addition, it limits the extent of plasma-to-interstitial glucose lag correction possible.


In some aspects of the present disclosure, a correction gain is determined based on temperature estimates calculated using the one-thermistor model and the two-thermistor model. For instance, two thermistors are disposed on the on-body sensor, such as described above for the two-thermistor model. Temperature estimates are calculated using the one-thermistor model technique, resulting in sensor temperature estimate T1TM. Temperature estimates are also calculated using the two-thermistor model, resulting in sensor temperature estimate T2TM.


In certain embodiments, present to recent past comparisons of the two temperature estimates T1TM and T2TM are used to improve the accuracy of the sensor temperature measured T1TM and utilize this recursively modified estimate of the sensor temperature. The result is a sensor temperature estimate that has the minute-to-minute smoothness (which is related to precision) of the one-thermistor model, yet has the site-to-site variability (which is related to accuracy) of the two-thermistor model. This approach allows for a smoother temperature corrected raw glucose signal, which helps improve the signal quality of the final product, reduce the uncertainty of threshold and projected alarms due to unnecessary noise, reduce the uncertainty of rate arrows, reduce the impact of non-physiological temperature transients, and allow for better concordance to reference blood glucose.



FIG. 9 illustrates method of compensating for ambient temperature using temperature sensors on an on-body unit, according to certain embodiments.


At block 1005, a sensor signal is received from an analyte sensor that is transcutaneously positioned within the skin of a subject, or otherwise implanted in vivo. For example, the on-body unit may include two temperature sensors (e.g., two thermistors) and a processor that is electrically coupled to the analyte sensor and receives the sensor signal.


At block 1010, first and second thermistors on the on-body unit are sampled by the processor. At block 1015, the processor determines ambient-compensated temperatures based on a one temperature model. At block 1020, the processor determines ambient-compensated temperatures based on a two temperature model.


At block 1025, correction gain or factor is determined based on past sampled ambient-compensated temperatures for the one-thermistor and two-thermistor models. At block 1030, a final ambient-compensated temperature is determined by applying the correction gain or factor to the ambient-compensated temperatures determined in block 1015.


For example, in certain embodiment, a simple gain error model is assumed on the one thermistor model. In other words:

T1TM(k)=K1TM(kT1TMnominal(k)


where T1TMnominal is the nominal output based on the one-thermistor model as previously described, K1TM is the correction gain for this model, and T1TM is the final ambient-compensated temperature resulting from using the improved one-thermistor model.


“k” refers to the index of the sample instance/time. Note that the value T1TMnominal is computed during every sample instance and attempts to reflect the latest temperature, which may or may not be rapidly varying over time. However, K1TM is computed such that the value changes very slowly over time, with the assumption that the biological and environmental factors that affect this gain error changes very slowly over time. K1TM changes at a rate slower than the sampling rate. In certain embodiments, this is achieved by performing a moving average between the nominal one-thermistor model and two-thermistor model outputs:








K

1

TM


(
k
)

:=


1
N






j
=
0


N
-
1





T

2

TM


(

k
-
j

)



T

1

TMnominal


(

k
-
j

)








where T2TM is the output of the two-thermistor model, and N is a relatively large positive window such that K1TM varies very slowly and reliably over time. The values of T1TMnominal and T2TM pairs are such that both values are valid and/or can be computed at any time index within the set of N most recent pairs.


In an alternative embodiment, the same assumptions are made as the previous embodiment, but the evolution of K1TM is governed by a calculation that is more robust to occasional T1TM nominal and T2TM outliers. As in the previous embodiment, the values of T1TMnominal and T2TM pairs must be such that both values are valid and/or can be computed at any time index within the set of N most recent pairs.








K

1

TM


(
k
)

:=





j
=
0


N
-
1




T

2

TM


(

k
-
j

)






j
=
0


N
-
1




T

1

TMnominal


(

k
-
j

)







In yet another embodiment, parameter adaption is used. One example is to use the MIT adaption rule:










d
/
dt




K

1

TM


(
t
)


=



-
γ



e

(
t
)





e




K

1

TM











=





γ
[



T

2

TM


(
k
)



T

1

TMnominal


(
k
)


]

2

[

1


K

1

TM


(
k
)


]

3








Where γ is an adaption scaling factor that governs the aggressiveness level of the adaptation, and needs to be tuned a priori. Taking a backwards difference approximation to discretize the above equation, the following difference equation that governs the time evolution of K1TM is obtained:








K

1

TM


(
k
)

=



K

1

TM


(

k
-
1

)

+




γ
δ

[



T

2

TM


(
k
)



T

1

TMnominal


(
k
)


]

2

[

1


K

1

TM


(
k
)


]






where δ is the sample time of the calculation. To avoid the need to solve for the root of a quadratic equation, a time delayed approximate can be used:








K

1

TM


(
k
)

=



K

1

TM


(

k
-
1

)

+




γ
δ

[



T

2

TM


(
k
)



T

1

TMnominal


(
k
)


]

2

[

1


K

1

TM


(

k
-
1

)


]






The three embodiments described above are based on the assumption that the main source of inaccuracy of the one-thermistor model is predominately a gain error. If an offset error is assumed, the same concepts described in the embodiments above can be implemented with a slight modification. For example, one would assume:

T1TM(k)=D1TM(k)+T1TMnominal(k)


where the offset difference D1TM can be corrected by the following windowed comparison between the nominal one-thermistor model and two-thermistor model approaches.








D

1

TM


(
k
)

:=





j
=
0


N
-
1




T

2

TM


(

k
-
j

)


-




j
=
0


N
-
1




T

1

TMnominal


(

k
-
j

)







The final ambient-compensated temperature may then be used, for example, to determine a temperature-compensated signal, as represented by block 1035. The corresponding analyte (e.g., glucose) level may then be transmitted or displayed, as represented by block 1040.


In addition, given that two thermistors are available, the above embodiments can be implemented on both thermistors such that instead of using a single modified one-thermistor model, an average of two modified one-thermsitor model outputs is used.


Again, as similarly stated above, it should be appreciated that the embodiment shown in FIG. 9 is exemplary, and that one or more steps may be performed by a processor on the on-body unit and/or a receiver in communication with the on-body unit in other embodiments. For example, in certain embodiments, the temperature sensors are coupled to the on-body unit and a processor on the on-body unit samples the temperatures sensors, determines the ambient-compensated temperature from the one-temperature sensor model and two-temperature sensor model, determines the correction factor or gain, determines the final ambient-compensated temperatures. The processor on the on-body unit may then either determine the temperature-compensated signal, or transmit the final ambient-compensated signal to a receiver having a processor that determines the temperature compensated signal and presents the corresponding analyte level on a user interface. It should be appreciated that these embodiments are exemplary, and that the steps may be split up in other combinations between the on-body unit and the receiver. For example, in other embodiments, one or more of the steps in determining the ambient-compensated signal and/or final ambient compensated signal may be performed by the receiver.


Provided below is an example analysis. It should be appreciated that the example analysis is exemplary and is not meant to be limiting.


Example Analysis:


Using the temperature sensor close to the skin, the equation for sensor (skin) temperature becomes:

T=0.25*Tc+0.75*T1


wherein Tc is the body core temperature 37 degrees C. and is treated as a constant.


Using the temperature sensor on the PCB, the equation for sensor (skin) temperature becomes:

T=0.54*Tc+0.46*T2


If the core temperature is 37 degrees C., these two equations will correct for the ambient effect. Further, the intrinsic measurement error in T1 or T2 is not amplified (like with the two temperature sensors implementation), but rather attenuated a bit.


Moreover, if the core body temperature does deviate from 37 degrees C., the resulting error is not significant, and further does not depend on the ambient temperature. For example, the following data was found:


For the temperature sensor close to the skin (T1): The resulting error, Terr, is 0.25 degrees C. per degree deviation from 37 degrees C.
















Glucose Error




(assume F = 105


Tc
Terr
rather than 1.07)

















36
0.25
−1.2% 


37
0
  0%


38
−0.25
1.2%


39
−0.5
2.5%


40
−0.75
3.7%









For the temperature on the PCB (T2), the resulting error is only modestly worse; Terr, is 0.5 degrees C. per degree deviation from 37 degrees C.
















Glucose Error




(assume F = 105


Tc
Terr
rather than 1.07)

















36
0.54
−2.6% 


37
0
  0%


38
−0.54
2.6%


39
−1.08
5.  




5.4%


40
−1.62
8.2%









Temperature Sensors Disposed Adjacent the Sensing Area


In some aspects of the present disclosure, an on-body sensor is provided with a temperature sensor disposed on the analyte sensor adjacent to the sensing area (e.g., at sensor tip on the sensor tail). In such case, extrapolation is not required to determine the temperature value at the sensing area. This may provide one or more benefits, such as less data required to be transmitted to the controller, promoting shorter RF packets and longer battery life, reducing complexity of system software, etc.


In some aspects of the present disclosure, embedded temperature sensors are provided. The term “embedded temperature sensor” is used herein to mean a temperature sensor that is disposed on an analyte sensor such that it is exposed to body fluids (e.g., interstitial fluids) when the analyte sensor is positioned in vivo.


An embedded temperature sensor enables the temperature of the interstitial fluid itself to be measured. In this way, the temperature at the location of the sensor chemistry of in vivo analyte sensors may be measured. Since the sensing chemistry is within interstitial fluid, a measurement of the interstitial fluid temperature provides a very accurate temperature measurement for the sensing area.


In certain aspects of the present disclosure, the embedded temperature sensors are resistive temperature detection (RTD) devices. RTDs are devices which increase in electrical resistance with increasing temperature. Temperature may be measured, for example, by driving a reference current through the device and measuring the voltage across the device. Platinum provides high accuracy, linearity, and stability when used as an RTD. It should be appreciated that other materials (e.g., metals or metal-alloys, etc.) may be used as an RTD.


As a non-limiting example, a platinum RTD may have a nominal resistance at 0 degrees C. and a temperature coefficient of 0.00385Ω/Ω/degrees C. The nominal 0 degrees C. resistance may range from 100Ω to 500Ω, for example, depending on construction. The absolute resistance of the RTD at any given temperature T determined as follows:

RTD(T)=RTD0+T*0.00385Ω/Ω/degrees C.


where RTD(T) is equal to the absolute RTD resistance in Ohms; RTD0 is equal to the resistance of the RTD at 0 degrees C. in Ohms; and T is equal to the temperature in degrees C. And further, the linearity of the platinum RTD may, for example, be less than +/−0.5% from 0-100 degrees C.


In certain embodiments, platinum is used as a sensor conductive base material to form an electrode that is also an embedded RTD. The platinum RTD trace may be made by any variety of manufacturing processes. For example, laser ablation may be used to create the electrodes and accommodate very fine feature sizes, as well as allow for a long platinum RTD trace to increase its resistance.



FIG. 10 illustrates an electrode arrangement for a typical three-terminal sensor, according to certain embodiments. The subcutaneous tail of a three-terminal analyte sensor is shown including a working electrode 1101, reference electrode 1102, and counter electrode 1103. Each of the three electrodes 1101, 1102, 1103 has a single electrical trace 1121, 1122, 1123, respectively, that extends from the along the sensor tail towards the electronics in the on-body sensor. The electrical traces provide the electrical communication path between the corresponding electrodes and electronics in the on-body sensor.



FIG. 11 illustrates an electrode arrangement for a three-terminal analyte sensor wherein one of the electrodes is also an embedded RTD, according to certain embodiments. The subcutaneous tail of the three-terminal analyte sensor is shown including a working electrode 1201 and reference electrode 1202, as well as a counter electrode 1203 that is also an embedded RTD. When the sensor is positioned in vivo into the skin of the subject, the embedded RTD and electrode 1203 is embedded in the subject and exposed to interstitial fluid.


The embedded RTD and electrode 1203 includes an electrical trace having two ends 1223a, 1223b such that current can be applied to the RTD and voltage measured across the two ends 1223a, 1223b. In the embodiment shown, the embedded RTD and electrode 1203 is a single electrical trace 1223 that extends back and forth longitudinally to increase the distance of the electrical trace. A long trace increases resistance and facilitates a better measurement. In certain embodiments, a long platinum RTD trace is used to increase its resistance and facilitate a better measurement.



FIG. 12 illustrates a partial circuit diagram for an example analog front-end circuit for a three-terminal analyte sensor with one of the electrodes as an embedded RTD, according to certain embodiments. As shown, analog front-end 1300 includes a working electrode contact point 1301 (e.g., to electrically couple to working electrode 1201 in FIG. 11) and a reference electrode contact point 1302 (e.g., to electrically couple to reference electrode 1202 in FIG. 11). Analog front-end 1300 also includes contact points 1303a, 1303b. Contact point 1303a electrically couples to the counter electrode of the analyte sensor and also serves as one end of the embedded RTD (e.g., end 1203a in FIG. 11). Contact point 1303b serves as a contact point that electrically couples to the other end of the embedded RTD (e.g., end 1203b in FIG. 11).


Analog front-end also includes amplifiers A1, A2 that are electrically coupled to the working and reference electrodes to provide the condition analyte signal 1331 for sampling by an A/D converter (not shown). Contact point 1303a is electrically coupled to the inverting input of amplifier A3. Contact point 1303b is electrically coupled to the non-inverting input of differential amplifier A3 along with the output 1332 of amplifier A2. Amplifier A3 measures the voltage across the RTD which is created by the flow of current provided through the RTD, as indicated by reference current, I1. The output 1333 of amplifier A3 provides the temperature signal to the A/D converter for the temperature sample.


It should be appreciated that other circuit elements may also be implemented to the analog front-end 1300—e.g., to improve performance, such as a reference resistor for the reference current to flow through, which could eliminate temperature and other errors in the A/D converter.


It should also be appreciated that in other embodiments, the embedded RTD could be implemented as one of the other electrodes—e.g., the reference electrode or working electrode. Furthermore, it should also be appreciated that an embedded RTD may be implemented in an analyte sensor with a different number of electrodes than three—e.g., a two-electrode sensor. For example, a two-electrode sensor may have a working electrode as well as a reference electrode that is also an embedded RTD.


It should be appreciated that the shape of the embedded RTD and electrode may vary in other embodiments. For example, in other embodiments, the embedded RTD and electrode may extend back and forth longitudinally a number of times that is different than shown in FIG. 11. Or alternatively, for example, the embedded RTD and electrode may extend back and forth latitudinally, or both latitudinally and longitudinally. It should be appreciated that in other embodiments, any variety of patterns and designs may be used for the shape of the embedded RTD and electrode, as long as the counter electrode has sufficient surface area exposed to the interstitial fluid. Moreover, the position of the two ends of the embedded RTD and electrode may also vary in different embodiments.


Temperature Sensors and Analyte Sensor Devices Having Elongated Members with Central Tunnels


In some aspects of the present disclosure, analyte sensor devices are provided that include a body having an elongated member (e.g., a hollow tube) with a central tunnel therein. Electrodes are disposed on the outside of the body and a temperature sensor coupled to the body. In certain embodiments, the central tunnel houses a temperature sensor. In this way, the temperature sensor provides a direct temperature measurement at the analyte sensor tip.


For example, in certain embodiments, a needle is disposed within the central tunnel during insertion. In certain embodiments, the sharp is withdrawn and a temperature sensor is inserted into the central tunnel of the hollow tube. The inserted temperature sensor may then provide temperature measurements at the analyte sensor tip.


In certain embodiments, the temperature sensor is adapted to pierce the skin and serve as the needle. For example, the temperature sensor may be formed as the needle, formed as part of the sharp, or coupled to a needle. In some instances, the temperature sensor is adapted to pierce the skin of the subject and is softened by exposure to body fluids—e.g., made from or include a material that softens when exposed to body fluids. In this way, the sharp softens when inserted into the subject and does not become an irritant.


In certain embodiments, the on-body housing of the analyte sensor device is adapted to couple to an insulin delivery tube and insulin pump. For example, the analyte sensor device may serve as an insulin delivery cannula. In such case, the analyte sensor device functions as an analyte monitoring system and integrated insulin delivery cannula.


In certain embodiments two conductors, such as wires or conductive plastic, are extruded in the walls of the insulin delivery cannula. One of the wires acts as a reference electrode for the analyte (e.g., glucose) sensing function. For example, in some instances, the one wire may be made from silver or other suitable conductor with or without a coating, and the second wire made from either gold or other highly conducting material. Both wires are fully embedded into the walls of the cannula (e.g., a soft cannula) and would extend near the tip of the cannula. At or near the tip of the cannula, each of the two wires terminates at a feature that allows the wires to electrochemically communicate with tissue and body fluids in conjunction with appropriate chemical or biological materials. For instance, the silver wire could be plated or chemically chloridized with silver chloride to form an Ag/AgCl reference electrode or auxiliary electrode in a two electrode system. The other wire may be, for example, coated or deposited with glucose sensing chemistry to form a working electrode. In some instances, either or both electrodes may be covered by a thin layer of membrane to restrict the glucose flux as well as to protect the electrode components. Further, in some instances, a section of the cannula may be laser ablated or chemically etched to increase the surface area of the active working or reference electrode.


In certain embodiments, a thermocouple is extruded into the insulin delivery cannula. For example, the thermocouple may be co-extruded into an insulin delivery cannula such as described above. The thermocouple may be co-extruded with the other materials in order to provide temperature sensing at the location of interest at the implanted site—e.g., close to the sensing chemistry.


In certain embodiments, the dual function soft cannula may be attached to a housing and adhesive patch to facilitate retention on the skin. The housing may include the additional components needed for continuous glucose sensing—e.g., a thermistor or thermocouple for skin temperature measurement and a counter electrode to return electrons to the body to form a closed sensor circuit. The wires of these two components may be molded inside the plastic cannula housing, for example. These wires along with the two electrode wires may be exposed at the distal end of the cannula and arranged around a keyed fluid and electrical connecting point. The connection point allows all wires to be connected to their counterparts embedded inside a connector on a multi conducting insulin delivery tube, for instance, when the cannula is connected to the tube.


In certain embodiments, the wires for the thermistor or thermocouple for skin temperature measurements and a wire to act as a counter electrode is extruded or embedded into the cannula, creating a multi-function structure.


The wires embedded inside the wall of the insulin delivery tubing enable a dual function device that delivers insulin and provides continuous glucose monitoring support functionality such as sensor signal transduction, calibration and user interface. The integrated system described above may be attached to or worn on the body.


In certain embodiments, the integrated system may include an insulin delivery pump, the CGM system, the data collection and processing hardware, and the user interface including control buttons and display. In some instances, the system may also have a discrete glucose meter embedded in it so that the user can check the blood glucose with the system using test strips.


In certain embodiments, the hardware of the insulin delivery pump and the continuous glucose monitor are combined into a more compact assembly and attached to the body using an adhesive patch. Other components (data processing algorithms, user interface, and/or discrete glucose meter, etc.) may, for example, be integrated into a separate controller that communicates with the assembly wirelessly. This embodiment may significantly improve usability of the system.


Thermocouples


In some aspects of the present disclosure, ambient temperature compensation is provided using a thermocouple temperature sensor. The thermocouple temperature sensors are included of dissimilar metals—e.g., metal-inks. Example metals may include, but are not limited to, gold, silver, carbon, titanium, and alloys thereof.


The physical properties of the dissimilar metals create a thermocouple temperature sensor at the junction of the dissimilar metals. A small voltage that is dependent on temperature will exist between the dissimilar metals. The voltage produced by a thermocouple is known and predictable based on the properties of the two dissimilar metals. Measurement of this voltage results in data that can be used to accurately determine the temperature of the analyte sensor (e.g., glucose sensor). For example, measurement of this small signal can be performed by the electronics located in the on-body unit—e.g., in the transmitter of the on-body unit.


For example, in certain embodiments, calibration can be done by applying two different voltages to a measurement circuit and computing the zero point and scale of the measurement circuit. This method may in some instances, include one or more benefits—e.g., cost, accuracy, and speed. For example, thermocouple sensors can be manufactured very inexpensively and may be conducive to high volume processing.


In certain embodiments, the thermocouple is created by depositing two different metals onto the analyte sensor tail and joining them at a junction located close to the actual sensing area. For example, the metals may be deposited onto the analyte sensor substrate by any variety of methods, such as, but not limited to, sputtering, electroplating, or using a metallic ink. In some instances, the thermocouple may be constructed using metal wire.


The two traces of different metals are electrically conducted (“bonded”) to form the junction. Having the junction adjacent to the actual sensor active area provides a temperature measurement close to the sensing area, resulting in an accurate measurement.


In certain embodiments, the thermocouple is formed on the same side of the analyte sensor as the sensing area (e.g., glucose sensing area). In other embodiments, the thermocouple is formed on the opposite side of the analyte sensor as the sensing area.



FIG. 13 illustrates a front-side view of an analyte sensor having thermocouple temperature sensor, according to certain embodiments. The analyte sensor 1400 shown is a glucose sensor having a glucose sensing area 1401 including three electrodes—e.g., working electrode, reference electrode, and counter electrode. Electrical traces 1402 extend from the electrodes in the sensing area 1401 to corresponding contact points 1402 for connection to the electronics in the on-body sensor.


Glucose sensor 1400 also includes two traces 1404, 1405. Trace 1404 and 1405 are made of dissimilar materials (e.g., different metals or metal-alloys) that extend from corresponding contact points 1407, 1408, respectively, to a junction point 1406 located next to the glucose sensing area 1401. Contact points 1407, 1408 provide electrical connection to the electronics on the on-body sensor for measurement of the voltage produced by the junction of dissimilar materials.


In the embodiment shown, the two traces 1404, 1405 of dissimilar materials are on the same side (e.g., front side) of the glucose sensor 1400, and further are on the same side of the sensor 1400 as the glucose sensing area 1401 and electrode traces 1402. While the distance between the junction point 1406 and the glucose sensing area 1401 may vary in different embodiments, having the junction point 1406 closer to the glucose sensing area 1401 provides a more accurate temperature estimate at the glucose sensing area 1401. Some space is needed to provide distance between the junction point 1406 and the glucose sensing area 1401 for insulation between the two.



FIG. 14 illustrates a back-side view of an analyte sensor having thermocouple temperature sensor, according to certain embodiments. The analyte sensor 1500 shown is a glucose sensor having a glucose sensing area 1501 including three electrodes—e.g., working electrode, reference electrode, and counter electrode. Electrical traces 1502 extend from the electrodes in the sensing area 1501 to corresponding contact points 1502 for connection to the electronics in the on-body sensor.


Glucose sensor 1500 also includes two traces 1504, 1505. Trace 1504 and 1505 are made of dissimilar materials (e.g., different metals or metal-alloys) that extend from corresponding contact points 1508, 1509, respectively, to a junction point 1506 located next to the glucose sensing area 1501. Contact points 1507, 1508 provide electrical connection to the electronics on the on-body sensor for measurement of the voltage produced by the junction of dissimilar materials.


In the embodiment shown, the two traces 1504,1505 of dissimilar materials are on the opposite side (e.g., back side) of the glucose sensor 1500 than the glucose sensing 1501 and electrode traces 1402 (e.g., on the front-side).


While the position of the junction point 1506 relative to the glucose sensing area 1501 may vary in different embodiments, having the junction point 1506 closer to the glucose sensing area 1501 provides a more accurate temperature estimate at the glucose sensing area 1501. In the embodiment shown, the junction point 1506 and the glucose sensing area 1501 are insulated from one another by the substrate itself, allowing the two traces 150 to extend further along the analyte sensor (e.g., directly opposite the glucose sensing area 1501).


It should be appreciated that in certain embodiments one of the two thermocouple traces could be made of the same material as the electrode traces. It should also be appreciated that in other embodiments one of the thermocouple traces may be on the opposite side of the sensor as the other thermocouple trace with a junction point near the glucose sensing area (e.g., implemented using a through-hole via).


In certain embodiments, the thermocouple sensor includes dissimilar metal traces on facing sides of two pieces of substrate (e.g., Kapton or another type of Polymer) that adhere together. In such case, the sensor is electrically isolated from the body as well as not crowding or disturbing the glucose sensing traces since the thermal sensing traces would be on a different plane. It should be appreciated that each of the dissimilar metals may be disposed on either inner facing side of the two pieces of substrate, independent of one another, such that a junction point is formed when the two pieces of substrate are combined. For example, one dissimilar metal may be one facing side while the other dissimilar metal is on the other facing side, and when the two facing sides are brought together, the two dissimilar metals forming a thermocouple junction point. This also applies to the other sensor concepts described herein as well.



FIG. 15 illustrates a system block diagram of an on-body sensor having a thermocouple temperature sensor, according to certain embodiments. On-body sensor 1600 includes a printed circuit board (PCB) 1601 having various electronic components thereon, including, for example, the analog front-end circuitry 1602. The thermocouple traces 1602 on the analyte sensor terminate on the PCB 1601 at contact points 1603 that are electrically coupled to non-thermocouple traces 1604 disposed on the PCB 1601. The non-thermocouple traces 1604 electrically couple the thermocouple traces 1602 to the analog front-end circuitry 1602 for measuring the voltage providing by the thermocouple.


In certain embodiments, such as shown, an ambient temperature sensor 1605 generates a signal that is used for “cold junction temperature” compensation in the system. In some instances, the “cold junction” temperature sensor 1605 is positioned at the point that the dissimilar metal traces 1602 are connected to the PCB 1601 in the on-body device. The voltage that is measured at the cold junction is a function of the temperature differential between the cold junction and the bonding point.


Thermocouple tape having two dissimilar metals is described in U.S. Pat. No. 3,729,343, filed on Jan. 8, 1971 and issued on Apr. 24, 1973, the entirety of which is hereby incorporated by reference.


In some aspects of the present disclosure, an analyte sensor is provided having a sensor substrate that includes two dissimilar materials on opposite sides with a thermocouple junction formed by a through-hole within the substrate.


In certain embodiments, a metal (or metal-alloy) trace is disposed on one side of the sensor substrate and a thermocouple trace (e.g., a conductive ink layer) on the opposite side of the substrate. A thermocouple junction is formed between the metal trace on one side and the conductive ink layer on the opposite side by a through-hole (e.g., a laser-drilled hole in the substrate). The conductive ink is disposed in the through-hole and forms a thermocouple junction between the metal trace on one side of the substrate and the conductive ink on the opposite side of the substrate. The conductive ink material may be made from any variety of materials suitable for creating a thermocouple junction—such as metal or metal alloys including, but not limited to, platinum, carbon, copper, iron, silver, etc.


In some aspects of the present disclosure, methods of making the above-mentioned thermocouple are provided. The methods include forming a metal or metal-alloy layer (e.g., a film plated with the metal or metal-alloy) on a sensor substrate; removing a portion of the metal or metal-alloy layer (e.g., by forming a laser-drilled hole); forming a conductive ink layer (e.g., a conductive ink trace) on the opposite side of the substrate as the metal or metal-ally layer; filling the through-hole with the conductive ink such that a thermocouple junction is formed between the conductive ink layer and the metal layer.


In certain embodiments, the metal or metal-alloy layer is also a sensor electrode. It should be appreciated that the conductive ink may be applied to the sensor substrate at various times. For example, in certain embodiments, the conductive ink layer may be applied before the through-hole is formed and again applied afterwards to fill the through-hole. In other embodiments, the conductive ink is applied after the through-hole to form the conductive ink layer and fill the through-hole.



FIG. 16 illustrates a cross-sectional view of an analyte sensor substrate having a thermocouple junction, according to certain embodiments. The sensor substrate 1701 includes a layer of gold 1702 on one side of the substrate 1701. A through-hole 1703 is formed (e.g., via laser drilling) in the sensor substrate 1701 such that a portion of the layer of gold 1702 is removed. It should be appreciated that in other embodiments, the portion of the layer of gold 1702 at the through-hole may be removed before the laser drilled through-hole is formed—e.g., via an etching process, etc.—or otherwise disposed on the substrate 1701 in a printed pattern.


As shown in FIG. 16, a conductive ink layer 1704 is disposed on the opposite side of the sensor substrate 1701 as the layer of gold 1702. The through-hole 1703 is filled with the conductive ink such that the conductive ink layer 1703 and layer of gold 1703 are connected and a thermocouple junction formed.


Provided below is an example analysis. It should be appreciated that the example analysis is exemplary and is not meant to be limiting.


Example Analysis:


The following analysis is provided for exemplary purposes and is not meant to be limiting. The following analysis is based on the following: a sensor temperature range of 32 degrees C. to 42 degrees C. (typical body temperature of 37 degrees C.+/−5 degrees C.); a cold junction temperature range of 10 degrees C. to 50 degrees C.; thermocouple op amp similar to operation amplifier, OPA333, manufactured by Texas Instruments; an analog to digital converter (ADC) with a resolution less than 0.1 degrees C. and input voltage range of 0 to 400 mV; a modulator clock of 32768 Hz and conversion time of 125 mS (12 Bits); thermocouple sensitivity of 40.7 μV/degrees C. (e.g., type T Cu-Cn).


The analysis was also based on the OPA333 operation amplifier having the following features: low offset voltage of 10 μV(max); zero drift of 0.05 μV/° C. (max); 0.01 Hz to 10 Hz noise of 1.1 μVpp; quiescent current of 17 μA; single-supply operation; supply voltage of 1.8V to 5.5V; rail-to-rail input/output; and microsize packages (SC70 and SOT23).


The results of the analysis were as follows: ADC 1 bit resolution=97.65 μV (12 bits—range of 400 mV); required minimum gain for thermocouple amplifier=2.4; maximum amplifier offset at ADC=24 μV (this is <1ADC count.); and type-T thermocouple output at 25.2C=1.000 mV. Any calibration for the ADC slope and offset variation may be done by applying a known voltage during manufacture, for example.


The actual gain may be chosen much higher than minimum. The signal as seen by the thermocouple amplifier is the combination of the cold junction thermocouple and the sensor tip thermocouple. Exact calculations depend on the Seebeck voltage of the materials chosen.


In some instances, the cold junction thermocouple may vary in a temperature range that is higher than the sensor tip thermocouple and also lower than the sensor tip thermocouple. In such case, provided the cold junction temperature is known and sensitivity of the cold junction TC is known, a subtraction can be made that eliminates the cold junction contribution.


In some instances, the method for cold junction compensation uses a precision thermistor and requires no calibration.


In certain embodiments, one of the existing sensor electrode conductors is used as one of the thermocouple connections. Having a thermocouple output that is a differential voltage allows the sensor electrode conductor to be used and avoid using two additional connections to the sensor.


In some instances, carbon-polymer contacts are used with a thermocouple amplifier having high impedance input (non-inverting). This method helps avoid some thermal gradient issue and provides a more direct sensor temperature measurement.


Types of Temperature Sensors:


It should be appreciated that any variety of temperature sensors may be applicable to the subject matter of the present disclosure. The following temperature sensors are exemplary and are not intended to be limiting.


Thermistor:


In some aspects of the present disclosure, a thermistor sensor may be used for temperature compensation. The thermistor sensor may be disposed, for example, on a sensor tail that is positioned under the skin or near the tip of the analyte sensor. Example thermistors that may be implemented include, but are not limited to, surface mounted thermistors of type 0402, 0201, or 0105. Other example may include, but are not limited to, glass beads types, epoxy bead types, or small chip thermistors.


In some aspects of the present disclosure, the thermistor sensor is located in a thermally conductive structure such that it protrudes from the bottom of the skin worn transmitter device and provides a low thermal resistance path from the user's skin to a thermistor located in the electronics.



FIG. 17 illustrates an on-body sensor having a thermistor located in a thermally conductive structure such that it protrudes from the bottom of the on-body sensor, according to certain embodiments. On-body sensor 1800 is shown attached to a patient's skin surface 1801. The on-body sensor 1800 includes a thermistor 1802 that is disposed within a thermally conductive material 1803. The thermistor 1802 is electrically coupled to the on-body sensor's printed circuit board (PCB) 1804 for electrical coupling to the electronics on the PCB. The on-body sensor 1800 includes an adhesive layer 1805 that mounts the on body sensor 1800 to the patient's skin 1801. The thermally conductive material 1803 including the thermistor 1802 extends beyond the adhesive layer 1805 and protrudes from the on-body sensor 1800. The thermally conductive material 1803 contacts the skin 1801 of the patient to provide temperature measurement of the patient's skin 1801.


Resistive Temperature Device:


In some aspects of the present disclosure, a resistive temperature device (RTD) type sensor may be used for temperature compensation. For example, an RTD type sensor may be constructed from traces of metal (e.g., including, but not limited to, metals such as gold or platinum, or metal-alloys thereof) and deposited onto the sensor substrate. For instance, an RTD device such as a wire wound encapsulated device may be incorporated onto the sensor tail. The RTD device may then measure by the sensor electronics.


Pyro-Electric Sensor:


In some aspects of the present disclosure, a pyro-electric sensor may be used for temperature compensation. Pyro-electric sensors are sensitive to the infra-red light emitted by a warm object—e.g., the patients skin. In certain embodiments, an optical path is constructed from the patient's skin surface to the pyro-electric sensor that is located inside the electronics of the on-body unit. In this way, the skin surface temperature can be sensed and measured.


Semiconductor Sensor:


In some aspects of the present disclosure, a semiconductor sensor may be used for temperature compensation. In certain embodiments, a semiconductor sensor (such as, but not limited to, a diode junction or band gap type temperature sensor) is disposed (e.g., directly or disposed on a small device) either on the sensor tail or very close to the sensor insertion site to sense the glucose sensor temperature.


Temperature Compensation and Sensing Elements:


In some aspects of the present disclosure, analyte monitoring devices and systems include a sensing area that includes two or more sensing elements disposed on the sensing surface. For example, the sensing surface may be on a working electrode. Additional details regarding multiple sensing elements disposed on a sensing surface may be found in U.S. Provisional Patent Application No. 61/421,371, filed Dec. 9, 2010, the entirety of which is incorporated herein by reference.


In certain embodiments, more than one sensing element is disposed at the sensing area (e.g., sensor tip). As demonstrated above, temperature compensation may be performed when multiple sensing elements are at the sensor tip. Furthermore, it has been shown that very small sensing layer areas improve repeatability of the sensor sensitivity. Further, multiple sensing dots may promote the collection of sufficient current for generating a viable signal.


In certain embodiments, on-body sensors are provided having multiple sensing elements at the sensing area, wherein some of the sensing elements are made of a different material than other sensing elements. For example, some of the sensing elements are made of a first material and the other sensing elements are made of a second material. The different materials have different temperature responses. Thus, current from the sensing elements of one material may be collected and compared to the current from the sensing elements of the second material to determine the temperature at the sensor tip. In this way, a temperature measurement is performed almost directly at the sensor tip.



FIG. 18 illustrates a top view of multiple sensing elements disposed on a sensing surface, according to certain embodiments. Sensing surface 1900 is shown including sensing elements A and sensing elements B. Sensing elements A are made of a first material and sensing elements B are made from a different material than sensing elements A. The different materials (e.g., sensing chemistries) have different temperature dependencies and thus different temperature responses. Current from sensing elements A are compared to current from sensing elements B to determine the temperature at the sensor tip. In this way, a temperature measurement is performed almost directly at the sensor tip.


It should be appreciated that the number of sensing elements may vary in different embodiments. Further, it should also be appreciated that the sensing elements may be disposed on the sensing surface in a variety of shapes and patterns, and should not be limited to the embodiment shown in FIG. 18.


Temperature Compensation and Electrodes with Different Chemistries


In some aspects of the present disclosure, temperature compensation is performed when multiple working electrodes having different chemistries are present. For example, in some instances, an OBU may include a double sensor having different enzymes. For example, an on-body sensor may include two working electrodes having different sensing chemistries on each electrode. Because the sensing chemistry is different, their temperature dependencies are different. However, in a limited temperature range, the functional dependence is the same. Sensor current may be determined by, for example:

I˜(1+a){circumflex over ( )}(T−Tnom)


where I is the sensor current, a is a known positive constant much less than unity, and Tnom is a set temperature. The sensor current also depends on the surface area, the amount of sensing material, and efficiency of the sensing chemistry and diffusion controlling membrane—collectively referred to herein as factor A. The ratio of the sensor currents is:








I
1


I
2


=




A
1

(

I
+

a
1


)


(

T
-

T
nom


)





A
2

(

I
+

a
2


)


(

T
-

T
nom


)







Solving for T:






T
=


T
nom

+



ln

(


I
1

/

I
2


)

-

ln

(


A
1

/

A
2


)



ln

(


I
+

a
1



I
+

a
2



)







All of the quantities on the rights side of the equation are, in principle, known. If A1 is set equal to A2, then I1=I2 when T=Tnom.


Once T is calculated, the sensor current is compensated for temperature and the analyte level calculated.


Temperature Compensation Using a Known Reservoir


In some aspects of the present disclosure, a secondary sensing element is used to directly measure the effect of temperature on the chemistry, independent of the user's analyte level (e.g., blood glucose). This measurement data is used in conjunction with measurement data from the primary sensor, which is dependent on temperature and the user's blood glucose, to remove the temperature effect. In this way, a more accurate estimate of the user's blood glucose concentration may be achieved. Moreover, temperature variation may be automatically compensated without implementing the mathematical model used in the some of the two sensor models described above, and instead use the chemistry to compensate itself.


In certain embodiments, an on-body sensor includes a secondary sensing element and a known volume of glucose at a known concentration (e.g., as provided by a “reservoir”). Having a secondary sensing element and a known volume of glucose at a known concentration (e.g., as provided by a “reservoir”) enables temperature variation to be “cancelled out” without having to model the actual temperature variation of the chemistry. The secondary sensing element may be disposed under the skin, for example, and the secondary dot and reservoir isolated from the rest of the system. In some instances, the reservoir is physically small, but lasts for the entire sensor life.


In certain embodiments, this type of thermometer may be operated in two ways; in the linear range, and in saturation. In the linear range, the current is a function of the glucose concentration and the temperature. The glucose concentration as a function of time is calculated by keeping track of the total charge collected. This yields the expected current at the nominal temperature. Any difference between the expected current and the actual current may be attributed to temperature variation. In certain embodiments, a membrane is disposed between the sensing element and the reservoir for operation in the linear range.


In saturation, the current is determined solely by enzyme activity. Since this is a function of temperature, temperature variation may be measured directly. When operating in saturation, the membrane may be thinner, even if glucose concentrations should need to remain high.


In certain embodiments, the reservoir is kept away from the sensing element until the sensor has started, whether operating in either the linear range or saturation. In this way, any time limit to the stability of the sensing layer in a wet environment is accounted for. For example, a temporary barrier may be implemented that ceases to separate the second sensing area and the reservoir when the analyte sensor is transcutaneously positioned—e.g., a barrier that is broken, dissolved, or otherwise removed upon the insertion process.


In certain embodiments, the secondary sensor signal is an analog signal which controls the gain of the primary sensor circuit. The gain control may be linear since the secondary signal itself contains the complex non-linear variation that may be more difficult to model.


In certain embodiments, the secondary sensor signal is sampled and the primary signal gain modified in a software algorithm. The software algorithm may be executed by a processing device in the on-body electronics for example. The gain control may be linear since the secondary signal itself contains the complex non-linear variation that may be more difficult to model.


Provided below are example analyses related to using a known reservoir. The example analyses are exemplary and are not meant to be limiting.


Example 1

A sensing dot with an area of 0.01 square millimeter ( 1/10 the area of the primary sensing dot), and a cubical reservoir of side length 0.5 millimeters filled with 10 millimolar glucose solution starts with a current of 6 nA, and finishes with a current of 0.6 nA.


Example 2





    • a=6.02×1023 molecules/mole

    • q=1.6×10−19 C/molecules

    • T−122 hours=439,200 seconds (sensor life)

    • β=6 nA/(mM/Liter)/mm2=6 (A/meter2)(1/(M/Liter))=10−23 (A/meter2)(1/molecule)(Liter)=10−26 (Amp)(m)/molecule





Example 3





    • Time Evolution of Glucose Concentration

    • N=# of molecules in reservoir

    • dN/dt=−αI

    • α=molecules/(Amp×sec)=molecules/c=1/q

    • n=#molecules/m3 concentration

    • V=reservoir volume

    • dn/dt=−I/(qV)

    • I=βAn

    • A=m2 area of sensing dot

    • dn/dt=−βAn/(qV)

    • n(t)=no exp(−βAn/(qV))=no exp (−6.25×10−8 At/V)





Example 4





    • Time Constant vs Sensor Life:

    • 6.25×10−8 (AT)/V≈2

    • A=10-8 m2

    • T=4.4×105 s

    • V≈1.4×10-10 m3

    • Cube: 0.5 mm on a side





Maximum and Minimum Concentrations and Currents

    • β=0.6 nA/(mM/Liter)
    • Maximum current Io=6 nA
    • Maximum concentration no=10 mM/L
    • After 5 days (and 2 time constants) If≈0.6 nA


It should be understood that techniques introduced above can be implemented by programmable circuitry programmed or configured by software and/or firmware, or they can be implemented entirely by special-purpose “hardwired” circuitry, or in a combination of such forms. Such special-purpose circuitry (if any) can be in the form of, for example, one or more application-specific integrated circuits (ASICS), programmable logic devices (PLDs), field-programmable gate arrays (FPGAs), etc.


Software or firmware implementing the techniques introduced herein may be stored on a machine-readable storage medium and may be executed by one or more general-purpose or special-purpose programmable microprocessors. A “machine-readable medium”, as the term is used herein, includes any mechanism that can store information in a form accessible by a machine (a machine may be, for example, a computer, network device, cellular phone, personal digital assistant (PDA), manufacturing took, any device with one or more processors, etc.). For example, a machine-accessible medium includes recordable/non-recordable media (e.g., read-only memory (ROM); random access memory (RAM); magnetic disk storage media; optical storage media; flash memory devices; etc.), etc.


The term “logic”, as used herein, can include, for example, special purpose hardwired circuitry, software and/or firmware in conjunction with programmable circuitry, or a combination thereof.


Electrochemical Sensors


Embodiments of the present disclosure relate to methods and devices for detecting at least one analyte, including glucose, in body fluid. Embodiments relate to the continuous and/or automatic in vivo monitoring of the level of one or more analytes using a continuous analyte monitoring system that includes an analyte sensor at least a portion of which is to be positioned beneath a skin surface of a user for a period of time and/or the discrete monitoring of one or more analytes using an in vitro blood glucose (“BG”) meter and an analyte test strip. Embodiments include combined or combinable devices, systems and methods and/or transferring data between an in vivo continuous system and an in vivo system. In certain embodiments, the systems, or at least a portion of the systems, are integrated into a single unit.


An analyte sensor as described herein may be an in vivo analyte sensor or an in vitro sensor (i.e., a discrete monitoring test strip). Such a sensor can be formed on a substrate, e.g., a substantially planar substrate. In certain embodiments, the sensor is a wire, e.g., a working electrode wire inner portion with one or more other electrodes associated (e.g., on, including wrapped around) therewith. The sensor may also include at least one counter electrode (or counter/reference electrode) and/or at least one reference electrode or at least one reference/counter electrode.


Accordingly, embodiments include analyte monitoring devices and systems that include an analyte sensor at least a portion of which is positionable beneath the skin surface of the user for the in vivo detection of an analyte, including glucose, lactate, ketones, and the like, in a body fluid. Embodiments include wholly implantable analyte sensors and analyte sensors in which only a portion of the sensor is positioned under the skin and a portion of the sensor resides above the skin, e.g., for contact to a sensor control unit (which may include a transmitter), a receiver/display unit, transceiver, processor, etc. The sensor may be, for example, subcutaneously positionable in a user for the continuous or periodic monitoring of a level of an analyte in the user's interstitial fluid. For the purposes of this description, continuous monitoring and periodic monitoring will be used interchangeably, unless noted otherwise. The sensor response may be correlated and/or converted to analyte levels in blood or other fluids. In certain embodiments, an analyte sensor may be positioned in contact with interstitial fluid to detect the level of glucose, which detected glucose may be used to infer the glucose level in the user's bloodstream. Analyte sensors may be insertable into a vein, artery, or other portion of the body containing fluid. Embodiments of the analyte sensors may be configured for monitoring the level of the analyte over a time period which may range from seconds, minutes, hours, days, weeks, to months, or longer.


In certain embodiments, the analyte sensors, such as glucose sensors, are capable of in vivo detection of an analyte for one hour or more, e.g., a few hours or more, e.g., a few days or more, e.g., three or more days, e.g., five days or more, e.g., seven days or more, e.g., several weeks or more, or one month or more. Future analyte levels may be predicted based on information obtained, e.g., the current analyte level at time to, the rate of change of the analyte, etc. Predictive alarms may notify the user of a predicted analyte level that may be of concern in advance of the user's analyte level reaching the future predicted analyte level. This provides the user an opportunity to take corrective action.



FIG. 1 shows a data monitoring and management system such as, for example, an analyte (e.g., glucose) monitoring system 100 in accordance with certain embodiments. Aspects of the subject disclosure are further described primarily with respect to glucose monitoring devices and systems, and methods of glucose detection, for convenience only and such description is in no way intended to limit the scope of the embodiments. It is to be understood that the analyte monitoring system may be configured to monitor a variety of analytes at the same time or at different times.


Analytes that may be monitored include, but are not limited to, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, glycosylated hemoglobin (HbA1c), creatine kinase (e.g., CK-MB), creatine, creatinine, DNA, fructosamine, glucose, glucose derivatives, glutamine, growth hormones, hormones, ketones, ketone bodies, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. In embodiments that monitor more than one analyte, the analytes may be monitored at the same or different times.


The analyte monitoring system 100 includes an analyte sensor 101, a data processing unit 102 connectable to the sensor 101, and a primary receiver unit 104. In some instances, the primary receiver unit 104 is configured to communicate with the data processing unit 102 via a communication link 103. In certain embodiments, the primary receiver unit 104 may be further configured to transmit data to a data processing terminal 105 to evaluate or otherwise process or format data received by the primary receiver unit 104. The data processing terminal 105 may be configured to receive data directly from the data processing unit 102 via a communication link 107, which may optionally be configured for bi-directional communication. Further, the data processing unit 102 may include a transmitter or a transceiver to transmit and/or receive data to and/or from the primary receiver unit 104 and/or the data processing terminal 105 and/or optionally a secondary receiver unit 106.


Also shown in FIG. 1 is an optional secondary receiver unit 106 which is operatively coupled to the communication link 103 and configured to receive data transmitted from the data processing unit 102. The secondary receiver unit 106 may be configured to communicate with the primary receiver unit 104, as well as the data processing terminal 105. In certain embodiments, the secondary receiver unit 106 may be configured for bi-directional wireless communication with each of the primary receiver unit 104 and the data processing terminal 105. As discussed in further detail below, in some instances, the secondary receiver unit 106 may be a de-featured receiver as compared to the primary receiver unit 104, for instance, the secondary receiver unit 106 may include a limited or minimal number of functions and features as compared with the primary receiver unit 104. As such, the secondary receiver unit 106 may include a smaller (in one or more, including all, dimensions), compact housing or embodied in a device including a wrist watch, arm band, PDA, mp3 player, cell phone, etc., for example. Alternatively, the secondary receiver unit 106 may be configured with the same or substantially similar functions and features as the primary receiver unit 104. The secondary receiver unit 106 may include a docking portion configured to mate with a docking cradle unit for placement by, e.g., the bedside for night time monitoring, and/or a bi-directional communication device. A docking cradle may recharge a power supply.


Only one analyte sensor 101, data processing unit 102 and data processing terminal 105 are shown in the embodiment of the analyte monitoring system 100 illustrated in FIG. 1. However, it will be appreciated by one of ordinary skill in the art that the analyte monitoring system 100 may include more than one sensor 101 and/or more than one data processing unit 102, and/or more than one data processing terminal 105. Multiple sensors may be positioned in a user for analyte monitoring at the same or different times. In certain embodiments, analyte information obtained by a first sensor positioned in a user may be employed as a comparison to analyte information obtained by a second sensor. This may be useful to confirm or validate analyte information obtained from one or both of the sensors. Such redundancy may be useful if analyte information is contemplated in critical therapy-related decisions. In certain embodiments, a first sensor may be used to calibrate a second sensor.


The analyte monitoring system 100 may be a continuous monitoring system, or semi-continuous, or a discrete monitoring system. In a multi-component environment, each component may be configured to be uniquely identified by one or more of the other components in the system so that communication conflict may be readily resolved between the various components within the analyte monitoring system 100. For example, unique IDs, communication channels, and the like, may be used.


In certain embodiments, the sensor 101 is physically positioned in or on the body of a user whose analyte level is being monitored. The sensor 101 may be configured to at least periodically sample the analyte level of the user and convert the sampled analyte level into a corresponding signal for transmission by the data processing unit 102. The data processing unit 102 is coupleable to the sensor 101 so that both devices are positioned in or on the user's body, with at least a portion of the analyte sensor 101 positioned transcutaneously. The data processing unit may include a fixation element, such as an adhesive or the like, to secure it to the user's body. A mount (not shown) attachable to the user and mateable with the data processing unit 102 may be used. For example, a mount may include an adhesive surface. The data processing unit 102 performs data processing functions, where such functions may include, but are not limited to, filtering and encoding of data signals, each of which corresponds to a sampled analyte level of the user, for transmission to the primary receiver unit 104 via the communication link 103. In certain embodiments, the sensor 101 or the data processing unit 102 or a combined sensor/data processing unit may be wholly implantable under the skin surface of the user.


In certain embodiments, the primary receiver unit 104 may include an analog interface section including an RF receiver and an antenna that is configured to communicate with the data processing unit 102 via the communication link 103, and a data processing section for processing the received data from the data processing unit 102 including data decoding, error detection and correction, data clock generation, data bit recovery, etc., or any combination thereof.


In operation, the primary receiver unit 104 in certain embodiments is configured to synchronize with the data processing unit 102 to uniquely identify the data processing unit 102, based on, for example, an identification information of the data processing unit 102, and thereafter, to periodically receive signals transmitted from the data processing unit 102 associated with the monitored analyte levels detected by the sensor 101.


Referring again to FIG. 1, the data processing terminal 105 may include a personal computer, a portable computer including a laptop or a handheld device (e.g., a personal digital assistant (PDA), a telephone including a cellular phone (e.g., a multimedia and Internet-enabled mobile phone including an iPhone™, a Blackberry®, or similar phone), an mp3 player (e.g., an iPOD™, etc.), a pager, and the like), and/or a drug delivery device (e.g., an infusion device), each of which may be configured for data communication with the receiver via a wired or a wireless connection. Additionally, the data processing terminal 105 may further be connected to a data network (not shown) for storing, retrieving, updating, and/or analyzing data corresponding to the detected analyte level of the user.


The data processing terminal 105 may include a drug delivery device (e.g., an infusion device), such as an insulin infusion pump or the like, which may be configured to administer a drug (e.g., insulin) to the user, and which may be configured to communicate with the primary receiver unit 104 for receiving, among others, the measured analyte level. Alternatively, the primary receiver unit 104 may be configured to integrate an infusion device therein so that the primary receiver unit 104 is configured to administer an appropriate drug (e.g., insulin) to users, for example, for administering and modifying basal profiles, as well as for determining appropriate boluses for administration based on, among others, the detected analyte levels received from the data processing unit 102. An infusion device may be an external device or an internal device, such as a device wholly implantable in a user.


In certain embodiments, the data processing terminal 105, which may include an infusion device, e.g., an insulin pump, may be configured to receive the analyte signals from the data processing unit 102, and thus, incorporate the functions of the primary receiver unit 104 including data processing for managing the user's insulin therapy and analyte monitoring. In certain embodiments, the communication link 103, as well as one or more of the other communication interfaces shown in FIG. 1, may use one or more wireless communication protocols, such as, but not limited to: an RF communication protocol, an infrared communication protocol, a Bluetooth enabled communication protocol, an 802.11x wireless communication protocol, or an equivalent wireless communication protocol which would allow secure, wireless communication of several units (for example, per Health Insurance Portability and Accountability Act (HIPPA) requirements), while avoiding potential data collision and interference.



FIG. 2 shows a block diagram of an embodiment of a data processing unit 102 of the analyte monitoring system shown in FIG. 1. User input and/or interface components may be included or a data processing unit may be free of user input and/or interface components. In certain embodiments, one or more application-specific integrated circuits (ASIC) may be used to implement one or more functions or routines associated with the operations of the data processing unit (and/or receiver unit) using for example one or more state machines and buffers.


As can be seen in the embodiment of FIG. 2, the analyte sensor 101 (FIG. 1) includes four contacts, three of which are electrodes: a work electrode (W) 210, a reference electrode (R) 212, and a counter electrode (C) 213, each operatively coupled to the analog interface 201 of the data processing unit 102. This embodiment also shows an optional guard contact (G) 211. Fewer or greater electrodes may be employed. For example, the counter and reference electrode functions may be served by a single counter/reference electrode. In some cases, there may be more than one working electrode and/or reference electrode and/or counter electrode, etc.



FIG. 3 is a block diagram of an embodiment of a receiver/monitor unit such as the primary receiver unit 104 of the analyte monitoring system shown in FIG. 1. The primary receiver unit 104 includes one or more of: a test strip interface 301, an RF receiver 302, a user input 303, an optional temperature detection section 304, and a clock 305, each of which is operatively coupled to a processing and storage section 307. The primary receiver unit 104 also includes a power supply 306 operatively coupled to a power conversion and monitoring section 308. Further, the power conversion and monitoring section 308 is also coupled to the processing and storage section 307. Moreover, also shown are a receiver serial communication section 309, and an output 310, each operatively coupled to the processing and storage section 307. The primary receiver unit 104 may include user input and/or interface components or may be free of user input and/or interface components.


In certain embodiments, the test strip interface 301 includes an analyte testing portion (e.g., a glucose level testing portion) to receive a blood (or other body fluid sample) analyte test or information related thereto. For example, the test strip interface 301 may include a test strip port to receive a test strip (e.g., a glucose test strip). The device may determine the analyte level of the test strip, and optionally display (or otherwise notice) the analyte level on the output 310 of the primary receiver unit 104. Any suitable test strip may be employed, e.g., test strips that only require a very small amount (e.g., 3 microliters or less, e.g., 1 microliter or less, e.g., 0.5 microliters or less, e.g., 0.1 microliters or less), of applied sample to the strip in order to obtain accurate glucose information. Embodiments of test strips include, e.g., FreeStyle® or Precision® blood glucose test strips from Abbott Diabetes Care Inc. (Alameda, Calif.). Glucose information obtained by an in vitro glucose testing device may be used for a variety of purposes, computations, etc. For example, the information may be used to calibrate sensor 101, confirm results of sensor 101 to increase the confidence thereof (e.g., in instances in which information obtained by sensor 101 is employed in therapy related decisions), etc.


In further embodiments, the data processing unit 102 and/or the primary receiver unit 104 and/or the secondary receiver unit 106, and/or the data processing terminal/infusion device 105 may be configured to receive the analyte value wirelessly over a communication link from, for example, a blood glucose meter. In further embodiments, a user manipulating or using the analyte monitoring system 100 (FIG. 1) may manually input the analyte value using, for example, a user interface (for example, a keyboard, keypad, voice commands, and the like) incorporated in one or more of the data processing unit 102, the primary receiver unit 104, secondary receiver unit 106, or the data processing terminal/infusion device 105.


Additional detailed descriptions of exemplary sensors are provided in U.S. Pat. Nos. 5,262,035; 5,264,104; 5,262,305; 5,320,715; 5,593,852; 6,175,752; 6,650,471; 6,746,582, and 7,811,231, each of which is incorporated herein by reference in their entirety.



FIG. 4 schematically shows an embodiment of an analyte sensor 400 in accordance with the embodiments of the present disclosure. This sensor embodiment includes electrodes 401, 402 and 403 on a base 404. Electrodes (and/or other features) may be applied or otherwise processed using any suitable technology, e.g., chemical vapor deposition (CVD), physical vapor deposition, sputtering, reactive sputtering, printing, coating, ablating (e.g., laser ablation), painting, dip coating, etching, and the like. Materials include, but are not limited to, any one or more of aluminum, carbon (including graphite), cobalt, copper, gallium, gold, indium, iridium, iron, lead, magnesium, mercury (as an amalgam), nickel, niobium, osmium, palladium, platinum, rhenium, rhodium, selenium, silicon (e.g., doped polycrystalline silicon), silver, tantalum, tin, titanium, tungsten, uranium, vanadium, zinc, zirconium, mixtures thereof, and alloys, oxides, or metallic compounds of these elements.


The analyte sensor 400 may be wholly implantable in a user or may be configured so that only a portion is positioned within (internal) a user and another portion outside (external) a user. For example, the sensor 400 may include a first portion positionable above a surface of the skin 410, and a second portion positioned below the surface of the skin. In such embodiments, the external portion may include contacts (connected to respective electrodes of the second portion by traces) to connect to another device also external to the user such as a transmitter unit. While the embodiment of FIG. 4 shows three electrodes side-by-side on the same surface of base 404, other configurations are contemplated, e.g., fewer or greater electrodes, some or all electrodes on different surfaces of the base or present on another base, some or all electrodes stacked together, electrodes of differing materials and dimensions, etc.


The substrate may be formed using a variety of non-conducting materials, including, for example, polymeric or plastic materials and ceramic materials. Suitable materials for a particular sensor may be determined, at least in part, based on the desired use of the sensor and properties of the materials.


In certain embodiments, the substrate is flexible. For example, if the sensor is configured for implantation into a user, then the sensor may be made flexible (although rigid sensors may also be used for implantable sensors) to reduce pain to the user and damage to the tissue caused by the implantation of and/or the wearing of the sensor. A flexible substrate often increases the user's comfort and allows a wider range of activities. Suitable materials for a flexible substrate include, for example, non-conducting plastic or polymeric materials and other non-conducting, flexible, deformable materials. Examples of useful plastic or polymeric materials include thermoplastics such as polycarbonates, polyesters (e.g., polyethylene terephthalate (PET)), polyvinyl chloride (PVC), polyurethanes, polyethers, polyamides, polyimides, or copolymers of these thermoplastics, such as PETG (glycol-modified polyethylene terephthalate).


In other embodiments, the sensors are made using a relatively rigid substrate to, for example, provide structural support against bending or breaking. Examples of rigid materials that may be used as the substrate include poorly conducting ceramics, such as aluminum oxide and silicon dioxide. An implantable sensor having a rigid substrate may have a sharp point and/or a sharp edge to aid in implantation of a sensor without an additional insertion device.


It will be appreciated that for many sensors and sensor applications, both rigid and flexible sensors will operate adequately. The flexibility of the sensor may also be controlled and varied along a continuum by changing, for example, the composition and/or thickness of the substrate.


In addition to considerations regarding flexibility, it is often desirable that implantable sensors should have a substrate which is physiologically harmless, for example, a substrate approved by a regulatory agency or private institution for in vivo use.


The sensor may include optional features to facilitate insertion of an implantable sensor. For example, the sensor may be pointed at the tip to ease insertion. In addition, the sensor may include a barb which assists in anchoring the sensor within the tissue of the user during operation of the sensor. However, the barb may be small enough so that little damage is caused to the subcutaneous tissue when the sensor is removed for replacement.


Electronics Unit


A sensor electronics unit such as a sensor control unit can be integrated in the sensor, part or all of which is subcutaneously implanted or it can be configured to be placed on the skin of a user. The sensor control unit is optionally formed in a shape that is comfortable to the user and which may permit concealment, for example, under a user's clothing. The thigh, leg, upper arm, shoulder, or abdomen are convenient parts of the user's body for placement of the sensor control unit to maintain concealment. However, the sensor control unit may be positioned on other portions of the user's body. Certain embodiments of the sensor control unit has a thin, oval shape to enhance concealment. However, other shapes and sizes may be used.


The particular profile, as well as the height, width, length, weight, and volume of the sensor control unit may vary and depends, at least in part, on the components and associated functions included in the sensor control unit. In general, the sensor control unit includes a housing may be formed as a single integral unit that rests on the skin of the user. The housing may contain most or all of the electronic components of the sensor control unit.


The housing of the sensor control unit may be formed using a variety of materials, including, for example, plastic and polymeric materials, such as rigid thermoplastics and engineering thermoplastics. Suitable materials include, for example, polyvinyl chloride, polyethylene, polypropylene, polystyrene, ABS polymers, and copolymers thereof. The housing of the sensor control unit may be formed using a variety of techniques including, for example, injection molding, compression molding, casting, and other molding methods. Hollow or recessed regions may be formed in the housing of the sensor control unit. The electronic components of the sensor control unit and/or other items, including a battery or a speaker for an audible alarm, may be placed in the hollow or recessed areas.


The sensor control unit may be attached to the skin of the user, for example, by adhering the sensor control unit directly to the skin of the user with an adhesive provided on at least a portion of the housing of the sensor control unit which contacts the skin or by suturing the sensor control unit to the skin through suture openings in the sensor control unit.


When positioned on the skin of a user, the sensor and the electronic components within the sensor control unit are coupled via conductive contacts. The one or more working electrodes, counter electrode (or counter/reference electrode), optional reference electrode, and optional temperature probe are attached to individual conductive contacts. For example, the conductive contacts are provided on the interior of the sensor control unit. Other embodiments of the sensor control unit have the conductive contacts disposed on the exterior of the housing. The placement of the conductive contacts is such that they are in contact with the contact pads on the sensor when the sensor is properly positioned within the sensor control unit.


Sensor Electronics


The sensor electronics also may include at least a portion of the electronic components that operate the sensor and the analyte monitoring device system. The electronic components of the sensor control unit may include a power supply for operating the sensor control unit and the sensor, a sensor circuit for obtaining signals from and operating the sensor, a measurement circuit that converts sensor signals to a desired format, and a processing circuit that, at minimum, obtains signals from the sensor circuit and/or measurement circuit and provides the signals to an optional transmitter. In certain embodiments, the processing circuit may also partially or completely evaluate the signals from the sensor and convey the resulting data to the optional transmitter and/or activate an optional alarm system if the analyte level exceeds a threshold. The processing circuit often includes digital logic circuitry.


The sensor control unit may optionally contain a transmitter for transmitting the sensor signals or processed data from the processing circuit to a receiver/display unit; a data storage unit for temporarily or permanently storing data from the processing circuit; a temperature probe circuit for receiving signals from and operating a temperature probe; a reference voltage generator for providing a reference voltage for comparison with sensor-generated signals; and/or a watchdog circuit that monitors the operation of the electronic components in the sensor control unit.


Moreover, the sensor control unit may also include digital and/or analog components utilizing semiconductor devices, including transistors. To operate these semiconductor devices, the sensor control unit may include other components including, for example, a bias control generator to correctly bias analog and digital semiconductor devices, an oscillator to provide a clock signal, and a digital logic and timing component to provide timing signals and logic operations for the digital components of the circuit.


As an example of the operation of these components, the sensor circuit and the optional temperature probe circuit provide raw signals from the sensor to the measurement circuit. The measurement circuit converts the raw signals to a desired format, using for example, a current-to-voltage converter, current-to-frequency converter, and/or a binary counter or other indicator that produces a signal proportional to the absolute value of the raw signal. This may be used, for example, to convert the raw signal to a format that can be used by digital logic circuits. The processing circuit may then, optionally, evaluate the data and provide commands to operate the electronics.


Calibration


Analyte sensors may be configured to require no system calibration or no user calibration. For example, a sensor may be factory calibrated and need not require further calibrating. In certain embodiments, calibration may be required, but may be done without user intervention, i.e., may be automatic. In those embodiments in which calibration by the user is required, the calibration may be according to a predetermined schedule or may be dynamic, i.e., the time for which may be determined by the system on a real-time basis according to various factors, including, but not limited to, glucose concentration and/or temperature and/or rate of change of glucose, etc.


In addition to a transmitter, an optional receiver may be included in the sensor control unit. In some cases, the transmitter is a transceiver, operating as both a transmitter and a receiver. The receiver may be used to receive calibration data for the sensor. The calibration data may be used by the processing circuit to correct signals from the sensor. This calibration data may be transmitted by the receiver/display unit or from some other source such as a control unit in a doctor's office. In addition, the optional receiver may be used to receive a signal from the receiver/display units to direct the transmitter, for example, to change frequencies or frequency bands, to activate or deactivate the optional alarm system and/or to direct the transmitter to transmit at a higher rate.


Calibration data may be obtained in a variety of ways. For instance, the calibration data may be factory-determined calibration measurements which can be input into the sensor control unit using the receiver or may alternatively be stored in a calibration data storage unit within the sensor control unit itself (in which case a receiver may not be needed). The calibration data storage unit may be, for example, a readable or readable/writeable memory circuit. In some cases, a system may only need to be calibrated once during the manufacturing process, where recalibration of the system is not required.


If necessary, calibration may be accomplished using an in vitro test strip (or other reference), e.g., a small sample test strip such as a test strip that requires less than about 1 microliter of sample (for example Freestyle® or Precision® blood glucose monitoring test strips from Abbott Diabetes Care, Alameda, Calif.). For example, test strips that require less than about 1 nanoliter of sample may be used. In certain embodiments, a sensor may be calibrated using only one sample of body fluid per calibration event. For example, a user need only lance a body part one time to obtain a sample for a calibration event (e.g., for a test strip), or may lance more than one time within a short period of time if an insufficient volume of sample is firstly obtained. Embodiments include obtaining and using multiple samples of body fluid for a given calibration event, where glucose values of each sample are substantially similar. Data obtained from a given calibration event may be used independently to calibrate or combined with data obtained from previous calibration events, e.g., averaged including weighted averaged, etc., to calibrate. In certain embodiments, a system need only be calibrated once by a user, where recalibration of the system is not required.


Alternative or additional calibration data may be provided based on tests performed by a health care professional or by the user. For example, it is common for diabetic individuals to determine their own blood glucose concentration using commercially available testing kits. The results of this test is input into the sensor control unit either directly, if an appropriate input device (e.g., a keypad, an optical signal receiver, or a port for connection to a keypad or computer) is incorporated in the sensor control unit, or indirectly by inputting the calibration data into the receiver/display unit and transmitting the calibration data to the sensor control unit.


Other methods of independently determining analyte levels may also be used to obtain calibration data. This type of calibration data may supplant or supplement factory-determined calibration values.


In certain embodiments of the present disclosure, calibration data may be required at periodic intervals, for example, every eight hours, once a day, or once a week, to confirm that accurate analyte levels are being reported. Calibration may also be required each time a new sensor is implanted or if the sensor exceeds a threshold minimum or maximum value or if the rate of change in the sensor signal exceeds a threshold value. In some cases, it may be necessary to wait a period of time after the implantation of the sensor before calibrating to allow the sensor to achieve equilibrium. In certain embodiments, the sensor is calibrated only after it has been inserted. In other embodiments, no calibration of the sensor is needed.


Analyte Monitoring Device


In certain embodiments, the analyte monitoring device includes a sensor control unit and a sensor. In these embodiments, the processing circuit of the sensor control unit is able to determine a level of the analyte and activate an alarm system if the analyte level exceeds a threshold value. The sensor control unit, in these embodiments, has an alarm system and may also include a display, such as an LCD or LED display.


A threshold value is exceeded if the datapoint has a value that is beyond the threshold value in a direction indicating a particular condition. For example, a datapoint which correlates to a glucose level of 200 mg/dL exceeds a threshold value for hyperglycemia of 180 mg/dL, because the datapoint indicates that the user has entered a hyperglycemic state. As another example, a datapoint which correlates to a glucose level of 65 mg/dL exceeds a threshold value for hypoglycemia of 70 mg/dL because the datapoint indicates that the user is hypoglycemic as defined by the threshold value. However, a datapoint which correlates to a glucose level of 75 mg/dL would not exceed the same threshold value of 70 mg/dL for hypoglycemia because the datapoint does not indicate that particular condition as defined by the chosen threshold value.


An alarm may also be activated if the sensor readings indicate a value that is outside of (e.g., above or below) a measurement range of the sensor. For glucose, the physiologically relevant measurement range may be 30-400 mg/dL, including 40-300 mg/dL and 50-250 mg/dL, of glucose in the interstitial fluid.


The alarm system may also, or alternatively, be activated when the rate of change or acceleration of the rate of change in analyte level increase or decrease reaches or exceeds a threshold rate or acceleration. For example, in the case of a subcutaneous glucose monitor, the alarm system may be activated if the rate of change in glucose concentration exceeds a threshold value which may indicate that a hyperglycemic or hypoglycemic condition is likely to occur. In some cases, the alarm system is activated if the acceleration of the rate of change in glucose concentration exceeds a threshold value which may indicate that a hyperglycemic or hypoglycemic condition is likely to occur.


A system may also include system alarms that notify a user of system information such as battery condition, calibration, sensor dislodgment, sensor malfunction, etc. Alarms may be, for example, auditory and/or visual. Other sensory-stimulating alarm systems may be used including alarm systems which heat, cool, vibrate, or produce a mild electrical shock when activated.


Drug Delivery System


The subject matter of the present disclosure also includes sensors used in sensor-based drug delivery systems. The system may provide a drug to counteract the high or low level of the analyte in response to the signals from one or more sensors. Alternatively, the system may monitor the drug concentration to ensure that the drug remains within a desired therapeutic range. The drug delivery system may include one or more (e.g., two or more) sensors, a processing unit such as a transmitter, a receiver/display unit, and a drug administration system. In some cases, some or all components may be integrated in a single unit. A sensor-based drug delivery system may use data from the one or more sensors to provide necessary input for a control algorithm/mechanism to adjust the administration of drugs, e.g., automatically or semi-automatically. As an example, a glucose sensor may be used to control and adjust the administration of insulin from an external or implanted insulin pump.


Each of the various references, presentations, publications, provisional and/or non-provisional U.S. Patent Applications, U.S. Patents, non-U.S. Patent Applications, and/or non-U.S. Patents that have been identified herein, is incorporated herein by reference in its entirety.


Other embodiments and modifications within the scope of the present disclosure will be apparent to those skilled in the relevant art. Various modifications, processes, as well as numerous structures to which the embodiments of the subject matter of the present disclosure may be applicable will be readily apparent to those of skill in the art to which the present disclosure is directed upon review of the specification. Various aspects and features of the present disclosure may have been explained or described in relation to understandings, beliefs, theories, underlying assumptions, and/or working or prophetic examples, although it will be understood that the present disclosure is not bound to any particular understanding, belief, theory, underlying assumption, and/or working or prophetic example. Although various aspects and features of the present disclosure may have been described largely with respect to applications, or more specifically, medical applications, involving diabetic humans, it will be understood that such aspects and features also relate to any of a variety of applications involving non-diabetic humans and any and all other animals. Further, although various aspects and features of the present disclosure may have been described largely with respect to applications involving partially implanted sensors, such as transcutaneous or subcutaneous sensors, it will be understood that such aspects and features also relate to any of a variety of sensors that are suitable for use in connection with the body of an animal or a human, such as those suitable for use as fully implanted in the body of an animal or a human. Finally, although the various aspects and features of the present disclosure have been described with respect to various embodiments and specific examples herein, all of which may be made or carried out conventionally, it will be understood that the present disclosure is entitled to protection within the full scope of the appended claims.


The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to make and use the embodiments of the present disclosure, and are not intended to limit the scope of what the inventors regard as their invention nor are they intended to represent that the experiments below are all or the only experiments performed. Efforts have been made to ensure accuracy with respect to numbers used (e.g., amounts, temperature, etc.) but some experimental errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, molecular weight is weight average molecular weight, temperature is in degrees Centigrade, and pressure is at or near atmospheric.


The temperature sensor may be internal or external to the on-body housing. The temperature sensor may also sit above the skin, or be provided as an electrode running along the analyte sensor to be transcutaneously implanted below the skin. The temperature sensor electrode would then be electrically coupled to a temperature measurement circuit within the on-body housing. The temperature measurements may be transmitted to the blood glucose meter upon request. For manufacturability and cost-effectiveness, particularly when the on-body housing is intended to be disposable, it may be desirable to avoid the inclusion of a temperature sensor and/or control circuitry in the on-body housing. As such, in certain embodiments, there is provided reader (e.g., a blood glucose meter, or other hand-held measurement or analysis instrument) with a temperature measurement sensor and control system. The temperature measurement sensor may be provided on the permanent hand-held instrument to avoid disposing of the temperature measurement components when the on-body housing is disposed.


The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. In those embodiments that monitor more than one analyte, the analytes may be monitored at the same or different times. In certain embodiments, the analyte sensor is a glucose sensor. In another embodiment, the analyte sensor is a ketone sensor.


Example Embodiments

In some aspects of the present disclosure, methods of detecting and/or determining an analyte level by compensating for ambient temperature using a single temperature sensor (e.g., coupled to an in vivo analyte sensor) are provided that include receiving an analyte sensor signal (e.g., analyte sensor information, such as current, voltage, etc.) derived from an in vivo analyte sensor; detecting a temperature measurement from a temperature sensor; determining, with a processor, whether a threshold requirement is exceeded based on the temperature measurement; and determining, with the processor, a temperature-compensated analyte sensor signal. When the threshold requirement is not exceeded, the temperature-compensated analyte sensor signal is determined using the temperature measurement. Only when the threshold requirement is exceeded, the temperature-compensated analyte sensor signal is determined using an ambient-compensated temperature that is derived by compensating the temperature measurement for ambient temperature.


In certain embodiments, the processor is coupled to an on-body unit including the in vivo analyte sensor.


In certain embodiments, the processor is coupled to a receiver that communicates wired or wirelessly with an on-body unit including the in vivo analyte sensor.


In certain embodiments, the temperature measurement is performed by an on-body unit including the in vivo analyte sensor.


In certain embodiments, the temperature measurement is performed by a receiver that communicates wired or wirelessly with an on-body unit including the in vivo analyte sensor.


In certain embodiments, the methods include determining an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature sensor is coupled to an on-body unit including the in vivo analyte sensor.


In certain embodiments, the temperature measurement represents skin temperature.


In certain embodiments, the ambient-compensated temperature is derived by adding a correction factor to the temperature measurement.


In certain embodiments, the analyte is glucose.


In certain embodiments, the threshold requirement includes an upper threshold value, and adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded.


In certain embodiments, the threshold requirement includes a lower threshold value, and adding a correction factor increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement includes an upper threshold value and a lower threshold value, and adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded and increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement is exceeded when a value of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the methods include detecting a calibration temperature measured by the temperature sensor when the on-body sensor is coupled to a body of a test subject; and determining, with a processor, a threshold requirement based on the calibration temperature.


In certain embodiments, the threshold requirement includes a predetermined amount of deviation from the calibration temperature.


In certain embodiments, the threshold requirement includes an amount of deviation from the calibration temperature, and the amount of deviation is detected by monitoring changes during a period of time.


In certain embodiments, the calibration temperature is determined based on temperature measurements during a period of time.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the processor determining the threshold requirement is coupled to an on-body unit including the in vivo analyte sensor.


In certain embodiments, the processor determining the threshold requirement is coupled to a receiver that communicates wired or wirelessly with an on-body unit including the in vivo analyte sensor.


In some aspects of the present disclosure, analyte monitoring devices are provided. The analyte monitoring devices include a housing; a processor coupled to the housing; and memory communicably coupled to the processor. An in vivo analyte sensor is communicably coupled to the processor, and a temperature sensor is communicably coupled to the processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to receive an sensor signal from the in vivo analyte sensor; detecting a temperature measurement from the temperature sensor; determine whether a threshold requirement is exceeded based on the temperature measurement; and determine a temperature-compensated analyte sensor signal. When the threshold requirement is not exceeded, the temperature-compensated analyte sensor signal is determined using the temperature measurement. Only when the threshold requirement is exceeded, the temperature-compensated analyte sensor signal is determined using an ambient-compensated temperature that is derived by compensating the temperature measurement for ambient temperature.


In certain embodiments, the temperature measurement represents skin temperature.


In certain embodiments, the ambient-compensated temperature is derived by adding a correction factor to the temperature measurement.


In certain embodiments, the analyte is glucose.


In certain embodiments, the threshold requirement includes an upper threshold value, and adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded.


In certain embodiments, the threshold requirement includes a lower threshold value, and adding a correction factor increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement includes an upper threshold value and a lower threshold value, and adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded and increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement is exceeded when a value of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to detect a calibration temperature measured by the temperature sensor when the analyte monitoring device is coupled to a body of a test subject; and determine a threshold requirement based on the calibration temperature.


In certain embodiments, the threshold requirement includes a predetermined amount of deviation from the calibration temperature.


In certain embodiments, the threshold requirement includes an amount of deviation from the calibration temperature, and the amount of deviation is detected by monitoring changes during a period of time.


In certain embodiments, the calibration temperature is determined based on temperature measurements during a period of time.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the in vivo analyte sensor is coupled to the housing.


In certain embodiments, the temperature sensor is coupled to the housing.


In certain embodiments, the in vivo analyte sensor is coupled to an on-body unit, and the analyte monitoring device receives wired or wireless communications from the on-body unit.


In certain embodiments, the temperature sensor is coupled to the housing.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature measurement is performed by an on-body unit including the in vivo analyte sensor and communicated to the analyte monitoring device.


In certain embodiments, the temperature measurement is performed by the analyte monitoring device.


In some aspects of the present disclosure, methods of compensating for ambient temperature using a single temperature sensor are provided. The methods include detecting a temperature measurement from a temperature sensor; and determining, with a processor, an ambient-compensated temperature from the temperature measurement using an offset term.


In certain embodiments, the offset term is based on a predetermined core body temperature.


In certain embodiments, the temperature sensor is coupled to an on-body unit including an in vivo analyte sensor.


In certain embodiments, the temperature sensor protrudes from a skin-contacting surface of the on-body sensor, and the temperature measurement represents skin temperature.


In certain embodiments, the methods include receiving a sensor signal from an in vivo analyte sensor; and determining, with a processor, a temperature-compensated analyte sensor signal with the ambient-compensated temperature.


In certain embodiments, the processor that determines the ambient-compensated temperature is the same processor as the processor that determines the temperature-compensated analyte sensor signal.


In certain embodiments, the processor that determines the ambient-compensated temperature and the processor that determines the temperature-compensated analyte sensor signal are coupled to a receiver that communicates wired or wirelessly with an on-body unit including the in vivo analyte sensor.


In certain embodiments, the processor that determines the ambient-compensated temperature and the processor that determines the temperature-compensated analyte sensor signal are coupled to an on-body unit including the in vivo analyte sensor.


In certain embodiments, the processor that determines the ambient-compensated temperature is coupled to an on-body unit including the in vivo analyte sensor, and the processor that determines the temperature-compensated analyte sensor signal is coupled to a receiver that communicates wired or wirelessly with the on-body unit.


In certain embodiments, the methods include determining an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature measurement is performed by an on-body unit including the in vivo analyte sensor.


In certain embodiments, the temperature measurement is performed by a receiver that communicates wired or wirelessly with an on-body unit including the in vivo analyte sensor.


In certain embodiments, the temperature sensor is disposed on a printed circuit board of the on-body sensor.


In certain embodiments, the predetermined core body temperature is between 36° C. and 38° C.


In certain embodiments, the predetermined core body temperature is approximately 37° C.


In some aspects of the present disclosure, analyte monitoring devices are provided. The analyte monitoring devices include a housing; a processor coupled to the housing; and memory communicably coupled to the processor. An in vivo analyte sensor is communicably coupled to the processor, and a temperature sensor is communicably coupled to the processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to detect a temperature measurement from the temperature sensor; and determine an ambient-compensated temperature from the temperature measurement using an offset term.


In certain embodiments, the offset term is based on a predetermined core body temperature.


In certain embodiments, the temperature sensor protrudes from a skin-contacting surface of the housing, and the temperature measurement represents skin temperature.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to receive a sensor signal from the in vivo analyte sensor; and determine a temperature-compensated analyte sensor signal with the ambient-compensated temperature.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the in vivo analyte sensor is coupled to the housing.


In certain embodiments, the temperature sensor is coupled to the housing.


In certain embodiments, the in vivo analyte sensor is coupled to an on-body unit, and the analyte monitoring device receives wired or wireless communications from the on-body unit.


In certain embodiments, the temperature sensor is coupled to the housing.


In certain embodiments, the temperature measurement is performed by an on-body unit including the in vivo analyte sensor and communicated to the analyte monitoring device.


In certain embodiments, the temperature measurement is performed by the analyte monitoring device.


In certain embodiments, the temperature sensor is coupled to an on-body unit including the in vivo analyte sensor.


In certain embodiments, the temperature sensor is disposed on a printed circuit board coupled to the housing.


In certain embodiments, the predetermined core body temperature is between 36° C. and 38° C.


In certain embodiments, the predetermined core body temperature is approximately 37° C.


In some aspects of the present disclosure, methods of compensating for ambient temperature using temperature sensors are provided. The methods include sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor; determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. The correction gain or factor changes value at a slower rate than the sampling rate.


In certain embodiments, the processor sampling first temperatures at a first sampling rate, the processor determining first ambient-compensated temperatures, and the processor determining final ambient compensated temperatures are the same processor.


In certain embodiments, the sampling of first temperatures at a first sampling rate, the determining of first ambient-compensated temperatures, and the determining of final ambient compensated temperatures are performed by an on-body unit including an in vivo analyte sensor.


In certain embodiments, the sampling of first temperatures at a first sampling rate, the determining of first ambient-compensated temperatures, and the determining of final ambient compensated temperatures are performed by a receiver that communicates with an on-body unit including an in vivo analyte sensor.


In certain embodiments, one or more of the processor sampling first temperatures at a first sampling rate, the processor determining first ambient-compensated temperatures, and the processor determining final ambient compensated temperatures are different processors.


In certain embodiments, the sampling of first temperatures at a first sampling rate, the determining of first ambient-compensated temperatures, and the determining of final ambient compensated temperatures are each performed by either a processor coupled to an on-body unit including an in vivo analyte sensor or by a processor coupled to a receiver that communicates with the on-body unit.


In certain embodiments, the correction gain is applied to the first ambient-compensated temperatures.


In certain embodiments, the methods include sampling at the first sampling rate, with a processor, second temperature measurements from a second temperature sensor on the on-body sensor; and determining, with a processor, second ambient-compensated temperatures with the second temperature measurements. The correction gain is calculated by performing a moving average between first ambient-compensated temperatures and second ambient-compensated temperatures, such that the correction gain is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, the processor sampling first temperatures at a first sampling rate, the processor determining first ambient-compensated temperatures, the processor determining final ambient compensated temperatures, the processor sampling second temperatures at the first sampling rate, and the processor determining the second ambient-compensated temperature are the same processor.


In certain embodiments, the sampling of first temperatures at a first rate, the determining of first ambient-compensated temperatures, the determining of final ambient compensated temperatures, the determining of final ambient compensated temperatures, the sampling of second temperatures at the first sampling rate, and the determining of the second ambient-compensated temperature are performed an on-body unit including an in vivo analyte sensor.


In certain embodiments, the sampling of first temperatures at a first rate, the determining of first ambient-compensated temperatures, the determining of final ambient compensated temperatures, the determining of final ambient compensated temperatures, the sampling of second temperatures at the first sampling rate, and the determining of the second ambient-compensated temperature are performed by a receiver that communicates with an on-body unit including an in vivo analyte sensor.


In certain embodiments, one or more of the processor sampling first temperatures at a first sampling rate, the processor determining first ambient-compensated temperatures, the processor determining final ambient compensated temperatures, the processor sampling second temperatures at the first sampling rate, and the processor determining the second ambient-compensated temperature are different processors.


In certain embodiments, the sampling of first temperatures at a first rate, the determining of first ambient-compensated temperatures, the determining of final ambient compensated temperatures, the determining of final ambient compensated temperatures, the sampling of second temperatures at the first sampling rate, and the determining of the second ambient-compensated temperature are each performed by either a processor coupled to an on-body unit including an in vivo analyte sensor or by a processor coupled to a receiver that communicates with the on-body unit.


In certain embodiments, the correction gain is calculated using parameter adaptation.


In certain embodiments, the parameter adaptation is MIT adaptation.


In certain embodiments, the correction factor is applied to the first ambient-compensated temperatures.


In certain embodiments, the methods include sampling at the first sampling rate, with a processor, second temperatures measured from a second temperature sensor on the on-body sensor; and determining, with a processor, second ambient-compensated temperatures with the second temperature measurements. The correction factor is calculated by performing windowed comparisons between the first ambient-compensated temperatures and the second ambient-compensated temperatures, such that the correction factor is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, the processor sampling first temperatures at a first sampling rate, the processor determining first ambient-compensated temperatures, the processor determining final ambient compensated temperatures, the processor sampling second temperatures at the first sampling rate, and the processor determining the second ambient-compensated temperature are the same processor.


In certain embodiments, the sampling of first temperatures at a first rate, the determining of first ambient-compensated temperatures, the determining of final ambient compensated temperatures, the determining of final ambient compensated temperatures, the sampling of second temperatures at the first sampling rate, and the determining of the second ambient-compensated temperature are performed an on-body unit including an in vivo analyte sensor.


In certain embodiments, the sampling of first temperatures at a first rate, the determining of first ambient-compensated temperatures, the determining of final ambient compensated temperatures, the determining of final ambient compensated temperatures, the sampling of second temperatures at the first sampling rate, and the determining of the second ambient-compensated temperature are performed by a receiver that communicates with an on-body unit including an in vivo analyte sensor.


In certain embodiments, one or more of the processor sampling first temperatures at a first sampling rate, the processor determining first ambient-compensated temperatures, the processor determining final ambient compensated temperatures, the processor sampling second temperatures at the first sampling rate, and the processor determining the second ambient-compensated temperature are different processors.


In certain embodiments, the sampling of first temperatures at a first rate, the determining of first ambient-compensated temperatures, the determining of final ambient compensated temperatures, the determining of final ambient compensated temperatures, the sampling of second temperatures at the first sampling rate, and the determining of the second ambient-compensated temperature are each performed by either a processor coupled to an on-body unit including an in vivo analyte sensor or by a processor coupled to a receiver that communicates with the on-body unit.


In some aspects of the present disclosure analyte monitoring device are provided. The analyte monitoring device include a housing; a processor coupled to the housing; and memory communicably coupled to the processor. An in vivo analyte sensor is communicably coupled to the processor, and a first temperature sensor and second temperature sensor are communicably coupled to the processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to sample at a first sampling rate, with a processor, first temperatures measured from a first temperature sensor on the housing; determine first ambient-compensated temperatures from the first temperature measurements; and determine final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. The correction gain or factor changes value at a slower rate than the sampling rate.


In certain embodiments, the in vivo analyte sensor is coupled to the housing.


In certain embodiments, the first temperature sensor and/or second temperature sensor is coupled to the housing.


In certain embodiments, the in vivo analyte sensor is coupled to an on-body unit, and the analyte monitoring device receives wired or wireless communications from the on-body unit.


In certain embodiments, the first temperature sensor and/or second temperature sensor is coupled to the housing.


In certain embodiments, the first temperature measurement and/or second temperature measurement is performed by an on-body unit including the in vivo analyte sensor and communicated to the analyte monitoring device.


In certain embodiments, the first temperature measurement and/or second temperature measurement is performed by the analyte monitoring device.


In certain embodiments, the correction gain is applied to the first ambient-compensated temperatures.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to sample at the first sampling rate second temperatures measured from a second temperature sensor on the housing; and determine second ambient-compensated temperatures with the second temperature measurements. The correction gain is calculated by performing a moving average between first ambient-compensated temperatures and second ambient-compensated temperatures, such that the correction gain is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, the in vivo analyte sensor is coupled to the housing.


In certain embodiments, the first temperature sensor and/or second temperature sensor is coupled to the housing.


In certain embodiments, the in vivo analyte sensor is coupled to an on-body unit, and the analyte monitoring device receives wired or wireless communications from the on-body unit.


In certain embodiments, the first temperature sensor and/or second temperature sensor is coupled to the housing.


In certain embodiments, the first temperature measurement and/or second temperature measurement is performed by an on-body unit including the in vivo analyte sensor and communicated to the analyte monitoring device.


In certain embodiments, the first temperature measurement and/or the second temperature measurement is performed by the analyte monitoring device.


In certain embodiments, the correction gain is calculated using parameter adaptation.


In certain embodiments, the correction gain is calculated using MIT adaptation.


In certain embodiments, the correction factor is applied to the first ambient-compensated temperatures.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to sample at the first sampling rate second temperatures measured from a second temperature sensor on the housing; and determine second ambient-compensated temperatures with the second temperature measurements. The correction factor is calculated by performing windowed comparisons between the first ambient-compensated temperatures and the second ambient-compensated temperatures, such that the correction factor is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, the first temperature sensor is disposed at a skin-contacting surface of the housing and the second temperature sensor is disposed on a printed circuit board coupled to the housing.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to receive a sensor signal from the in vivo analyte sensor; and determine a temperature-compensated analyte sensor signal with the ambient-compensated temperature.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine, with the processor, an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the in vivo analyte sensor is coupled to the housing.


In certain embodiments, the first temperature sensor and/or second temperature sensor is coupled to the housing.


In certain embodiments, the in vivo analyte sensor is coupled to an on-body unit, and the analyte monitoring device receives wired or wireless communications from the on-body unit.


In certain embodiments, the first temperature sensor is disposed at a skin-contacting surface of the housing and the second temperature sensor is disposed on a printed circuit board on the housing.


In some aspects of the present disclosure, in vivo analyte sensors are provided. The in vivo analyte sensors include a substrate layer; an electrode layer disposed on the substrate layer; and a temperature sensing element disposed on the substrate layer, the temperature sensing element providing a signal for determining temperature adjacent the sensing area. The electrode layer includes a sensing area,


In certain embodiments, the temperature sensing element is a thermistor.


In certain embodiments, the temperature sensing element is a resistance temperature detector (RTD).


In certain embodiments, the electrode layer includes a plurality of electrodes, and one electrode of the plurality of electrodes is the temperature sensing element.


In certain embodiments, the plurality of electrodes includes a working electrode, reference, electrode, and a counter electrode, and the temperature sensing element is the counter electrode and includes two contact points for electric coupling to a current providing circuit.


In certain embodiments, the temperature sensing element extends back and forth a plurality of times.


In certain embodiments, the temperature sensing element includes two traces of dissimilar metals that join at a junction adjacent the sensing area.


In certain embodiments, the two dissimilar metals are gold, silver, carbon, titanium, or an alloy thereof.


In certain embodiments, the two traces are on a same side of the substrate layer as the electrode layer.


In certain embodiments, the two traces are on an opposite side of the substrate layer as the electrode layer.


In certain embodiments, the junction is directly opposite the sensing area.


In certain embodiments, each of the two traces are on a different side of the substrate layer from one another, and a through-hole is used to join the two traces.


In certain embodiments, the two traces are conductive ink.


In certain embodiments, the temperature sensing element is a pyro-electric sensor.


In certain embodiments, the temperature sensing element is a semiconductor sensor.


In certain embodiments, the temperature sensing element includes a second sensing area and a analyte reservoir, the analyte reservoir includes a known volume of analyte at a known concentration.


In certain embodiments, the secondary sensing area is isolated and the reservoir lasts for the life of the sensor.


In certain embodiments, the analyte sensors include a membrane between the second sensing area and the reservoir.


In certain embodiments, the analyte sensors include a temporary barrier between the second sensing area and the reservoir that ceases to separate the second sensing area and the reservoir when the analyte sensor is positioned in vivo.


In some aspects of the present disclosure, analyte monitoring devices are provided that include a housing; electronic circuitry coupled to the housing, the electronic circuitry including a processor; and an in vivo analyte sensor electrically coupled to the electronic circuitry and extending from the housing. The in vivo analyte sensor include a substrate layer; an electrode layer disposed on the substrate layer; and a temperature sensing element disposed on the substrate layer, the temperature sensing element providing a signal for determining temperature adjacent a sensing area.


In certain embodiments, the temperature sensing element is a thermistor.


In certain embodiments, the temperature sensing element is a resistance temperature detector (RTD).


In certain embodiments, the electrode layer includes a plurality of electrodes, and one electrode of the plurality of electrodes is the temperature sensing element.


In certain embodiments, the plurality of electrodes includes a working electrode, reference, electrode, and a counter electrode, and the temperature sensing element is the counter electrode and includes two electrical contacts for electric coupling to a current providing circuit.


In certain embodiments, the temperature sensing element extends back and forth a plurality of times.


In certain embodiments, the electronic circuitry includes a working electrode contact that electrically couple to the working electrode, a reference electrode contact that electrically couple to the reference electrode, and two counter electrode contacts that electrically couple to the two electrical contacts of the temperature sensing element and supply the temperature sensing element with current.


In certain embodiments, the electronic circuitry includes two electrode contacts that electrically couple to two electrical contacts of the temperature sensing element and supply the temperature sensing element with current.


In certain embodiments, the temperature sensing element includes two traces of dissimilar metals that join at a junction adjacent the sensing area.


In certain embodiments, the two dissimilar metals are gold, silver, carbon, titanium, or an alloy thereof.


In certain embodiments, the two traces are on a same side of the substrate layer as the electrode layer.


In certain embodiments, the two traces are on an opposite side of the substrate layer as the electrode layer.


In certain embodiments, the junction is directly opposite the sensing area.


In certain embodiments, each of the two traces are on a different side of the substrate layer from one another, and a through-hole is used to join the two traces.


In certain embodiments, the two traces are conductive ink.


In certain embodiments, the temperature sensing element is a pyro-electric sensor.


In certain embodiments, the temperature sensing element is a semiconductor sensor.


In certain embodiments, the temperature sensing element includes a second sensing area and a analyte reservoir, the analyte reservoir includes a known volume of analyte at a known concentration.


In certain embodiments, the secondary sensing area is isolated and the reservoir lasts for the life of the analyte sensor.


In certain embodiments, the analyte sensors include a membrane between the second sensing area and the reservoir.


In certain embodiments, the analyte sensors include a temporary barrier between the second sensing area and the reservoir that ceases to separate the second sensing area and the reservoir when the analyte sensor is positioned in vivo.


In some aspects of the present disclosure, analyte sensor devices are provided that include a body including an elongated member having a central tunnel that inserts into skin of a subject; electrodes disposed on the body; and a temperature sensor coupled to the body. The body is adapted to couple to the skin of the subject.


In certain embodiments, the temperature sensor is disposed within the central tunnel and adapted to pierce the skin of the patient, and the electrodes disposed on the outside of the body.


In certain embodiments, the temperature sensor is softened by exposure to body fluids.


In certain embodiments, the central tunnel is for insulin delivery.


In certain embodiments, the electrodes include wires disposed on the body, and the temperature sensor includes a thermocouple wire disposed on the body.


In certain embodiments, the analyte sensor device includes a housing adapted to couple to an insulin delivery tube and insulin pump; and electronic circuitry coupled to the housing, the electronic circuitry including a processor for determining analyte levels.


In some aspects of the present disclosure, methods are provided that include coupling an analyte sensor device to a skin of a subject and inserting a temperature sensor within the skin of the subject. The temperature sensor is disposed within the central tunnel. The sensor coupling device includes a body including an elongated member having a central tunnel that inserts into the skin of a subject, and electrodes disposed on the body. The body is adapted to couple to the skin of the subject.


In certain embodiments, before the temperature sensor is inserted within the skin of the subject, the methods include piercing the skin of the subject with a needle disposed within the central tunnel; removing the needle from the central tunnel; and inserting the temperature sensor within the central tunnel.


In certain embodiments, the methods include determining an analyte level based on a sensor signal from the electrodes that has been compensated for temperature from the temperature sensor.


In certain embodiments, the temperature sensor is adapted to pierce the skin of the subject.


In certain embodiments, the temperature sensor is softened by exposure to body fluids.


In some aspects of the present disclosure, methods are provided that include receiving a first sensor signal from a first electrode on an in vivo analyte sensor on an on-body sensor; receiving a second sensor signal from a second electrode on the in vivo analyte sensor, and determining, with a processor, a compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes. The first electrode and second electrode include different sensing chemistries with different temperature dependencies.


In certain embodiments, the temperature is determined based on a ratio of the first sensor signal and the second sensor signal.


In certain embodiments, the temperature is determined based on a predetermined temperature, sensor areas, quantity of sensing materials, and efficiencies of the sensing chemistries, and diffusion controlling membrane.


In certain embodiments, the methods include determining, with a processor, a temperature-compensated analyte sensor signal with the compensated temperature.


In certain embodiments, the processor that determines the compensated temperature is the same processor as the processor that determines the temperature-compensated analyte sensor signal.


In certain embodiments, the processor that determines the compensated temperature and the processor that determines the temperature-compensated analyte sensor signal are coupled to a receiver that communicates wired or wirelessly with an on-body unit including the in vivo analyte sensor.


In certain embodiments, the processor that determines the compensated temperature and the processor that determines the temperature-compensated analyte sensor signal are coupled to an on-body unit including the in vivo analyte sensor.


In certain embodiments, the processor that determines the compensated temperature is coupled to an on-body unit including the in vivo analyte sensor, and the processor that determines the temperature-compensated analyte sensor signal is coupled to a receiver that communicates wired or wirelessly with the on-body unit.


In certain embodiments, the methods include determining an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the first sensor signal and not the second sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the second sensor signal and not the first sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with both the first sensor signal and the second sensor signal.


In certain embodiments, the first electrode includes a first plurality of sensing elements on the in vivo analyte sensor and the second electrode includes a second plurality of sensing elements disposed on the in vivo analyte sensor.


In some aspects of the present disclosure, analyte monitoring devices are provided that include a housing; a processor coupled to the housing; and memory communicably coupled to the processor. An in vivo analyte sensor is communicably coupled to the processor, and the in vivo analyte sensor includes two working electrodes. The memory includes instructions stored therein that, when executed by the processor, cause the processor to detect a first sensor signal from a first electrode on the in vivo analyte sensor; detect a second sensor signal from a second electrode on the in vivo analyte sensor; and determine a compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes. The first electrode and second electrode include different sensing chemistries with different temperature dependencies.


In certain embodiments, the in vivo analyte sensor is coupled to the housing.


In certain embodiments, the compensated temperature is determined by the analyte monitoring device.


In certain embodiments, the in vivo analyte sensor is coupled to an on-body unit, and the analyte monitoring device receives wired or wireless communications from the on-body unit.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the compensated temperature is determined by an on-body unit including the in vivo analyte sensor and communicated to the analyte monitoring device.


In certain embodiments, the temperature is determined based on a ratio of the first sensor signal and the second sensor signal,


In certain embodiments, the temperature is determined based on a predetermined temperature, sensor areas, quantity of sensing materials, and efficiencies of the sensing chemistries, and diffusion controlling membrane.


In certain embodiments, the memory includes instructions stored therein that, when executed by the processor, cause the processor to determining a temperature-compensated analyte sensor signal with the compensated temperature.


In certain embodiments, the in vivo analyte sensor is coupled to the housing.


In certain embodiments, the compensated temperature is determined by the analyte monitoring device.


In certain embodiments, the in vivo analyte sensor is coupled to an on-body unit, and the analyte monitoring device receives wired or wireless communications from the on-body unit.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the compensated temperature is determined by an on-body unit including the in vivo analyte sensor and communicated to the analyte monitoring device.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the first sensor signal and not the second sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the second sensor signal and not the first sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with both the first sensor signal and the second sensor signal.


In certain embodiments, the first electrode includes a first plurality of sensing elements on the in vivo analyte sensor and the second electrode includes a second plurality of sensing elements disposed on the in vivo analyte sensor.


In some aspects of the present disclosure, analyte monitoring systems are provided that include an on-body unit and receiver. The on-body includes a first processor and first memory communicably coupled to the first processor; an in vivo analyte sensor communicably coupled to the first processor; and a temperature sensor communicably coupled to the first processor. The receiver is configured to communicate with the on-body unit and includes a second processor and second memory communicably coupled to the second processor. At least one of the first and second memory includes instructions stored therein that, when executed by at least one of the first and second processors, cause the at least one first and second processors to receive a sensor signal from the in vivo analyte sensor; detect a temperature measurement from the temperature sensor; determine whether a threshold requirement is exceeded based on the temperature measurement; and determine a temperature-compensated analyte sensor signal. When the threshold requirement is not exceeded, the temperature-compensated analyte sensor signal is determined using the temperature measurement. Only when the threshold requirement is exceeded, the temperature-compensated analyte sensor signal is determined using an ambient-compensated temperature that is derived by compensating the temperature measurement for ambient temperature.


It should be appreciated that the steps may be performed in various combinations by the processor on the on-body unit and the receiver in communication with the on-body unit in different embodiments. For example, in certain embodiments, the temperature sensor is coupled to the on-body unit and a processor on the on-body unit is detecting the temperature measurement, determining whether the threshold requirement is met, performing the ambient temperature compensation, and determining the temperature-compensated signal. Then, for example, the temperature-compensated signal is sent to a receiver wherein the temperature-compensated analyte level is displayed on a user-interface of the receiver for instance. In another embodiment, for example, the temperature sensor is coupled to the on-body unit and a processor on the on-body unit transmits the temperature measurements to the receiver where a processor coupled to the receiver determines whether the threshold requirement is met, performs the ambient temperature compensation, and determines the temperature-compensated signal. Then, for example, the temperature-compensated analyte level is displayed on a user-interface of the receiver for instance. It should be appreciated that the steps may be split up in other combinations between the on-body unit and the receiver.


In certain embodiments, the temperature measurement represents skin temperature.


In certain embodiments, the ambient-compensated temperature is derived by adding a correction factor to the temperature measurement.


In certain embodiments, the analyte is glucose.


In certain embodiments, the threshold requirement includes an upper threshold value, and wherein adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded.


In certain embodiments, the threshold requirement includes a lower threshold value, and wherein adding a correction factor increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement includes an upper threshold value and a lower threshold value, and wherein adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded and increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement is exceeded when a value of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to detect a calibration temperature measured by the temperature sensor when the on-body unit is coupled to a body of a test subject; and determine a threshold requirement based on the calibration temperature.


In certain embodiments, the threshold requirement includes a predetermined amount of deviation from the calibration temperature.


In certain embodiments, the threshold requirement includes an amount of deviation from the calibration temperature, and wherein the amount of deviation is detected by monitoring changes during a period of time.


In certain embodiments, the calibration temperature is determined based on temperature measurements during a period of time.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature measurement is performed by the on-body unit and communicated to the receiver.


In certain embodiments, the temperature measurement is performed by the receiver.


In some aspects of the present disclosure, analyte monitoring systems are provided that include an on-body unit and receiver. The on-body includes a first processor and first memory communicably coupled to the first processor; an in vivo analyte sensor communicably coupled to the first processor; and a temperature sensor communicably coupled to the first processor. The receiver is configured to communicate with the on-body unit and includes a second processor and second memory communicably coupled to the second processor. At least one of the first and second memory includes instructions stored therein that, when executed by at least one of the first and second processors, cause the at least one first and second processors to detect a temperature measurement from the temperature sensor; and determine an ambient-compensated temperature from the temperature measurement using an offset term.


It should be appreciated that the steps may be performed in various combinations by the processor on the on-body unit and the receiver in communication with the on-body unit in different embodiments. For example, in certain embodiments, the temperature sensor is coupled to the on-body unit and a processor on the on-body unit detects the temperature measurement, determines an ambient-compensated temperature from the measured temperature using an offset term, and determines the temperature-compensated signal. Then, for example, the temperature-compensated signal is sent to a receiver wherein the temperature-compensated analyte level is displayed on a user-interface of the receiver for instance. In another embodiment, for example, the temperature sensor is coupled to the on-body unit and a processor on the on-body unit transmits the temperature measurements to the receiver where a processor coupled to the receiver determines an ambient-compensated temperature from the measured temperature using an offset term, and determines the temperature-compensated signal. Then, for example, the temperature-compensated analyte level is displayed on a user-interface of the receiver for instance. It should be appreciated that in other embodiments, the steps may be split up in other combinations between the on-body unit and the receiver.


In certain embodiments, the temperature sensor protrudes from a skin-contacting surface of the on-body unit, and wherein the temperature measurement represents skin temperature.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to receive a sensor signal from the in vivo analyte sensor; and determine a temperature-compensated analyte sensor signal with the ambient-compensated temperature.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature measurement is performed by an on-body unit and communicated to the receiver.


In certain embodiments, the offset term that is based on a predetermined core body temperature.


In certain embodiments, the temperature sensor is disposed on a printed circuit board coupled to the on-body unit.


In certain embodiments, the offset term that is based on a predetermined core body temperature, and wherein the predetermined core body temperature is between 36° C. and 38° C.


In certain embodiments, the offset term that is based on a predetermined core body temperature, and wherein the predetermined core body temperature is approximately 37° C.


In some aspects of the present disclosure, analyte monitoring systems are provided that include an on-body unit and receiver. The on-body includes a first processor and first memory communicably coupled to the first processor; an in vivo analyte sensor communicably coupled to the first processor; and a first temperature sensor and second temperature sensor communicably coupled to the first processor. The receiver is configured to communicate with the on-body unit and includes a second processor and second memory communicably coupled to the second processor. At least one of the first and second memory includes instructions stored therein that, when executed by at least one of the first and second processors, cause the at least one first and second processors to sample, at a first sampling rate, first temperatures measured from a first temperature sensor; determine first ambient-compensated temperatures from the first temperature measurements; and determine final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. The correction gain or factor changes value at a slower rate than the sampling rate.


It should be appreciated that the steps may be performed in various combinations by the processor on the on-body unit and the receiver in communication with the on-body unit in different embodiments. For example, in certain embodiments, the temperature sensors are coupled to the on-body unit and a processor on the on-body unit samples the temperatures sensors, determines the ambient-compensated temperature from the one-temperature sensor model and two-temperature sensor model, determines the correction factor or gain, determines the final ambient-compensated temperatures. The processor on the on-body unit may then, for example, either determine the temperature-compensated signal, or transmit the final ambient-compensated signal to a receiver having a processor that determines the temperature compensated signal and presents the corresponding analyte level on a user interface. It should be appreciated that the steps may be split up in other combinations between the on-body unit and the receiver in other embodiments. For example, in other embodiments, one or more of the steps in determining the ambient-compensated signal and/or final ambient compensated signal may be performed by the receiver.


In certain embodiments, the first temperature measurement and/or second temperature measurement is performed by the on-body unit and communicated to the receiver.


In certain embodiments, the first temperature measurement and/or second temperature measurement is performed by the receiver.


In certain embodiments, the correction gain is applied to the first ambient-compensated temperatures.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to sample at the first sampling rate second temperatures measured from a second temperature sensor; and determine second ambient-compensated temperatures with the second temperature measurements. The correction gain is calculated by performing a moving average between first ambient-compensated temperatures and second ambient-compensated temperatures, such that the correction gain is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, the first temperature measurement and/or second temperature measurement is performed by the on-body unit and communicated to the receiver.


In certain embodiments, the first temperature measurement and/or the second temperature measurement is performed by the receiver.


In certain embodiments, the correction gain is calculated using parameter adaptation.


In certain embodiments, the correction gain is calculated using MIT adaptation.


In certain embodiments, the correction factor is applied to the first ambient-compensated temperatures.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to sample at the first sampling rate second temperatures measured from a second temperature sensor; and determine second ambient-compensated temperatures with the second temperature measurements. The correction factor is calculated by performing windowed comparisons between the first ambient-compensated temperatures and the second ambient-compensated temperatures, such that the correction factor is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, the first temperature sensor is disposed at a skin-contacting surface of the on-body unit and the second temperature sensor is disposed on a printed circuit board of the on-body unit.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to receive a sensor signal from the in vivo analyte sensor; and determine a temperature-compensated analyte sensor signal with the ambient-compensated temperature.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to determine, with the processor, an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the first temperature sensor is disposed at a skin-contacting surface of the on-body unit and the second temperature sensor is disposed on a printed circuit board of the on-body unit.


In some aspects of the present disclosure, analyte monitoring system are provided that include an on-body unit and receiver. The on-body includes a first processor and first memory communicably coupled to the first processor; and an in vivo analyte sensor communicably coupled to the first processor. The in vivo analyte sensor includes two working electrodes. The receiver is configured to communicate with the on-body unit and includes a second processor and second memory communicably coupled to the second processor. At least one of the first and second memory includes instructions stored therein that, when executed by at least one of the first and second processors, cause the at least one first and second processors to detect a first sensor signal from a first electrode on the in vivo analyte sensor; detect a second sensor signal from a second electrode on the in vivo analyte sensor; and determine a compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes. The first electrode and second electrode include different sensing chemistries with different temperature dependencies.


It should be appreciated that the steps may be performed in various combinations by the processor on the on-body unit and the receiver in communication with the on-body unit in different embodiments. For example, in certain embodiments, the processor on the on-body unit detects the first sensor signal from the first electrode on the in vivo analyte sensor; detects the second sensor signal from a second electrode on the in vivo analyte sensor; and determines the compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes. As another example, in certain embodiments, the processor on the on-body unit detects the first sensor signal from the first electrode on the in vivo analyte sensor and detects the second sensor signal from a second electrode on the in vivo analyte sensor. The first sensor signal and the second sensor signal are transmitted to the receiver. The receiver receives the first sensor signal and the second sensor signal. After the detecting the first sensor signal and the second sensor signal, the processor on the receiver determines the compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes.


In certain embodiments, the compensated temperature is determined by the on-body unit.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the compensated temperature is determined by the on-body unit and communicated to the receiver.


In certain embodiments, the temperature is determined based on a ratio of the first sensor signal and the second sensor signal,


In certain embodiments, the temperature is determined based on a predetermined temperature, sensor areas, quantity of sensing materials, and efficiencies of the sensing chemistries, and diffusion controlling membrane.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to determining a temperature-compensated analyte sensor signal with the compensated temperature.


In certain embodiments, the at least one memory includes instructions that, when executed by the at least one first and second processor, cause the at least one first and second processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the compensated temperature is determined by the on-body unit and communicated to the receiver.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the first sensor signal and not the second sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the second sensor signal and not the first sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with both the first sensor signal and the second sensor signal.


In certain embodiments, the first electrode includes a first plurality of sensing elements on the in vivo analyte sensor and the second electrode includes a second plurality of sensing elements disposed on the in vivo analyte sensor.


In some aspects of the present disclosure, computer systems are provided that include a processor; and memory communicably coupled to the first processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to receive analyte data (e.g., a sensor signal from an in vivo analyte sensor); receive temperature data (e.g., a temperature measurement from a temperature sensor); determine whether a threshold requirement is exceeded based on the temperature measurement; and determine a temperature-compensated analyte sensor signal. When the threshold requirement is not exceeded, the temperature-compensated analyte sensor signal is determined using the temperature measurement. Only when the threshold requirement is exceeded, the temperature-compensated analyte sensor signal is determined using an ambient-compensated temperature that is derived by compensating the temperature measurement for ambient temperature.


In certain embodiments, the computer systems include an in vivo analyte sensor, at least one temperature sensor, a sensor electronics unit that receives analyte data from the in vivo analyte sensor, and a receiver unit that receives analyte data from the sensor electronics unit.


In certain embodiments, the temperature measurement represents skin temperature.


In certain embodiments, the ambient-compensated temperature is derived by adding a correction factor to the temperature measurement.


In certain embodiments, the analyte is glucose.


In certain embodiments, the threshold requirement includes an upper threshold value, and wherein adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded.


In certain embodiments, the threshold requirement includes a lower threshold value, and wherein adding a correction factor increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement includes an upper threshold value and a lower threshold value, and wherein adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded and increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement is exceeded when a value of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to detect a calibration temperature measured by the temperature sensor when an on-body unit including the in vivo analyte sensor is coupled to a body of a test subject; and determine a threshold requirement based on the calibration temperature.


In certain embodiments, the threshold requirement includes a predetermined amount of deviation from the calibration temperature.


In certain embodiments, the threshold requirement includes an amount of deviation from the calibration temperature, and wherein the amount of deviation is detected by monitoring changes during a period of time.


In certain embodiments, the calibration temperature is determined based on temperature measurements during a period of time.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature measurement is performed by an on-body unit and communicated to a receiver.


In certain embodiments, the temperature measurement is performed by a receiver.


In some aspects of the present disclosure, computer systems are provided that include a processor; and memory communicably coupled to the first processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to receive temperature data (e.g., a temperature measurement from a temperature sensor); and determine an ambient-compensated temperature from the temperature measurement using an offset term.


In certain embodiments, the computer systems include an in vivo analyte sensor, at least one temperature sensor, a sensor electronics unit that receives analyte data from the in vivo analyte sensor, and a receiver unit that receives analyte data from the sensor electronics unit.


In certain embodiments, the temperature sensor protrudes from a skin-contacting surface of an on-body unit, and wherein the temperature measurement represents skin temperature.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to receive analyte data (e.g., a sensor signal from the in vivo analyte sensor); and determine a temperature-compensated analyte sensor signal with the ambient-compensated temperature.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature measurement is performed by an on-body unit and communicated to a receiver.


In certain embodiments, the offset term that is based on a predetermined core body temperature.


In certain embodiments, the temperature sensor is disposed on a printed circuit board coupled to an on-body unit.


In certain embodiments, the offset term that is based on a predetermined core body temperature, and wherein the predetermined core body temperature is between 36° C. and 38° C.


In certain embodiments, the offset term that is based on a predetermined core body temperature, and wherein the predetermined core body temperature is approximately 37° C.


In some aspects of the present disclosure, computer systems are provided that include a processor; and memory communicably coupled to the first processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to (receive temperature data (e.g., sample, at a first sampling rate, first temperatures measured from a first temperature sensor); determine first ambient-compensated temperatures from the first temperature measurements; and determine final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. The correction gain or factor changes value at a slower rate than the sampling rate.


In certain embodiments, the computer systems include an in vivo analyte sensor, at least one temperature sensor, a sensor electronics unit that receives analyte data from the in vivo analyte sensor, and a receiver unit that receives analyte data from the sensor electronics unit.


In certain embodiments, the first temperature measurement and/or a second temperature measurement is performed by the on-body unit and communicated to the receiver.


In certain embodiments, the first temperature measurement and/or a second temperature measurement is performed by the receiver.


In certain embodiments, the correction gain is applied to the first ambient-compensated temperatures.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to sample, at the first sampling rate, additional temperature data (e.g., second temperatures measured from a second temperature sensor); and determine second ambient-compensated temperatures with the second temperature measurements. The correction gain is calculated by performing a moving average between first ambient-compensated temperatures and second ambient-compensated temperatures, such that the correction gain is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, the first temperature measurement and/or second temperature measurement is performed by an on-body unit and communicated to a receiver.


In certain embodiments, the first temperature measurement and/or the second temperature measurement is performed by a receiver.


In certain embodiments, the correction gain is calculated using parameter adaptation.


In certain embodiments, the correction gain is calculated using MIT adaptation.


In certain embodiments, the correction factor is applied to the first ambient-compensated temperatures.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to sample, at the first sampling rate, second temperatures measured from a second temperature sensor; and determine second ambient-compensated temperatures with the second temperature measurements. The correction factor is calculated by performing windowed comparisons between the first ambient-compensated temperatures and the second ambient-compensated temperatures, such that the correction factor is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, the first temperature sensor is disposed at a skin-contacting surface of an on-body unit and the second temperature sensor is disposed on a printed circuit board of the on-body unit.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to receive analyte data (e.g., a sensor signal from the in vivo analyte sensor); and determine a temperature-compensated analyte sensor signal with the ambient-compensated temperature.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine, with the processor, an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the first temperature sensor is disposed at a skin-contacting surface of an on-body unit and the second temperature sensor is disposed on a printed circuit board of the on-body unit.


In some aspects of the present disclosure, computer systems are provided that include a processor; and memory communicably coupled to the first processor. The memory includes instructions stored therein that, when executed by the processor, cause the processor to receive sensor data (e.g., detect a first sensor signal) from a first electrode on the in vivo analyte sensor; receive additional sensor data (e.g., detect a second sensor signal) from a second electrode on the in vivo analyte sensor, wherein the first electrode and second electrode include different sensing chemistries with different temperature dependencies; and determine a compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes.


In certain embodiments, the computer systems include an in vivo analyte sensor, at least one temperature sensor, a sensor electronics unit that receives analyte data from the in vivo analyte sensor, and a receiver unit that receives analyte data from the sensor electronics unit.


In certain embodiments, the compensated temperature is determined by an on-body unit.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the compensated temperature is determined by an on-body unit and communicated to a receiver.


In certain embodiments, the temperature is determined based on a ratio of the first sensor signal and the second sensor signal,


In certain embodiments, the temperature is determined based on a predetermined temperature, sensor areas, quantity of sensing materials, and efficiencies of the sensing chemistries, and diffusion controlling membrane.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determining a temperature-compensated analyte sensor signal with the compensated temperature.


In certain embodiments, the memory includes instructions that, when executed by the processor, cause the processor to determine an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the compensated temperature is determined by an on-body unit and communicated to a receiver.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the first sensor signal and not the second sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the second sensor signal and not the first sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with both the first sensor signal and the second sensor signal.


In certain embodiments, the first electrode includes a first plurality of sensing elements on the in vivo analyte sensor and the second electrode includes a second plurality of sensing elements disposed on the in vivo analyte sensor.


In some aspects of the present disclosure, computer-implemented methods of determining an analyte level by compensating for ambient temperature using a temperature sensor are provided. The computer-implemented method include receiving analyte data (e.g., a sensor signal derived from an in vivo analyte sensor); receiving temperature data (e.g., detecting a temperature measurement from a temperature sensor); determining, with a processor, whether a threshold requirement is exceeded based on the temperature measurement; and determining, with the processor, a temperature-compensated analyte sensor signal. When the threshold requirement is not exceeded, the temperature-compensated analyte sensor signal is determined using the temperature measurement. Only when the threshold requirement is exceeded, the temperature-compensated analyte sensor signal is determined using an ambient-compensated temperature that is derived by compensating the temperature measurement for ambient temperature.


In certain embodiments, the computer-implemented methods include determining an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature sensor is coupled to an on-body unit including the in vivo analyte sensor.


In certain embodiments, the temperature measurement represents skin temperature.


In certain embodiments, the ambient-compensated temperature is derived by adding a correction factor to the temperature measurement.


In certain embodiments, the analyte is glucose.


In certain embodiments, the threshold requirement includes an upper threshold value, and wherein adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded.


In certain embodiments, the threshold requirement includes a lower threshold value, and wherein adding a correction factor increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement includes an upper threshold value and a lower threshold value, and wherein adding a correction factor decreases the temperature measurement when the upper threshold value is exceeded and increases the temperature measurement when the lower threshold value is exceeded.


In certain embodiments, the threshold requirement is exceeded when a value of the temperature measurement exceeds the threshold requirement.


In certain embodiments, the threshold requirement is exceeded when a rate-of-change of the temperature measurement exceeds the threshold requirement.


In some aspects of the present disclosure, computer-implemented methods of compensating for ambient temperature using a temperature sensor are provided. The computer-implemented methods include receiving temperature data (e.g., detecting a temperature measurement from a temperature sensor); and determining, with a processor, an ambient-compensated temperature from the temperature measurement using an offset term.


In certain embodiments, the computer-implemented methods include receiving analyte data (e.g., a sensor signal from an in vivo analyte sensor); and determining, with a processor, a temperature-compensated analyte sensor signal with the ambient-compensated temperature.


In certain embodiments, the computer-implemented methods include determining an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the offset term that is based on a predetermined core body temperature.


In certain embodiments, the predetermined core body temperature is between 36° C. and 38° C.


In certain embodiments, the predetermined core body temperature is approximately 37° C.


In some aspects of the present disclosure, computer-implemented methods of compensating for ambient temperature using temperature sensors are provided. The computer-implemented methods include receiving temperature data (e.g., sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor); determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. The correction gain or factor changes value at a slower rate than the sampling rate.


In certain embodiments, the correction gain is applied to the first ambient-compensated temperatures.


In certain embodiments, the computer-implemented methods include receiving second sensor data (e.g., sampling at the first sampling rate, with a processor, second temperature measurements from a second temperature sensor on the on-body sensor); and determining, with a processor, second ambient-compensated temperatures with the second temperature measurements. The correction gain is calculated by performing a moving average between first ambient-compensated temperatures and second ambient-compensated temperatures, such that the correction gain is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In certain embodiments, one or more of the processor sampling first temperatures at a first sampling rate, the processor determining first ambient-compensated temperatures, the processor determining final ambient compensated temperatures, the processor sampling second temperatures at the first sampling rate, and the processor determining the second ambient-compensated temperature are different processors.


In certain embodiments, the sampling of first temperatures at a first rate, the determining of first ambient-compensated temperatures, the determining of final ambient compensated temperatures, the determining of final ambient compensated temperatures, the sampling of second temperatures at the first sampling rate, and the determining of the second ambient-compensated temperature are each performed by either a processor coupled to an on-body unit including an in vivo analyte sensor or by a processor coupled to a receiver that communicates with the on-body unit.


In certain embodiments, the correction gain is calculated using parameter adaptation.


In certain embodiments, the parameter adaptation is MIT adaptation.


In certain embodiments, the correction factor is applied to the first ambient-compensated temperatures.


In certain embodiments, the computer-implemented methods include sampling at the first sampling rate, with a processor, second temperatures measured from a second temperature sensor on the on-body sensor; and determining, with a processor, second ambient-compensated temperatures with the second temperature measurements. The correction factor is calculated by performing windowed comparisons between the first ambient-compensated temperatures and the second ambient-compensated temperatures, such that the correction factor is based on a set of recent pairs of first ambient-compensated temperatures and second ambient-compensated temperatures.


In some aspects of the present disclosure, computer-implemented methods are provided that receive sensor data (e.g., a first sensor signal from a first electrode on an in vivo analyte sensor on an on-body sensor); receive additional sensor data (e.g., a second sensor signal from a second electrode on the in vivo analyte sensor); and determine a compensated temperature at the two working electrodes based on the difference between the temperature dependencies for the different sensing chemistries on the two working electrodes. The first electrode and second electrode include different sensing chemistries with different temperature dependencies.


In certain embodiments, the temperature is determined based on a ratio of the first sensor signal and the second sensor signal.


In certain embodiments, the temperature is determined based on a predetermined temperature, sensor areas, quantity of sensing materials, and efficiencies of the sensing chemistries, and diffusion controlling membrane.


In certain embodiments, the computer-implemented methods include determining, with a processor, a temperature-compensated analyte sensor signal with the compensated temperature.


In certain embodiments, the computer-implemented methods include determining an analyte level based on the temperature-compensated analyte sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the first sensor signal and not the second sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with the second sensor signal and not the first sensor signal.


In certain embodiments, the temperature-compensated analyte sensor signal is determined with both the first sensor signal and the second sensor signal.


In certain embodiments, the first electrode includes a first plurality of sensing elements on the in vivo analyte sensor and the second electrode includes a second plurality of sensing elements disposed on the in vivo analyte sensor.


Various other modifications and alterations in the structure and method of operation of this disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the embodiments of the present disclosure. Although the present disclosure has been described in connection with particular embodiments, it should be understood that the present disclosure as claimed should not be unduly limited to such particular embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.


It should be understood that techniques introduced above can be implemented by programmable circuitry programmed or configured by software and/or firmware, or they can be implemented entirely by special-purpose “hardwired” circuitry, or in a combination of such forms. Such special-purpose circuitry (if any) can be in the form of, for example, one or more application-specific integrated circuits (ASICS), programmable logic devices (PLDs), field-programmable gate arrays (FPGAs), etc.


Software or firmware implementing the techniques introduced herein may be stored on a machine-readable storage medium and may be executed by one or more general-purpose or special-purpose programmable microprocessors. A “machine-readable medium”, as the term is used herein, includes any mechanism that can store information in a form accessible by a machine (a machine may be, for example, a computer, network device, cellular phone, personal digital assistant (PDA), manufacturing took, any device with one or more processors, etc.). For example, a machine-accessible medium includes recordable/non-recordable media (e.g., read-only memory (ROM); random access memory (RAM); magnetic disk storage media; optical storage media; flash memory devices; etc.), etc.


The term “logic”, as used herein, can include, for example, special purpose hardwired circuitry, software and/or firmware in conjunction with programmable circuitry, or a combination thereof.

Claims
  • 1. A method of compensating for ambient temperature using a single temperature sensor comprising: receiving a sensor signal from an in vivo glucose sensor comprising a sensing area, wherein the in vivo glucose sensor comprises a first portion arranged above a skin surface of a user and a second portion positioned below the skin surface and in contact with interstitial fluid, wherein the second portion comprises the sensing area;detecting a temperature measurement from a temperature sensor, wherein the temperature sensor is disposed in a housing and is arranged above the skin surface of the user;determining, with a processor communicably coupled to the in vivo glucose sensor and the temperature sensor, an ambient-compensated temperature from the temperature measurement using an offset term based on a core body temperature, wherein the ambient-compensated temperature is an estimated temperature of the sensing area; anddetermining, with the processor, a temperature-compensated glucose sensor signal with the thus determined ambient-compensated temperature.
  • 2. The method according to claim 1, wherein the offset term is between 36° C. and 38° C.
  • 3. The method according to claim 2, wherein the core body temperature is approximately 37° C.
  • 4. A glucose monitoring device, comprising: a housing;a processor coupled to the housing;wherein an in vivo glucose sensor comprising a sensing area is communicably coupled to the processor, wherein the in vivo glucose sensor comprises a first portion configured to be arranged above a skin surface of a user and a second portion configured to be positioned below the skin surface and in contact with interstitial fluid, wherein the second portion comprises the sensing area;wherein a temperature sensor is communicably coupled to the processor, wherein the temperature sensor is disposed in the housing and is configured to be arranged above the skin surface of the user; andmemory communicably coupled to the processor, wherein the memory includes instructions stored therein that, when executed by the processor, cause the processor to: receive a sensor signal from the in vivo glucose sensor;detect a temperature measurement from the temperature sensor; anddetermine an ambient-compensated temperature from the temperature measurement using an offset term based on a core body temperature, wherein the ambient-compensated temperature is an estimated temperature of the sensing area; anddetermine a temperature-compensated glucose sensor signal with the thus determined ambient-compensated temperature.
  • 5. A glucose monitoring device according to claim 4, wherein the offset term is between 36° C. and 38° C.
  • 6. A glucose monitoring device according to claim 5, wherein the offset term is approximately 37° C.
  • 7. A glucose monitoring system, comprising: a glucose monitoring device, comprising: a first processor and a first memory communicably coupled to the first processor;an in vivo glucose sensor comprising a sensing area communicably coupled to the first processor, wherein the in vivo glucose sensor comprises a first portion configured to be arranged above a skin surface of a user and a second portion configured to be positioned below the skin surface and in contact with interstitial fluid, wherein the second portion comprises the sensing area; anda temperature sensor communicably coupled to the first processor, wherein the temperature sensor is disposed in a housing and is configured to be arranged above the skin surface of the user; anda receiver configured to communicate with the glucose monitoring device, the receiver comprising: a second processor and a second memory communicably coupled to the second processor;wherein at least one of the first memory and the second memory includes instructions stored therein that, when executed by at least one of the first and second processors, cause the at least one of the first and second processors to: receive a sensor signal from the in vivo glucose sensor;detect a temperature measurement from the temperature sensor;determine an ambient-compensated temperature from the temperature measurement using an offset term based on a core body temperature, wherein the ambient-compensated temperature is an estimated temperature of the sensing area; anddetermine a temperature-compensated glucose sensor signal with the thus determined ambient-compensated temperature.
  • 8. The method of claim 1, wherein the temperature sensor comprises a pyroelectric sensor having an optical path to the skin surface, and wherein the detected temperature is a temperature of the skin surface.
  • 9. The glucose monitoring device of claim 4, wherein the temperature sensor comprises a pyroelectric sensor having an optical path to the skin surface, and wherein the detected temperature is a temperature of the skin surface.
  • 10. The glucose monitoring device of claim 4, wherein the temperature sensor comprises a thermocouple temperature sensor, wherein the in vivo glucose sensor comprises a sensor substrate having a metal trace disposed on a first side of the sensor substrate and conductive ink disposed on a second side of the sensor substrate, wherein the sensor substrate defines a through-hole extending from the first side to the second side and containing the conductive ink so as to form a thermocouple junction between the metal trace and the conductive ink.
  • 11. The glucose monitoring device of claim 4, wherein the in vivo glucose sensor further comprises a second sensing area and a reservoir containing a glucose solution at a known concentration, wherein the second sensing area is configured to be arranged under the skin surface to generate a second sensor signal, and wherein the sensor signal is adjusted based on the second sensor signal to account for temperature.
  • 12. The glucose monitoring system of claim 7, wherein the in vivo glucose sensor further comprises a second sensing area and a reservoir containing a glucose solution at a known concentration, wherein the second sensing area is configured to be arranged under the skin surface to generate a second sensor signal, and wherein the sensor signal is adjusted based on the second sensor signal to account for temperature.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/525,915, filed Jul. 30, 2019, which is a continuation of U.S. application Ser. No. 15/873,464, filed Jan. 17, 2018, now U.S. Pat. No. 10,398,363; which is a divisional of U.S. application Ser. No. 13/526,394 filed Jun. 18, 2012, now U.S. Pat. No. 9,974,472; which application claims priority to U.S. Provisional Application No. 61/497,821, filed Jun. 16, 2011, the disclosures of each application are incorporated by reference herein in their entireties. The following patents, applications and/or publications are incorporated herein by reference for all purposes: U.S. Pat. Nos. 7,041,468; 5,356,786; 6,175,752; 6,560,471; 5,262,035; 6,881,551; 6,121,009; 7,167,818; 6,270,455; 6,161,095; 5,918,603; 6,144,837; 5,601,435; 5,822,715; 5,899,855; 6,071,391; 6,120,676; 6,143,164; 6,299,757; 6,338,790; 6,377,894; 6,600,997; 6,773,671; 6,514,460; 6,592,745; 5,628,890; 5,820,551; 6,736,957; 4,545,382; 4,711,245; 5,509,410; 6,540,891; 6,730,200; 6,764,581; 6,299,757; 6,461,496; 6,503,381; 6,591,125; 6,616,819; 6,618,934; 6,676,816; 6,749,740; 6,893,545; 6,942,518; 6,514,718; 5,264,014; 5,262,305; 5,320,715; 5,593,852; 6,746,582; 6,284,478; 7,299,082; 7,866,026; U.S. Patent Publication No. 2010/0326842; U.S. Patent Publication No. 2010/0198034; U.S. Pat. Nos. 9,402,544; 7,811,231; U.S. Publication No. 2007/0095661; U.S. Publication No. 2006/0091006; U.S. Pat. No. 7,740,581; U.S. Publication No. 2008/0267823; U.S. Publication No. 2007/0108048; U.S. Publication No. 2008/0102441; U.S. Publication No. 2008/0066305; U.S. Publication No. 2007/0199818; U.S. Publication No. 2008/0148873; U.S. Publication No. 2007/0068807; US Publication No. 2010/0198034; U.S. Publication No. 2010/0325868; the disclosures of each of which are incorporated herein by reference in their entirety.

US Referenced Citations (1195)
Number Name Date Kind
3581062 Aston May 1971 A
3729343 Thomas Apr 1973 A
3926760 Allen et al. Dec 1975 A
3949388 Fuller Apr 1976 A
3960497 Acord Jun 1976 A
4036749 Anderson Jul 1977 A
4055175 Clemens et al. Oct 1977 A
4129128 McFarlane Dec 1978 A
4245634 Albisser et al. Jan 1981 A
4327725 Cortese et al. May 1982 A
4344438 Schultz Aug 1982 A
4349728 Phillips et al. Sep 1982 A
4373527 Fischell Feb 1983 A
4392849 Petre et al. Jul 1983 A
4425920 Bourland et al. Jan 1984 A
4431004 Bessman Feb 1984 A
4441968 Emmer et al. Apr 1984 A
4464170 Clemens et al. Aug 1984 A
4478976 Goertz et al. Oct 1984 A
4494950 Fischell Jan 1985 A
4509531 Ward Apr 1985 A
4527240 Kvitash Jul 1985 A
4538616 Rogoff Sep 1985 A
4545382 Higgins et al. Oct 1985 A
4619793 Lee Oct 1986 A
4671288 Gough Jun 1987 A
4703756 Gough et al. Nov 1987 A
4711245 Higgins et al. Dec 1987 A
4731726 Allen, III Mar 1988 A
4749985 Corsberg Jun 1988 A
4757022 Shults et al. Jul 1988 A
4777953 Ash et al. Oct 1988 A
4779618 Mund et al. Oct 1988 A
4847785 Stephens Jul 1989 A
4854322 Ash et al. Aug 1989 A
4871351 Feingold Oct 1989 A
4890620 Gough Jan 1990 A
4925268 Iyer et al. May 1990 A
4953552 DeMarzo Sep 1990 A
4986271 Wilkins Jan 1991 A
4995402 Smith et al. Feb 1991 A
5000180 Kuypers et al. Mar 1991 A
5002054 Ash et al. Mar 1991 A
5019974 Beckers May 1991 A
5050612 Matsumura Sep 1991 A
5051688 Murase et al. Sep 1991 A
5055171 Peck Oct 1991 A
5068536 Rosenthal Nov 1991 A
5082550 Rishpon et al. Jan 1992 A
5106365 Hernandez Apr 1992 A
5122925 Inpyn Jun 1992 A
5135004 Adams et al. Aug 1992 A
5165407 Wilson et al. Nov 1992 A
5202261 Musho et al. Apr 1993 A
5204264 Kaminer Apr 1993 A
5210778 Massart May 1993 A
5228449 Christ et al. Jul 1993 A
5231988 Wernicke et al. Aug 1993 A
5246867 Lakowicz et al. Sep 1993 A
5251126 Kahn et al. Oct 1993 A
5262035 Gregg et al. Nov 1993 A
5262305 Heller et al. Nov 1993 A
5264014 Lannefors et al. Nov 1993 A
5264104 Gregg et al. Nov 1993 A
5264105 Gregg et al. Nov 1993 A
5279294 Anderson et al. Jan 1994 A
5285792 Sjoquist et al. Feb 1994 A
5293877 O'Hara et al. Mar 1994 A
5299571 Mastrototaro Apr 1994 A
5320715 Berg Jun 1994 A
5320725 Gregg et al. Jun 1994 A
5322063 Allen et al. Jun 1994 A
5327029 Ericson et al. Jul 1994 A
5330634 Wong et al. Jul 1994 A
5340722 Wolfbeis et al. Aug 1994 A
5342789 Chick et al. Aug 1994 A
5356786 Heller et al. Oct 1994 A
5360404 Novacek et al. Nov 1994 A
5372427 Padovani et al. Dec 1994 A
5379238 Stark Jan 1995 A
5384547 Lynk, Jr. et al. Jan 1995 A
5390671 Lord et al. Feb 1995 A
5391250 Cheney, II et al. Feb 1995 A
5408999 Singh et al. Apr 1995 A
5410326 Goldstein Apr 1995 A
5411647 Johnson et al. May 1995 A
5425868 Pedersen Jun 1995 A
5429602 Hauser Jul 1995 A
5431160 Wilkins Jul 1995 A
5431921 Thombre Jul 1995 A
5438983 Falcone Aug 1995 A
5462645 Albery et al. Oct 1995 A
5472317 Field et al. Dec 1995 A
5489414 Schreiber et al. Feb 1996 A
5497772 Schulman et al. Mar 1996 A
5505828 Wong et al. Apr 1996 A
5507288 Bocker et al. Apr 1996 A
5509410 Hill et al. Apr 1996 A
5514718 Lewis et al. May 1996 A
5531878 Vadgama et al. Jul 1996 A
5532686 Urbas et al. Jul 1996 A
5552997 Massart Sep 1996 A
5568400 Stark et al. Oct 1996 A
5568806 Cheney, II et al. Oct 1996 A
5569186 Lord et al. Oct 1996 A
5582184 Erickson et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5593852 Heller et al. Jan 1997 A
5601435 Quy Feb 1997 A
5609575 Larson et al. Mar 1997 A
5628310 Rao et al. May 1997 A
5628890 Carter et al. May 1997 A
5634468 Platt et al. Jun 1997 A
5653239 Pompei et al. Aug 1997 A
5660163 Schulman et al. Aug 1997 A
5665222 Heller et al. Sep 1997 A
5707502 McCaffrey et al. Jan 1998 A
5711001 Bussan et al. Jan 1998 A
5711861 Ward et al. Jan 1998 A
5724030 Urbas et al. Mar 1998 A
5726646 Bane et al. Mar 1998 A
5733259 Valcke et al. Mar 1998 A
5735285 Albert et al. Apr 1998 A
5748103 Flach et al. May 1998 A
5749907 Mann May 1998 A
5772586 Heinonen et al. Jun 1998 A
5791344 Schulman et al. Aug 1998 A
5804047 Karube et al. Sep 1998 A
5820551 Hill et al. Oct 1998 A
5822715 Worthington et al. Oct 1998 A
5833603 Kovacs et al. Nov 1998 A
5842189 Keeler et al. Nov 1998 A
5891049 Cyrus et al. Apr 1999 A
5899855 Brown May 1999 A
5914026 Blubaugh, Jr. et al. Jun 1999 A
5918603 Brown Jul 1999 A
5919141 Money et al. Jul 1999 A
5925021 Castellano et al. Jul 1999 A
5935224 Svancarek et al. Aug 1999 A
5942979 Luppino Aug 1999 A
5951485 Cyrus et al. Sep 1999 A
5957854 Besson et al. Sep 1999 A
5961451 Reber et al. Oct 1999 A
5964993 Blubaugh, Jr. et al. Oct 1999 A
5965380 Heller et al. Oct 1999 A
5971922 Arita et al. Oct 1999 A
5980708 Champagne et al. Nov 1999 A
5995860 Sun et al. Nov 1999 A
6001067 Shults et al. Dec 1999 A
6024699 Surwit et al. Feb 2000 A
6028413 Brockmann Feb 2000 A
6049727 Crothall Apr 2000 A
6052565 Ishikura et al. Apr 2000 A
6066243 Anderson et al. May 2000 A
6071391 Gotoh et al. Jun 2000 A
6083710 Heller et al. Jul 2000 A
6088608 Schulman et al. Jul 2000 A
6091976 Pfeiffer et al. Jul 2000 A
6091987 Thompson Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6096364 Bok et al. Aug 2000 A
6103033 Say et al. Aug 2000 A
6117290 Say et al. Sep 2000 A
6119028 Schulman et al. Sep 2000 A
6120676 Heller et al. Sep 2000 A
6121009 Heller et al. Sep 2000 A
6121611 Lindsay et al. Sep 2000 A
6122351 Schlueter, Jr. et al. Sep 2000 A
6130623 MacLellan et al. Oct 2000 A
6134461 Say et al. Oct 2000 A
6143164 Heller et al. Nov 2000 A
6144837 Quy Nov 2000 A
6144871 Saito et al. Nov 2000 A
6159147 Lichter et al. Dec 2000 A
6161095 Brown Dec 2000 A
6162611 Heller et al. Dec 2000 A
6175752 Say et al. Jan 2001 B1
6200265 Walsh et al. Mar 2001 B1
6212416 Ward et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6223283 Chaiken et al. Apr 2001 B1
6233471 Berner et al. May 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6254586 Mann et al. Jul 2001 B1
6270455 Brown Aug 2001 B1
6275717 Gross et al. Aug 2001 B1
6283761 Joao Sep 2001 B1
6284478 Heller et al. Sep 2001 B1
6291200 LeJeune et al. Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6294997 Paratore et al. Sep 2001 B1
6295506 Heinonen et al. Sep 2001 B1
6299347 Pompei Oct 2001 B1
6299757 Feldman et al. Oct 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309884 Cooper et al. Oct 2001 B1
6314317 Willis Nov 2001 B1
6329161 Heller et al. Dec 2001 B1
6338790 Feldman et al. Jan 2002 B1
6348640 Navot et al. Feb 2002 B1
6359270 Bridson Mar 2002 B1
6359444 Grimes Mar 2002 B1
6360888 McIvor et al. Mar 2002 B1
6366794 Moussy et al. Apr 2002 B1
6377828 Chaiken et al. Apr 2002 B1
6377894 Deweese et al. Apr 2002 B1
6379301 Worthington et al. Apr 2002 B1
6387048 Schulman et al. May 2002 B1
6400974 Lesho Jun 2002 B1
6405066 Essenpreis et al. Jun 2002 B1
6413393 Van Antwerp et al. Jul 2002 B1
6416471 Kumar et al. Jul 2002 B1
6418346 Nelson et al. Jul 2002 B1
6424847 Mastrototaro et al. Jul 2002 B1
6427088 Bowman, IV et al. Jul 2002 B1
6440068 Brown et al. Aug 2002 B1
6461496 Feldman et al. Oct 2002 B1
6471689 Joseph et al. Oct 2002 B1
6478736 Mault Nov 2002 B1
6484046 Say et al. Nov 2002 B1
6493069 Nagashimada et al. Dec 2002 B1
6496729 Thompson Dec 2002 B2
6497655 Linberg et al. Dec 2002 B1
6498043 Schulman et al. Dec 2002 B1
6503381 Gotoh et al. Jan 2003 B1
6510344 Halpern Jan 2003 B1
6514460 Fendrock Feb 2003 B1
6514718 Heller et al. Feb 2003 B2
6520326 McIvor et al. Feb 2003 B2
6540891 Stewart et al. Apr 2003 B1
6544212 Galley et al. Apr 2003 B2
6546268 Ishikawa et al. Apr 2003 B1
6549796 Sohrab Apr 2003 B2
6551494 Heller et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6558321 Burd et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6560471 Heller May 2003 B1
6561975 Pool et al. May 2003 B1
6561978 Conn et al. May 2003 B1
6562001 Lebel et al. May 2003 B2
6564105 Starkweather et al. May 2003 B2
6565509 Say et al. May 2003 B1
6571128 Lebel et al. May 2003 B2
6572545 Knobbe et al. Jun 2003 B2
6574490 Abbink et al. Jun 2003 B2
6574510 Von Arx et al. Jun 2003 B2
6576101 Heller et al. Jun 2003 B1
6577899 Lebel et al. Jun 2003 B2
6579231 Phipps Jun 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6585644 Lebel et al. Jul 2003 B2
6591125 Buse et al. Jul 2003 B1
6592745 Feldman et al. Jul 2003 B1
6595919 Berner et al. Jul 2003 B2
6600997 Deweese et al. Jul 2003 B2
6605200 Mao et al. Aug 2003 B1
6605201 Mao et al. Aug 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6610012 Mault Aug 2003 B2
6616819 Liamos et al. Sep 2003 B1
6618934 Feldman et al. Sep 2003 B1
6633772 Ford et al. Oct 2003 B2
6635014 Starkweather et al. Oct 2003 B2
6635167 Batman et al. Oct 2003 B1
6641533 Causey, III et al. Nov 2003 B2
6648821 Lebel et al. Nov 2003 B2
6650471 Doi Nov 2003 B2
6654625 Say et al. Nov 2003 B1
6656114 Poulsen et al. Dec 2003 B1
6658396 Tang et al. Dec 2003 B1
6659948 Lebel et al. Dec 2003 B2
6668196 Villegas et al. Dec 2003 B1
6675030 Ciurczak et al. Jan 2004 B2
6676816 Mao et al. Jan 2004 B2
6687546 Lebel et al. Feb 2004 B2
6689056 Kilcoyne et al. Feb 2004 B1
6694191 Starkweather et al. Feb 2004 B2
6695860 Ward et al. Feb 2004 B1
6698269 Baber et al. Mar 2004 B2
6702857 Brauker et al. Mar 2004 B2
6730025 Platt May 2004 B1
6730200 Stewart et al. May 2004 B1
6731976 Penn et al. May 2004 B2
6733446 Lebel et al. May 2004 B2
6735183 O'Toole et al. May 2004 B2
6736957 Forrow et al. May 2004 B1
6740075 Lebel et al. May 2004 B2
6740518 Duong et al. May 2004 B1
6741877 Shults et al. May 2004 B1
6746582 Heller et al. Jun 2004 B2
6749740 Liamos et al. Jun 2004 B2
6758810 Lebel et al. Jul 2004 B2
6764581 Forrow et al. Jul 2004 B1
6770030 Schaupp et al. Aug 2004 B1
6773671 Lewis et al. Aug 2004 B1
6789195 Prihoda et al. Sep 2004 B1
6790178 Mault et al. Sep 2004 B1
6804558 Haller et al. Oct 2004 B2
6809653 Mann et al. Oct 2004 B1
6810290 Lebel et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6811534 Bowman, IV et al. Nov 2004 B2
6813519 Lebel et al. Nov 2004 B2
6850790 Berner et al. Feb 2005 B2
6862465 Shults et al. Mar 2005 B2
6865407 Kimball et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6878112 Linberg et al. Apr 2005 B2
6881551 Heller et al. Apr 2005 B2
6882940 Potts et al. Apr 2005 B2
6892085 McIvor et al. May 2005 B2
6893545 Gotoh et al. May 2005 B2
6895263 Shin et al. May 2005 B2
6895265 Silver May 2005 B2
6923763 Kovatchev et al. Aug 2005 B1
6923764 Aceti et al. Aug 2005 B2
6931327 Goode, Jr. et al. Aug 2005 B2
6932894 Mao et al. Aug 2005 B2
6936006 Sabra Aug 2005 B2
6940403 Kail, IV Sep 2005 B2
6941163 Ford et al. Sep 2005 B2
6942518 Liamos et al. Sep 2005 B2
6950708 Bowman, IV et al. Sep 2005 B2
6958705 Lebel et al. Oct 2005 B2
6968294 Gutta et al. Nov 2005 B2
6971274 Olin Dec 2005 B2
6974437 Lebel et al. Dec 2005 B2
6983176 Gardner et al. Jan 2006 B2
6990366 Say et al. Jan 2006 B2
6997907 Safabash et al. Feb 2006 B2
6998247 Monfre et al. Feb 2006 B2
6999854 Roth Feb 2006 B2
7003336 Holker et al. Feb 2006 B2
7003340 Say et al. Feb 2006 B2
7003341 Say et al. Feb 2006 B2
7009511 Mazar et al. Mar 2006 B2
7015817 Copley et al. Mar 2006 B2
7016713 Gardner et al. Mar 2006 B2
7020508 Stivoric et al. Mar 2006 B2
7022072 Fox et al. Apr 2006 B2
7022219 Mansouri et al. Apr 2006 B2
7024236 Ford et al. Apr 2006 B2
7024245 Lebel et al. Apr 2006 B2
7025425 Kovatchev et al. Apr 2006 B2
7027848 Robinson et al. Apr 2006 B2
7027931 Jones et al. Apr 2006 B1
7029444 Shin et al. Apr 2006 B2
7041068 Freeman et al. May 2006 B2
7041468 Drucker et al. May 2006 B2
7043305 Kenknight et al. May 2006 B2
7046153 Oja et al. May 2006 B2
7052483 Wojcik May 2006 B2
7056302 Douglas Jun 2006 B2
7058453 Nelson et al. Jun 2006 B2
7060031 Webb et al. Jun 2006 B2
7074307 Simpson et al. Jul 2006 B2
7081195 Simpson et al. Jul 2006 B2
7082334 Boute et al. Jul 2006 B2
7092891 Maus et al. Aug 2006 B2
7098803 Mann et al. Aug 2006 B2
7108778 Simpson et al. Sep 2006 B2
7110803 Shults et al. Sep 2006 B2
7113821 Sun et al. Sep 2006 B1
7118667 Lee Oct 2006 B2
7123950 Mannheimer Oct 2006 B2
7125382 Zhou et al. Oct 2006 B2
7134999 Brauker et al. Nov 2006 B2
7136689 Shults et al. Nov 2006 B2
7153265 Vachon Dec 2006 B2
7155290 Von Arx et al. Dec 2006 B2
7167818 Brown Jan 2007 B2
7171274 Starkweather et al. Jan 2007 B2
7179226 Crothall et al. Feb 2007 B2
7190988 Say et al. Mar 2007 B2
7192450 Brauker et al. Mar 2007 B2
7198606 Boecker et al. Apr 2007 B2
7203549 Schommer et al. Apr 2007 B2
7207974 Safabash et al. Apr 2007 B2
7225535 Feldman et al. Jun 2007 B2
7226442 Sheppard, Jr. et al. Jun 2007 B2
7226978 Tapsak et al. Jun 2007 B2
7228182 Healy et al. Jun 2007 B2
7237712 DeRocco et al. Jul 2007 B2
7258673 Racchini et al. Aug 2007 B2
7267665 Steil et al. Sep 2007 B2
7276029 Goode, Jr. et al. Oct 2007 B2
7278983 Ireland et al. Oct 2007 B2
7286894 Grant et al. Oct 2007 B1
7295867 Berner et al. Nov 2007 B2
7299082 Feldman et al. Nov 2007 B2
7301463 Paterno Nov 2007 B1
7310544 Brister et al. Dec 2007 B2
7317938 Lorenz et al. Jan 2008 B2
7318816 Bobroff et al. Jan 2008 B2
7324850 Persen et al. Jan 2008 B2
7329239 Safabash et al. Feb 2008 B2
7335294 Heller et al. Feb 2008 B2
7347819 Lebel et al. Mar 2008 B2
7354420 Steil et al. Apr 2008 B2
7364592 Carr-Brendel et al. Apr 2008 B2
7366556 Brister et al. Apr 2008 B2
7379765 Petisce et al. May 2008 B2
7384397 Zhang et al. Jun 2008 B2
7387010 Sunshine Jun 2008 B2
7399277 Saidara et al. Jul 2008 B2
7402153 Steil et al. Jul 2008 B2
7404796 Ginsberg Jul 2008 B2
7419573 Gundel Sep 2008 B2
7424318 Brister et al. Sep 2008 B2
7460898 Brister et al. Dec 2008 B2
7467003 Brister et al. Dec 2008 B2
7468125 Kraft et al. Dec 2008 B2
7471972 Rhodes et al. Dec 2008 B2
7474992 Ariyur Jan 2009 B2
7492254 Bandy et al. Feb 2009 B2
7494465 Brister et al. Feb 2009 B2
7497827 Brister et al. Mar 2009 B2
7519408 Rasdal et al. Apr 2009 B2
7547281 Hayes et al. Jun 2009 B2
7565197 Haubrich et al. Jul 2009 B2
7569030 Lebel et al. Aug 2009 B2
7574266 Dudding et al. Aug 2009 B2
7583990 Goode, Jr. et al. Sep 2009 B2
7591801 Brauker et al. Sep 2009 B2
7599726 Goode, Jr. et al. Oct 2009 B2
7602310 Mann et al. Oct 2009 B2
7604178 Stewart Oct 2009 B2
7613491 Boock et al. Nov 2009 B2
7615007 Shults et al. Nov 2009 B2
7618369 Hayter et al. Nov 2009 B2
7630748 Budiman Dec 2009 B2
7632228 Brauker et al. Dec 2009 B2
7635594 Holmes et al. Dec 2009 B2
7637868 Saint et al. Dec 2009 B2
7640048 Dobbles et al. Dec 2009 B2
7643798 Ljung Jan 2010 B2
7651596 Petisce et al. Jan 2010 B2
7651845 Doyle, III et al. Jan 2010 B2
7653425 Hayter et al. Jan 2010 B2
7654956 Brister et al. Feb 2010 B2
7657297 Simpson et al. Feb 2010 B2
7659823 Killian et al. Feb 2010 B1
7668596 Von Arx et al. Feb 2010 B2
7699775 Desai et al. Apr 2010 B2
7699964 Feldman et al. Apr 2010 B2
7711402 Shults et al. May 2010 B2
7713574 Brister et al. May 2010 B2
7715893 Kamath et al. May 2010 B2
7736310 Taub Jun 2010 B2
7741734 Joannopoulos et al. Jun 2010 B2
7766829 Sloan et al. Aug 2010 B2
7768386 Hayter Aug 2010 B2
7768387 Fennell Aug 2010 B2
7771352 Shults et al. Aug 2010 B2
7774145 Brauker et al. Aug 2010 B2
7778680 Goode, Jr. et al. Aug 2010 B2
7779332 Karr et al. Aug 2010 B2
7782192 Jeckelmann et al. Aug 2010 B2
7783333 Brister et al. Aug 2010 B2
7791467 Mazar et al. Sep 2010 B2
7792562 Shults et al. Sep 2010 B2
7811231 Jin et al. Oct 2010 B2
7813809 Strother et al. Oct 2010 B2
7826382 Sicurello et al. Nov 2010 B2
7826981 Goode, Jr. et al. Nov 2010 B2
7831310 Lebel et al. Nov 2010 B2
7835925 Roe et al. Nov 2010 B2
7860574 Von Arx et al. Dec 2010 B2
7882611 Shah et al. Feb 2011 B2
7889069 Fifolt et al. Feb 2011 B2
7899511 Shults et al. Mar 2011 B2
7899545 John Mar 2011 B2
7905833 Brister et al. Mar 2011 B2
7912674 Killoren Clark et al. Mar 2011 B2
7914450 Goode, Jr. et al. Mar 2011 B2
7916013 Stevenson Mar 2011 B2
7920906 Goode, Jr. et al. Apr 2011 B2
7920907 McGarraugh et al. Apr 2011 B2
7928850 Hayter et al. Apr 2011 B2
7938797 Estes May 2011 B2
7941200 Weinert et al. May 2011 B2
7946985 Mastrototaro et al. May 2011 B2
7955258 Goscha et al. Jun 2011 B2
7970448 Shults et al. Jun 2011 B2
7972296 Braig et al. Jul 2011 B2
7974672 Shults et al. Jul 2011 B2
7976466 Ward et al. Jul 2011 B2
7978063 Baldus et al. Jul 2011 B2
7999674 Kamen Aug 2011 B2
8010174 Goode, Jr. et al. Aug 2011 B2
8010256 Oowada Aug 2011 B2
8072310 Everhart Dec 2011 B1
8090445 Ginggen Jan 2012 B2
8093991 Stevenson et al. Jan 2012 B2
8094009 Allen et al. Jan 2012 B2
8098159 Batra et al. Jan 2012 B2
8098160 Howarth et al. Jan 2012 B2
8098161 Lavedas Jan 2012 B2
8098201 Choi et al. Jan 2012 B2
8098208 Ficker et al. Jan 2012 B2
8102021 Degani Jan 2012 B2
8102154 Bishop et al. Jan 2012 B2
8102263 Yeo et al. Jan 2012 B2
8102789 Rosar et al. Jan 2012 B2
8103241 Young et al. Jan 2012 B2
8103325 Swedlow et al. Jan 2012 B2
8111042 Bennett Feb 2012 B2
8115488 McDowell Feb 2012 B2
8116681 Baarman Feb 2012 B2
8116683 Baarman Feb 2012 B2
8117481 Anselmi et al. Feb 2012 B2
8120493 Burr Feb 2012 B2
8124452 Sheats Feb 2012 B2
8130093 Mazar et al. Mar 2012 B2
8131351 Kalgren et al. Mar 2012 B2
8131365 Zhang et al. Mar 2012 B2
8131551 Cosatto et al. Mar 2012 B1
8131565 Dicks et al. Mar 2012 B2
8132037 Fehr et al. Mar 2012 B2
8135352 Langsweirdt et al. Mar 2012 B2
8136735 Arai et al. Mar 2012 B2
8138925 Downie et al. Mar 2012 B2
8140160 Pless et al. Mar 2012 B2
8140168 Olson et al. Mar 2012 B2
8140299 Siess Mar 2012 B2
8150321 Winter et al. Apr 2012 B2
8150516 Levine et al. Apr 2012 B2
8179266 Hermle May 2012 B2
8192394 Estes et al. Jun 2012 B2
8216138 McGarraugh Jul 2012 B1
8255026 Al-Ali Aug 2012 B1
8282549 Brauker et al. Oct 2012 B2
8374668 Hayter et al. Feb 2013 B1
8461985 Fennell et al. Jun 2013 B2
8597570 Terashima et al. Dec 2013 B2
8710993 Hayter et al. Apr 2014 B2
8845536 Brauker et al. Sep 2014 B2
9974472 Hayter et al. May 2018 B2
10111608 Hayter Oct 2018 B2
10398363 Hayter et al. Sep 2019 B2
11039767 Hayter Jun 2021 B2
20010037366 Webb et al. Nov 2001 A1
20020019022 Dunn et al. Feb 2002 A1
20020019612 Watanabe et al. Feb 2002 A1
20020042090 Heller et al. Apr 2002 A1
20020054320 Ogino May 2002 A1
20020068860 Clark Jun 2002 A1
20020072784 Sheppard et al. Jun 2002 A1
20020095076 Krausman et al. Jul 2002 A1
20020103499 Perez et al. Aug 2002 A1
20020106709 Potts et al. Aug 2002 A1
20020120186 Keimel Aug 2002 A1
20020128594 Das et al. Sep 2002 A1
20020147135 Schnell Oct 2002 A1
20020161288 Shin et al. Oct 2002 A1
20020169439 Flaherty Nov 2002 A1
20020169635 Shillingburg Nov 2002 A1
20030004403 Drinan et al. Jan 2003 A1
20030010089 Holmes Jan 2003 A1
20030023317 Brauker et al. Jan 2003 A1
20030023461 Quintanilla et al. Jan 2003 A1
20030028089 Galley et al. Feb 2003 A1
20030028184 Lebel et al. Feb 2003 A1
20030032077 Itoh et al. Feb 2003 A1
20030032867 Crothall et al. Feb 2003 A1
20030032874 Rhodes et al. Feb 2003 A1
20030042137 Mao et al. Mar 2003 A1
20030055380 Flaherty Mar 2003 A1
20030060692 Ruchti et al. Mar 2003 A1
20030060753 Starkweather et al. Mar 2003 A1
20030065308 Lebel et al. Apr 2003 A1
20030076082 Morgan et al. Apr 2003 A1
20030100040 Bonnecaze et al. May 2003 A1
20030100821 Heller et al. May 2003 A1
20030114897 Von Arx et al. Jun 2003 A1
20030125612 Fox et al. Jul 2003 A1
20030130616 Steil et al. Jul 2003 A1
20030134347 Heller et al. Jul 2003 A1
20030147515 Kai et al. Aug 2003 A1
20030159945 Miyazaki et al. Aug 2003 A1
20030167035 Flaherty et al. Sep 2003 A1
20030168338 Gao et al. Sep 2003 A1
20030169800 Pompei Sep 2003 A1
20030176933 Lebel et al. Sep 2003 A1
20030187338 Say et al. Oct 2003 A1
20030191377 Robinson et al. Oct 2003 A1
20030199744 Buse et al. Oct 2003 A1
20030199790 Boecker et al. Oct 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030211617 Jones Nov 2003 A1
20030212317 Kovatchev et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030216630 Jersey-Willuhn et al. Nov 2003 A1
20030217966 Tapsak et al. Nov 2003 A1
20030225361 Sabra Dec 2003 A1
20040010186 Kimball et al. Jan 2004 A1
20040010207 Flaherty et al. Jan 2004 A1
20040011671 Shults et al. Jan 2004 A1
20040015131 Flaherty et al. Jan 2004 A1
20040024553 Monfre et al. Feb 2004 A1
20040039298 Abreu Feb 2004 A1
20040040840 Mao et al. Mar 2004 A1
20040041749 Dixon Mar 2004 A1
20040045879 Shults et al. Mar 2004 A1
20040054263 Moerman et al. Mar 2004 A1
20040063435 Sakamoto et al. Apr 2004 A1
20040064068 DeNUZZIO et al. Apr 2004 A1
20040064088 Gorman et al. Apr 2004 A1
20040064096 Flaherty et al. Apr 2004 A1
20040099529 Mao et al. May 2004 A1
20040106858 Say et al. Jun 2004 A1
20040117204 Mazar et al. Jun 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040133164 Funderburk et al. Jul 2004 A1
20040133390 Osorio et al. Jul 2004 A1
20040135684 Steinthal et al. Jul 2004 A1
20040138588 Saikley et al. Jul 2004 A1
20040142483 Genshaw Jul 2004 A1
20040146909 Duong et al. Jul 2004 A1
20040147872 Thompson Jul 2004 A1
20040152622 Keith et al. Aug 2004 A1
20040153032 Garribotto et al. Aug 2004 A1
20040158167 Smith et al. Aug 2004 A1
20040167464 Ireland et al. Aug 2004 A1
20040167801 Say et al. Aug 2004 A1
20040171921 Say et al. Sep 2004 A1
20040176672 Silver et al. Sep 2004 A1
20040186362 Brauker et al. Sep 2004 A1
20040186365 Jin et al. Sep 2004 A1
20040193020 Chiba et al. Sep 2004 A1
20040193025 Steil et al. Sep 2004 A1
20040193090 Lebel et al. Sep 2004 A1
20040197846 Hockersmith et al. Oct 2004 A1
20040199056 Husemann et al. Oct 2004 A1
20040199059 Brauker et al. Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204868 Maynard et al. Oct 2004 A1
20040219664 Heller et al. Nov 2004 A1
20040225338 Lebel et al. Nov 2004 A1
20040236200 Say et al. Nov 2004 A1
20040249253 Racchini et al. Dec 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040254434 Goodnow et al. Dec 2004 A1
20040260478 Schwamm Dec 2004 A1
20040267300 Mace Dec 2004 A1
20050001024 Kusaka et al. Jan 2005 A1
20050004439 Shin et al. Jan 2005 A1
20050004494 Perez et al. Jan 2005 A1
20050010269 Lebel et al. Jan 2005 A1
20050017864 Tsoukalis Jan 2005 A1
20050027177 Shin et al. Feb 2005 A1
20050027180 Goode et al. Feb 2005 A1
20050027181 Goode et al. Feb 2005 A1
20050027182 Siddiqui et al. Feb 2005 A1
20050027462 Goode et al. Feb 2005 A1
20050027463 Goode et al. Feb 2005 A1
20050031689 Shults et al. Feb 2005 A1
20050038332 Saidara et al. Feb 2005 A1
20050043598 Goode et al. Feb 2005 A1
20050049179 Davidson et al. Mar 2005 A1
20050070774 Addison et al. Mar 2005 A1
20050070777 Cho et al. Mar 2005 A1
20050090607 Tapsak et al. Apr 2005 A1
20050096511 Fox et al. May 2005 A1
20050096512 Fox et al. May 2005 A1
20050096516 Soykan et al. May 2005 A1
20050112169 Brauker et al. May 2005 A1
20050113648 Yang et al. May 2005 A1
20050113653 Fox et al. May 2005 A1
20050113886 Fischell et al. May 2005 A1
20050114068 Chey et al. May 2005 A1
20050115832 Simpson et al. Jun 2005 A1
20050116683 Cheng et al. Jun 2005 A1
20050121322 Say et al. Jun 2005 A1
20050131346 Douglas Jun 2005 A1
20050137530 Campbell et al. Jun 2005 A1
20050143635 Kamath et al. Jun 2005 A1
20050148003 Keith et al. Jul 2005 A1
20050154271 Rasdal et al. Jul 2005 A1
20050176136 Burd et al. Aug 2005 A1
20050177398 Watanabe et al. Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050187442 Cho et al. Aug 2005 A1
20050187720 Goode et al. Aug 2005 A1
20050192494 Ginsberg Sep 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050195930 Spital et al. Sep 2005 A1
20050199494 Say et al. Sep 2005 A1
20050203360 Brauker et al. Sep 2005 A1
20050204134 Von Arx et al. Sep 2005 A1
20050214892 Kovatchev et al. Sep 2005 A1
20050239154 Feldman et al. Oct 2005 A1
20050239156 Drucker et al. Oct 2005 A1
20050241957 Mao et al. Nov 2005 A1
20050244811 Soundarrajan et al. Nov 2005 A1
20050245795 Goode et al. Nov 2005 A1
20050245799 Brauker et al. Nov 2005 A1
20050245839 Stivoric et al. Nov 2005 A1
20050245904 Estes et al. Nov 2005 A1
20050251033 Scarantino et al. Nov 2005 A1
20050272985 Kotulla et al. Dec 2005 A1
20050277164 Drucker et al. Dec 2005 A1
20050277912 John Dec 2005 A1
20050283208 Von Arx et al. Dec 2005 A1
20050287620 Heller et al. Dec 2005 A1
20060001538 Kraft et al. Jan 2006 A1
20060001551 Kraft et al. Jan 2006 A1
20060004270 Bedard et al. Jan 2006 A1
20060010098 Goodnow et al. Jan 2006 A1
20060015020 Neale et al. Jan 2006 A1
20060015024 Brister et al. Jan 2006 A1
20060016700 Brister et al. Jan 2006 A1
20060017923 Ruchti et al. Jan 2006 A1
20060019327 Brister et al. Jan 2006 A1
20060020186 Brister et al. Jan 2006 A1
20060020187 Brister et al. Jan 2006 A1
20060020188 Kamath et al. Jan 2006 A1
20060020189 Brister et al. Jan 2006 A1
20060020190 Kamath et al. Jan 2006 A1
20060020191 Brister et al. Jan 2006 A1
20060020192 Brister et al. Jan 2006 A1
20060020300 Nghiem et al. Jan 2006 A1
20060025662 Buse et al. Feb 2006 A1
20060025663 Talbot et al. Feb 2006 A1
20060029177 Cranford et al. Feb 2006 A1
20060031094 Cohen et al. Feb 2006 A1
20060036139 Brister et al. Feb 2006 A1
20060036140 Brister et al. Feb 2006 A1
20060036141 Kamath et al. Feb 2006 A1
20060036142 Brister et al. Feb 2006 A1
20060036143 Brister et al. Feb 2006 A1
20060036144 Brister et al. Feb 2006 A1
20060036145 Brister et al. Feb 2006 A1
20060056487 Kuroda et al. Mar 2006 A1
20060058588 Zdeblick Mar 2006 A1
20060079740 Silver et al. Apr 2006 A1
20060091006 Wang et al. May 2006 A1
20060142651 Brister et al. Jun 2006 A1
20060154642 Scannell Jul 2006 A1
20060155180 Brister et al. Jul 2006 A1
20060156796 Burke et al. Jul 2006 A1
20060166629 Reggiardo Jul 2006 A1
20060173260 Gaoni et al. Aug 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060173444 Choy et al. Aug 2006 A1
20060183984 Dobbles et al. Aug 2006 A1
20060183985 Brister et al. Aug 2006 A1
20060189863 Peyser et al. Aug 2006 A1
20060193375 Lee Aug 2006 A1
20060202805 Schulman et al. Sep 2006 A1
20060211072 Ryan et al. Sep 2006 A1
20060222566 Brauker et al. Oct 2006 A1
20060224109 Steil et al. Oct 2006 A1
20060224141 Rush et al. Oct 2006 A1
20060229512 Petisce et al. Oct 2006 A1
20060247508 Fennell Nov 2006 A1
20060247710 Goetz et al. Nov 2006 A1
20060247985 Liamos et al. Nov 2006 A1
20060253296 Liisberg et al. Nov 2006 A1
20060258929 Goode et al. Nov 2006 A1
20060272652 Stocker et al. Dec 2006 A1
20060276771 Galley et al. Dec 2006 A1
20060281985 Ward et al. Dec 2006 A1
20060287691 Drew Dec 2006 A1
20060290496 Peeters Dec 2006 A1
20060293607 Alt et al. Dec 2006 A1
20070000163 Buckner Jan 2007 A1
20070000273 Sanders Jan 2007 A1
20070002443 Toyama Jan 2007 A1
20070010950 Abensour et al. Jan 2007 A1
20070016381 Kamath et al. Jan 2007 A1
20070017983 Frank et al. Jan 2007 A1
20070027381 Stafford Feb 2007 A1
20070032706 Kamath et al. Feb 2007 A1
20070032717 Brister et al. Feb 2007 A1
20070033074 Nitzan et al. Feb 2007 A1
20070038044 Dobbles et al. Feb 2007 A1
20070055799 Koehler et al. Mar 2007 A1
20070060803 Liljeryd et al. Mar 2007 A1
20070060814 Stafford Mar 2007 A1
20070060869 Tolle et al. Mar 2007 A1
20070060979 Strother et al. Mar 2007 A1
20070066873 Kamath et al. Mar 2007 A1
20070066956 Finkel Mar 2007 A1
20070068807 Feldman et al. Mar 2007 A1
20070071681 Gadkar et al. Mar 2007 A1
20070073129 Shah et al. Mar 2007 A1
20070078320 Stafford Apr 2007 A1
20070078321 Mazza et al. Apr 2007 A1
20070078322 Stafford Apr 2007 A1
20070078323 Reggiardo et al. Apr 2007 A1
20070078818 Zivitz et al. Apr 2007 A1
20070093786 Goldsmith et al. Apr 2007 A1
20070094216 Mathias et al. Apr 2007 A1
20070095661 Wang et al. May 2007 A1
20070100222 Mastrototaro et al. May 2007 A1
20070106135 Sloan et al. May 2007 A1
20070108048 Wang et al. May 2007 A1
20070118405 Campbell et al. May 2007 A1
20070124002 Estes et al. May 2007 A1
20070149875 Ouyang et al. Jun 2007 A1
20070151869 Heller et al. Jul 2007 A1
20070156033 Causey, III et al. Jul 2007 A1
20070163880 Woo et al. Jul 2007 A1
20070168224 Letzt et al. Jul 2007 A1
20070173706 Neinast et al. Jul 2007 A1
20070173709 Petisce et al. Jul 2007 A1
20070173710 Petisce et al. Jul 2007 A1
20070173761 Kanderian et al. Jul 2007 A1
20070179349 Hoyme et al. Aug 2007 A1
20070179352 Randlov et al. Aug 2007 A1
20070191701 Feldman et al. Aug 2007 A1
20070191702 Yodfat et al. Aug 2007 A1
20070199818 Petyt et al. Aug 2007 A1
20070203407 Hoss et al. Aug 2007 A1
20070203966 Brauker et al. Aug 2007 A1
20070208244 Brauker et al. Sep 2007 A1
20070208246 Brauker et al. Sep 2007 A1
20070213657 Jennewine et al. Sep 2007 A1
20070228071 Kamen et al. Oct 2007 A1
20070232878 Kovatchev et al. Oct 2007 A1
20070232880 Siddiqui et al. Oct 2007 A1
20070235331 Simpson et al. Oct 2007 A1
20070244383 Talbot et al. Oct 2007 A1
20070249922 Peyser et al. Oct 2007 A1
20070253021 Mehta et al. Nov 2007 A1
20070255116 Mehta et al. Nov 2007 A1
20070255321 Gerber et al. Nov 2007 A1
20070255348 Holtzclaw Nov 2007 A1
20070255531 Drew Nov 2007 A1
20070258395 Jollota et al. Nov 2007 A1
20070270672 Hayter Nov 2007 A1
20070271285 Eichorn et al. Nov 2007 A1
20070282299 Hellwig Dec 2007 A1
20070285238 Batra Dec 2007 A1
20070299617 Willis Dec 2007 A1
20080004515 Jennewine Jan 2008 A1
20080004601 Jennewine et al. Jan 2008 A1
20080009692 Stafford Jan 2008 A1
20080017522 Heller et al. Jan 2008 A1
20080018433 Pitt-Pladdy Jan 2008 A1
20080021436 Wolpert et al. Jan 2008 A1
20080021666 Goode et al. Jan 2008 A1
20080029391 Mao et al. Feb 2008 A1
20080030369 Mann et al. Feb 2008 A1
20080033254 Kamath et al. Feb 2008 A1
20080039702 Hayter et al. Feb 2008 A1
20080045824 Tapsak et al. Feb 2008 A1
20080058625 McGarraugh et al. Mar 2008 A1
20080058773 John Mar 2008 A1
20080060955 Goodnow Mar 2008 A1
20080061961 John Mar 2008 A1
20080064937 McGarraugh et al. Mar 2008 A1
20080064943 Talbot et al. Mar 2008 A1
20080066305 Wang et al. Mar 2008 A1
20080071156 Brister et al. Mar 2008 A1
20080071157 McGarraugh et al. Mar 2008 A1
20080071158 McGarraugh et al. Mar 2008 A1
20080071328 Haubrich et al. Mar 2008 A1
20080081977 Hayter et al. Apr 2008 A1
20080083617 Simpson et al. Apr 2008 A1
20080086042 Brister et al. Apr 2008 A1
20080086044 Brister et al. Apr 2008 A1
20080086273 Shults et al. Apr 2008 A1
20080092638 Brenneman et al. Apr 2008 A1
20080097289 Steil et al. Apr 2008 A1
20080102441 Chen et al. May 2008 A1
20080103447 Reggiardo et al. May 2008 A1
20080108942 Brister et al. May 2008 A1
20080114228 McCluskey et al. May 2008 A1
20080119705 Patel et al. May 2008 A1
20080119710 Reggiardo et al. May 2008 A1
20080139910 Mastrototaro et al. Jun 2008 A1
20080148873 Wang Jun 2008 A1
20080154513 Kovatchev et al. Jun 2008 A1
20080161666 Feldman et al. Jul 2008 A1
20080161707 Farringdon et al. Jul 2008 A1
20080167543 Say et al. Jul 2008 A1
20080167572 Stivoric et al. Jul 2008 A1
20080172205 Breton et al. Jul 2008 A1
20080177149 Weinert et al. Jul 2008 A1
20080177165 Blomquist et al. Jul 2008 A1
20080182537 Manku et al. Jul 2008 A1
20080183060 Steil et al. Jul 2008 A1
20080183061 Goode et al. Jul 2008 A1
20080183399 Goode et al. Jul 2008 A1
20080188731 Brister et al. Aug 2008 A1
20080188796 Steil et al. Aug 2008 A1
20080189051 Goode et al. Aug 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080194935 Brister et al. Aug 2008 A1
20080194936 Goode et al. Aug 2008 A1
20080194937 Goode et al. Aug 2008 A1
20080194938 Brister et al. Aug 2008 A1
20080195232 Carr-Brendel et al. Aug 2008 A1
20080195967 Goode et al. Aug 2008 A1
20080197024 Simpson et al. Aug 2008 A1
20080200788 Brister et al. Aug 2008 A1
20080200789 Brister et al. Aug 2008 A1
20080200791 Simpson et al. Aug 2008 A1
20080201325 Doniger et al. Aug 2008 A1
20080208025 Shults et al. Aug 2008 A1
20080208026 Noujaim et al. Aug 2008 A1
20080208113 Damiano et al. Aug 2008 A1
20080214900 Fennell et al. Sep 2008 A1
20080214915 Brister et al. Sep 2008 A1
20080214918 Brister et al. Sep 2008 A1
20080228051 Shults et al. Sep 2008 A1
20080228054 Shults et al. Sep 2008 A1
20080228055 Sher Sep 2008 A1
20080234663 Yodfat et al. Sep 2008 A1
20080234943 Ray et al. Sep 2008 A1
20080234992 Ray et al. Sep 2008 A1
20080235469 Drew Sep 2008 A1
20080242961 Brister et al. Oct 2008 A1
20080242963 Essenpreis et al. Oct 2008 A1
20080254544 Modzelewski et al. Oct 2008 A1
20080255434 Hayter et al. Oct 2008 A1
20080255437 Hayter Oct 2008 A1
20080255438 Saidara et al. Oct 2008 A1
20080255808 Hayter Oct 2008 A1
20080256048 Hayter Oct 2008 A1
20080262304 Nisani et al. Oct 2008 A1
20080262469 Brister et al. Oct 2008 A1
20080267823 Wang et al. Oct 2008 A1
20080269714 Mastrototaro et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080275313 Brister et al. Nov 2008 A1
20080281179 Fennell et al. Nov 2008 A1
20080287761 Hayter et al. Nov 2008 A1
20080287762 Hayter et al. Nov 2008 A1
20080287763 Hayter Nov 2008 A1
20080287764 Rasdal et al. Nov 2008 A1
20080287765 Rasdal et al. Nov 2008 A1
20080287766 Rasdal et al. Nov 2008 A1
20080288180 Hayter et al. Nov 2008 A1
20080288204 Hayter et al. Nov 2008 A1
20080294024 Cosentino et al. Nov 2008 A1
20080296155 Shults et al. Dec 2008 A1
20080300572 Rankers et al. Dec 2008 A1
20080300919 Charlton et al. Dec 2008 A1
20080306368 Goode, Jr. et al. Dec 2008 A1
20080306434 Dobbles et al. Dec 2008 A1
20080306435 Kamath et al. Dec 2008 A1
20080306444 Brister et al. Dec 2008 A1
20080312518 Jina et al. Dec 2008 A1
20080312841 Hayter Dec 2008 A1
20080312842 Hayter et al. Dec 2008 A1
20080312844 Hayter et al. Dec 2008 A1
20080312845 Hayter et al. Dec 2008 A1
20080314395 Kovatchev et al. Dec 2008 A1
20080319085 Wright et al. Dec 2008 A1
20080319279 Ramsay et al. Dec 2008 A1
20090001923 Gallegos-Lopez et al. Jan 2009 A1
20090005665 Hayter et al. Jan 2009 A1
20090005666 Shin et al. Jan 2009 A1
20090005729 Hendrixson et al. Jan 2009 A1
20090006034 Hayter et al. Jan 2009 A1
20090006061 Thukral et al. Jan 2009 A1
20090006133 Weinert et al. Jan 2009 A1
20090012376 Agus Jan 2009 A1
20090012379 Goode, Jr. et al. Jan 2009 A1
20090018424 Kamath et al. Jan 2009 A1
20090018425 Ouyang et al. Jan 2009 A1
20090023222 Wu et al. Jan 2009 A1
20090027040 Kermani et al. Jan 2009 A1
20090030293 Cooper et al. Jan 2009 A1
20090030294 Petisce et al. Jan 2009 A1
20090030641 Fjield Jan 2009 A1
20090033482 Hayter et al. Feb 2009 A1
20090036747 Hayter et al. Feb 2009 A1
20090036758 Brauker et al. Feb 2009 A1
20090036760 Hayter Feb 2009 A1
20090036763 Brauker et al. Feb 2009 A1
20090040022 Finkenzeller Feb 2009 A1
20090043181 Brauker et al. Feb 2009 A1
20090043182 Brauker et al. Feb 2009 A1
20090043525 Brauker et al. Feb 2009 A1
20090043541 Brauker et al. Feb 2009 A1
20090043542 Brauker et al. Feb 2009 A1
20090045055 Rhodes et al. Feb 2009 A1
20090048503 Dalal et al. Feb 2009 A1
20090054737 Magar et al. Feb 2009 A1
20090054745 Jennewine Feb 2009 A1
20090054747 Fennell Feb 2009 A1
20090054748 Feldman Feb 2009 A1
20090055149 Hayter et al. Feb 2009 A1
20090062633 Brauker et al. Mar 2009 A1
20090062635 Brauker et al. Mar 2009 A1
20090062767 Van Antwerp et al. Mar 2009 A1
20090063402 Hayter Mar 2009 A1
20090076356 Simpson et al. Mar 2009 A1
20090076360 Brister et al. Mar 2009 A1
20090076361 Kamath et al. Mar 2009 A1
20090082693 Stafford Mar 2009 A1
20090085768 Patel et al. Apr 2009 A1
20090085873 Betts et al. Apr 2009 A1
20090088614 Taub Apr 2009 A1
20090093687 Telfort et al. Apr 2009 A1
20090099436 Brister et al. Apr 2009 A1
20090105554 Stahmann et al. Apr 2009 A1
20090105560 Solomon Apr 2009 A1
20090105570 Sloan et al. Apr 2009 A1
20090105571 Fennell et al. Apr 2009 A1
20090105636 Hayter et al. Apr 2009 A1
20090112478 Mueller, Jr. et al. Apr 2009 A1
20090118604 Phan et al. May 2009 A1
20090124877 Goode, Jr. et al. May 2009 A1
20090124878 Goode, Jr. et al. May 2009 A1
20090124879 Brister et al. May 2009 A1
20090124964 Leach et al. May 2009 A1
20090131768 Simpson et al. May 2009 A1
20090131769 Leach et al. May 2009 A1
20090131776 Simpson et al. May 2009 A1
20090131777 Simpson et al. May 2009 A1
20090137886 Shariati et al. May 2009 A1
20090137887 Shariati et al. May 2009 A1
20090143659 Li et al. Jun 2009 A1
20090143660 Brister et al. Jun 2009 A1
20090150186 Cohen et al. Jun 2009 A1
20090156919 Brister et al. Jun 2009 A1
20090156924 Shariati et al. Jun 2009 A1
20090163790 Brister et al. Jun 2009 A1
20090163791 Brister et al. Jun 2009 A1
20090164190 Hayter Jun 2009 A1
20090164239 Hayter et al. Jun 2009 A1
20090164251 Hayter Jun 2009 A1
20090177068 Stivoric et al. Jul 2009 A1
20090178459 Li et al. Jul 2009 A1
20090182217 Li et al. Jul 2009 A1
20090189738 Hermle Jul 2009 A1
20090192366 Mensinger et al. Jul 2009 A1
20090192380 Shariati et al. Jul 2009 A1
20090192722 Shariati et al. Jul 2009 A1
20090192724 Brauker et al. Jul 2009 A1
20090192745 Kamath et al. Jul 2009 A1
20090192751 Kamath et al. Jul 2009 A1
20090198118 Hayter et al. Aug 2009 A1
20090203981 Brauker et al. Aug 2009 A1
20090204341 Brauker et al. Aug 2009 A1
20090209904 Peeters Aug 2009 A1
20090216100 Ebner et al. Aug 2009 A1
20090216103 Brister et al. Aug 2009 A1
20090227855 Hill et al. Sep 2009 A1
20090234200 Husheer Sep 2009 A1
20090236237 Shinno et al. Sep 2009 A1
20090240120 Mensinger et al. Sep 2009 A1
20090240128 Mensinger et al. Sep 2009 A1
20090240193 Mensinger et al. Sep 2009 A1
20090240440 Shurabura et al. Sep 2009 A1
20090242399 Kamath et al. Oct 2009 A1
20090242425 Kamath et al. Oct 2009 A1
20090247855 Boock et al. Oct 2009 A1
20090247856 Boock et al. Oct 2009 A1
20090247857 Harper et al. Oct 2009 A1
20090247931 Damgaard-Sorensen Oct 2009 A1
20090253973 Bashan et al. Oct 2009 A1
20090259118 Feldman et al. Oct 2009 A1
20090267765 Greene et al. Oct 2009 A1
20090275815 Bickoff Nov 2009 A1
20090276017 Achenbach et al. Nov 2009 A1
20090287073 Boock et al. Nov 2009 A1
20090287074 Shults et al. Nov 2009 A1
20090289796 Blumberg, Jr. Nov 2009 A1
20090291634 Saarisalo Nov 2009 A1
20090292188 Hoss et al. Nov 2009 A1
20090296742 Sicurello et al. Dec 2009 A1
20090298182 Schulat et al. Dec 2009 A1
20090299155 Yang et al. Dec 2009 A1
20090299156 Simpson et al. Dec 2009 A1
20090299162 Brauker et al. Dec 2009 A1
20090299276 Brauker et al. Dec 2009 A1
20090318792 Fennell et al. Dec 2009 A1
20100010324 Brauker et al. Jan 2010 A1
20100010329 Taub et al. Jan 2010 A1
20100010331 Brauker et al. Jan 2010 A1
20100010332 Brauker et al. Jan 2010 A1
20100016687 Brauker et al. Jan 2010 A1
20100016698 Rasdal et al. Jan 2010 A1
20100022855 Brauker et al. Jan 2010 A1
20100030038 Brauker et al. Feb 2010 A1
20100030053 Goode, Jr. et al. Feb 2010 A1
20100030484 Brauker et al. Feb 2010 A1
20100030485 Brauker et al. Feb 2010 A1
20100036215 Goode, Jr. et al. Feb 2010 A1
20100036216 Goode, Jr. et al. Feb 2010 A1
20100036222 Goode, Jr. et al. Feb 2010 A1
20100036223 Goode, Jr. et al. Feb 2010 A1
20100036225 Goode, Jr. et al. Feb 2010 A1
20100041971 Goode, Jr. et al. Feb 2010 A1
20100045465 Brauker et al. Feb 2010 A1
20100049016 Aronowitz et al. Feb 2010 A1
20100049024 Saint et al. Feb 2010 A1
20100056992 Hayter Mar 2010 A1
20100057040 Hayter Mar 2010 A1
20100057041 Hayter Mar 2010 A1
20100057042 Hayter Mar 2010 A1
20100057044 Hayter Mar 2010 A1
20100057057 Hayter et al. Mar 2010 A1
20100063373 Kamath et al. Mar 2010 A1
20100076283 Simpson et al. Mar 2010 A1
20100081906 Hayter et al. Apr 2010 A1
20100081908 Dobbles et al. Apr 2010 A1
20100081909 Budiman et al. Apr 2010 A1
20100081910 Brister et al. Apr 2010 A1
20100087724 Brauker et al. Apr 2010 A1
20100096259 Zhang et al. Apr 2010 A1
20100099970 Shults et al. Apr 2010 A1
20100099971 Shults et al. Apr 2010 A1
20100105999 Dixon et al. Apr 2010 A1
20100119693 Tapsak et al. May 2010 A1
20100121169 Petisce et al. May 2010 A1
20100128754 Jetter et al. May 2010 A1
20100141656 Krieftewirth Jun 2010 A1
20100152554 Steine et al. Jun 2010 A1
20100160759 Celentano et al. Jun 2010 A1
20100168538 Keenan et al. Jul 2010 A1
20100168546 Kamath et al. Jul 2010 A1
20100174266 Estes Jul 2010 A1
20100185175 Kamen et al. Jul 2010 A1
20100190435 Cook et al. Jul 2010 A1
20100191082 Brister et al. Jul 2010 A1
20100191085 Budiman Jul 2010 A1
20100191472 Doniger et al. Jul 2010 A1
20100198034 Thomas et al. Aug 2010 A1
20100198142 Sloan et al. Aug 2010 A1
20100198314 Wei Aug 2010 A1
20100204557 Kiaie et al. Aug 2010 A1
20100213080 Celentano et al. Aug 2010 A1
20100234710 Budiman et al. Sep 2010 A1
20100240975 Goode, Jr. et al. Sep 2010 A1
20100253361 Nakamura et al. Oct 2010 A1
20100268475 Kusumoto Oct 2010 A1
20100274111 Say et al. Oct 2010 A1
20100274515 Hoss et al. Oct 2010 A1
20100277342 Sicurello et al. Nov 2010 A1
20100312176 Lauer et al. Dec 2010 A1
20100313105 Nekoomaram et al. Dec 2010 A1
20100317958 Beck et al. Dec 2010 A1
20100324392 Yee et al. Dec 2010 A1
20100325868 Wang et al. Dec 2010 A1
20100326842 Mazza et al. Dec 2010 A1
20110004276 Blair et al. Jan 2011 A1
20110024043 Boock et al. Feb 2011 A1
20110024307 Simpson et al. Feb 2011 A1
20110027127 Simpson et al. Feb 2011 A1
20110027453 Boock et al. Feb 2011 A1
20110027458 Boock et al. Feb 2011 A1
20110028815 Simpson et al. Feb 2011 A1
20110028816 Simpson et al. Feb 2011 A1
20110031986 Bhat et al. Feb 2011 A1
20110058485 Sloan Mar 2011 A1
20110077490 Simpson et al. Mar 2011 A1
20110077494 Doniger et al. Mar 2011 A1
20110081726 Berman Apr 2011 A1
20110105873 Feldman May 2011 A1
20110112696 Yodfat et al. May 2011 A1
20110148905 Simmons et al. Jun 2011 A1
20110152637 Kateraas et al. Jun 2011 A1
20110152658 Peyser Jun 2011 A1
20110174638 Katsuki Jul 2011 A1
20110184265 Hayter Jul 2011 A1
20110193704 Harper et al. Aug 2011 A1
20110208027 Wagner et al. Aug 2011 A1
20110210830 Talty et al. Sep 2011 A1
20110213225 Bernstein et al. Sep 2011 A1
20110257495 Hoss et al. Oct 2011 A1
20110257895 Brauker et al. Oct 2011 A1
20110287528 Fern et al. Nov 2011 A1
20110289497 Kiaie et al. Nov 2011 A1
20110320130 Valdes et al. Dec 2011 A1
20110320167 Budiman Dec 2011 A1
20120028283 Hoss et al. Feb 2012 A1
20120078071 Bohm et al. Mar 2012 A1
20120084053 Yuen et al. Apr 2012 A1
20120108934 Valdes et al. May 2012 A1
20120150005 Hoss et al. Jun 2012 A1
20120157801 Hoss et al. Jun 2012 A1
20120161793 Satake et al. Jun 2012 A1
20120161959 Palmer et al. Jun 2012 A1
20120165626 Irina et al. Jun 2012 A1
20120165635 Radhakrishnan Jun 2012 A1
20120165640 Galley et al. Jun 2012 A1
20120173200 Breton et al. Jul 2012 A1
20120233679 Shedrinsky Sep 2012 A1
20120238851 Kamen et al. Sep 2012 A1
20120250610 Budampati et al. Oct 2012 A1
20120255875 Vicente et al. Oct 2012 A1
20120309302 Buhot Dec 2012 A1
20120313785 Hanson et al. Dec 2012 A1
20130035575 Mayou et al. Feb 2013 A1
20130235166 Jones et al. Sep 2013 A1
20200029871 Hayter et al. Jan 2020 A1
Foreign Referenced Citations (119)
Number Date Country
2143172 Jul 2005 CA
2396613 Mar 2008 CA
2413148 Aug 2010 CA
2766339 Jan 2011 CA
4401400 Jul 1995 DE
0098592 Jan 1984 EP
0127958 Dec 1984 EP
0320109 Jun 1989 EP
0353328 Feb 1990 EP
0390390 Oct 1990 EP
0396788 Nov 1990 EP
0355328 Jun 1994 EP
0286118 Jan 1995 EP
0678308 Oct 1995 EP
0724859 Aug 1996 EP
0678308 May 2000 EP
1048264 Nov 2000 EP
1077634 Feb 2001 EP
1292218 Mar 2003 EP
1077634 Jul 2003 EP
1448489 Aug 2004 EP
1568309 Aug 2005 EP
1666091 Jun 2006 EP
1681992 Jul 2006 EP
1703697 Sep 2006 EP
1704893 Sep 2006 EP
1897487 Mar 2008 EP
1897488 Mar 2008 EP
1897492 Mar 2008 EP
1971396 Sep 2008 EP
1897487 Nov 2009 EP
1897492 Nov 2009 EP
2113864 Nov 2009 EP
1897488 Dec 2009 EP
2153382 Feb 2010 EP
1681992 Apr 2010 EP
2201969 Jun 2010 EP
1448489 Aug 2010 EP
1971396 Aug 2010 EP
2284773 Feb 2011 EP
2201969 Mar 2011 EP
2153382 Feb 2012 EP
2284773 Feb 2012 EP
2450699 May 2012 EP
2498196 Sep 2012 EP
2939158 Mar 2022 EP
2409951 Jul 2005 GB
5353991 Nov 2013 JP
WO-9306237 Apr 1993 WO
WO-9625089 Aug 1996 WO
WO-9635370 Nov 1996 WO
WO 9718639 May 1997 WO
WO-9733513 Sep 1997 WO
WO-9835053 Aug 1998 WO
WO-9956613 Nov 1999 WO
WO-0019887 Apr 2000 WO
WO-0049940 Aug 2000 WO
WO-0059370 Oct 2000 WO
WO-0074753 Dec 2000 WO
WO-0078992 Dec 2000 WO
WO-0152935 Jul 2001 WO
WO-0154753 Aug 2001 WO
WO-0216905 Feb 2002 WO
WO-02058537 Aug 2002 WO
WO-03076893 Sep 2003 WO
WO-03082091 Oct 2003 WO
WO-03085372 Oct 2003 WO
WO-2004047445 Jun 2004 WO
WO-2004061420 Jul 2004 WO
WO-2005010756 Feb 2005 WO
WO-2005040404 May 2005 WO
WO-2005041766 May 2005 WO
WO-2005045744 May 2005 WO
WO-2005065538 Jul 2005 WO
WO-2005089103 Sep 2005 WO
WO-2005119238 Dec 2005 WO
WO-2005121785 Dec 2005 WO
WO-2006024671 Mar 2006 WO
WO-2006032653 Mar 2006 WO
WO-2006051466 May 2006 WO
WO-2006064397 Jun 2006 WO
WO-2006079114 Jul 2006 WO
WO-2006079867 Aug 2006 WO
WO-2006118947 Nov 2006 WO
WO-2006124099 Nov 2006 WO
WO-2007007459 Jan 2007 WO
WO-2007016399 Feb 2007 WO
WO-2007027788 Mar 2007 WO
WO-2007041069 Apr 2007 WO
WO-2007041070 Apr 2007 WO
WO-2007041248 Apr 2007 WO
WO-2007053832 May 2007 WO
WO-2007056638 May 2007 WO
WO-2007097754 Aug 2007 WO
WO-2007101223 Sep 2007 WO
WO-2007120363 Oct 2007 WO
WO-2007126444 Nov 2007 WO
WO-2007143225 Dec 2007 WO
WO-2008005124 Jan 2008 WO
WO-2008021913 Feb 2008 WO
WO-2008042760 Apr 2008 WO
WO 2008051924 May 2008 WO
WO-2008076574 Jun 2008 WO
WO-2008086541 Jul 2008 WO
WO-2008128210 Oct 2008 WO
WO-2008130896 Oct 2008 WO
WO-2008130897 Oct 2008 WO
WO-2008130898 Oct 2008 WO
WO 2008143943 Nov 2008 WO
WO-2008151452 Dec 2008 WO
WO-2009018058 Feb 2009 WO
WO-2009049252 Apr 2009 WO
WO-2009086216 Jul 2009 WO
WO-2009097597 Aug 2009 WO
2010040090 Apr 2010 WO
WO-2010077329 Jul 2010 WO
WO-2011022418 Feb 2011 WO
WO 2013019225 Feb 2013 WO
WO-2014070456 May 2014 WO
Non-Patent Literature Citations (161)
Entry
Extended European Search Report in counterpart European application No. EP 19155366.8 dated Aug. 30, 2019 (8 pages).
Decision to Grant in counterpart European application No. EP 19155366.8 dated Aug. 4, 2022 (2 pages).
Extended European Search Report in counterpart European application No. EP 12800721.8 dated Dec. 4, 2014 (8 pages).
Decision to Grant in counterpart European application No. EP 12800721.8 dated Jan. 10, 2019 (2 pages).
Extended European Search Report in counterpart European application No. EP 22179316.9 dated Dec. 22, 2022 (10 pages).
International Search Report and Written Opinion of the International Searching Authority directed to related International Patent Application No. PCT/US2012/43012, dated Nov. 30, 2012; 13 pages.
Klonoff, David C., M.D., F.A.C.P., “Continuous Glucose Monitoring, Roadmap for 21st Century Diabetes Therapy,” Diabetes Care, vol. 28, No. 5, May 2005; pp. 1231-1239.
Klonoff, David, M.D., F.A.C.P., “A Review of Continuous Glucose Monitoring Technology,” Diabetes Tech. & Therapeutics, vol. 7, No. 5, 2005; 6 pages.
Townsend, Kevin, “Getting Started with Bluetooth Low Energy,” Book description for preview version, May 2014; 3 pages; available at: https://www.oreilly.com.
Wikipedia, “Blood Glucose Monitoring,” Sep. 8, 2004; 6 pages; available at: https://https://en.wikipedia.org/wiki/Blood_glucose_monitoring.
Document D4a to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Lecture notes from the ENSC 388 Engineering Thermodynamics and Heat Transfer course at Simon Fraser University, Canada given by Dr Majid Bahrami, retrieved from https://www.sfu.ca/˜mbahrami/ensc388.html.
Document D4b to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Screenshot of the Adobe Acrobat Reader metadata for D4a showing that the date D4a was last modified was Nov. 5, 2009.
Document D5 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Pennes H. H. “Analysis of tissue and arterial blood temperatures in the resting human forearm”. J Appl Physiol. Aug. 1948; vol. 1, No. 2: pp. 93-122.
Document D6 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Saxena V. P. and Singh R., “Unsteady state radial heat flow in the outer layers of spherical regions of human or animal body”, J nanabha, vol. 34, 2004, pp. 47-54.
Document D7 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Gurung, D. “Thermoregulation Through Skin at Low Atmospheric Temperatures”. Kathmandu University Journal of Science, Engineering and Technology, vol. 5, No. 1, Jan. 2009, pp. 14-22.
Document D8 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Saxena VP and Arya D. “Steady-state Heat Distribution in Epidermis, Dermis and Subdermal Tissues”. J Theor Biol. Apr. 7, 1981; 89(3): 423-32.
Document D9 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Saxena V. P. “Effect of blood flow on temperature distribution in human skin and sub dermal tissues”, 9th National Conference, Fluid Mechanics and Fluid Power, Dec. 1979, vol. 2, pp. 156-161.
Document D10 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Khanday, M.A., Saxena, V.P. “Mathematical estimation of physiological disturbances in human dermal parts at extreme conditions: One dimensional steady state case”. Analysis in Theory and Applications. Vol. 25, No. 4, 2009, pp. 325-332.
Document D11 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Lenhardt R, Sessler DI, “Estimation of mean body temperature from mean skin and core temperature”. Anesthesiology. Dec. 2006; 105(6):1117-21.
Document D12 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Burton AC., “Human Calorimetry: The average temperature of the tissues of the body”. Journal of Nutrition. Mar. 1935, vol. 9, No. 3, pp. 261-280.
Document D13 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Yildirim E.D. “A mathematical model of the human thermal system”, Master's thesis, Graduate School of Engineering and Sciences of Izmir Institute of Technology, 2005.
Document D14 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, V.P. Saxena, K.R. Pardasani and p. M. Saxena, “Exact solution to temperature distribution problems in spherical tissue layers”, Ganita Sandesh, 1991, vol. 5, No. 2, pp. 72-78.
Document D15 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, V.P Saxena and D. Arya, “Variational finite element approach to heat distribution problems in human skin and subdermal tissues”. Proceedings of the First International Conference on Numerical Methods in Thermal Problems (ed.K. Morgan (UK: Pineridge Press), 1981, pp. 1067-1076.
Document D16 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, A, John Anderson, “Foundations of Computer Technology”, 1994, ISBN: 0-412-59810-8, pp. 55-57.
Document D17 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Santinram Kal, “Basic Electronics”, 2006, ISBN: 81-203-1952-4, p. 412.
Document D18 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, David D. Cunningham and Julie A. Stenken, “In Vivo Glucose Sensing”, 2010, ISBN: 978-0-470-11296-0, Chapters 1 and 5.
Document D19 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Frank P. Incropera et al. “Fundamentals of Heat and Mass Transfer”, 2007, ISBN: 978-0-471-45728-2, pp. 162-163.
Document D20 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Susan S. Ricci and Terri Kyle, “Maternity and Pediatric Nursing”, 2009, ISBN: 978-0-7817-8055-1, p. 949.
Document D21 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Paul G. Barash et al., “Clinical Anesthesia”, 2009, ISBN: 978-0-7817-8763-5, p. 711.
Document D22 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, El-Radhi AS, Barry W. “Thermometry in paediatric practice”. Arch Dis Child. Apr. 2006; 91(4): 351-6.
Document D23 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Nelson, D., Nunneley, S. “Brain temperature and limits on transcranial cooling in humans: quantitative modeling results”, Eur J Appl Physiol, 1998, 78: 353-359.
Document D24 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Wikipedia entry for “Human Body Temperature” from Feb. 2011.
Document D25 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Michael Kent, “Advanced Biology”, 2000, ISBN: 0-19-9141950-9, p. 154.
Document D26 to the Evidence List presented in the Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023, Steven B. Heymsfield et al., “Human Body Composition”, 2005, ISBN: 978-0-7360-4655-8, p. 168.
Notice of Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023; 138 pages.
Preliminary Opinion in the Opposition to EP3556285, filed Feb. 8, 2024; 14 pages.
Reply to Notice of Opposition to EP3556285, filed by Abbott Diabetes Care, Inc., Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed Oct. 23, 2023; 31 pages.
Document (E1) D27 in Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., Benedict, FG; Miles, WR; Johnson, A (Jun. 1919): “The Temperature of the Human Skin”, Proceedings of the National Academy of Sciences of the United States of America; pp. 218-222.
Document (E2) D28 in Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., Webb, Paul, Eur J Appl Physiol (1992) 64: 471-476, “Temperatures of skin, subcutaneous tissue, muscle and core in resting men in cold, comfortable and hot conditions.”.
Document (E3) D29 in Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., Bierman, William, “The Temperature of the Skin Surface” (Journal of the American Medical Association. 106 (14): 1158-1162).
Abbott Diabetes Care, Inc. Reply to Summons in the Opposition to EP3556285, dated Aug. 20, 2024; 19 pages.
Dexcom Inc.'s Written Submission in support of the Opposition to EP3556285, dated Aug. 14, 2024; 115 pages.
Definition of “housing” from the Collins English dictionary. Exhibit D31 in the Opposition to EP3556285.
GlucoWatch User Manual, 2003. Exhibit D33 in the Opposition to EP3556285; 70 pages.
Burnham RS, Mckinley RS, Vincent DD, “Three types of skin-surface thermometers: a comparison of reliability, validity, and responsiveness.” Am J Phys Med Rehabil. Jul. 2006; 85(7):553-558. Exhibit D36 in the Opposition to EP3556285.
Kei-Ichiro Kitamura, Xin Zhu, Wenxi Chen, Tetsu Nemoto, “Development of a new method for the noninvasive measurement of deep body temperature without a heater,” Medical Engineering & Physics, vol. 32, Issue 1, 2010, pp. 1-6. Exhibit D37 in the Opposition to EP3556285.
Kimberger O., Thell R., Schuh M., Koch J., Sessler D.I., Kurz A., “Accuracy and precision of a novel non-invasive core thermometer.” British Journal of Anaesthesia, Aug. 2009; 103(2):226-231. Exhibit D38 in the Opposition to EP3556285.
Dexcom Letter in advance of Oral Proceedings, dated Oct. 11, 2024; 54 pages, in the Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023.
Information regarding the result of oral proceedings, dated Oct. 17, 2024; 2 pages, in the Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023.
Summons to Abbott Diabetes Care, Inc. to attend oral proceedings, dated Oct. 30, 2024, 1 page, in the Opposition to EP3556285, Abbott Diabetes Care, Inc. v. Dexcom, Inc., filed May 6, 2023.
Aleppo, G., et al., “Replace-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes,” Diabetes Care 40(4):538-545, American Diabetes Association, United States (Apr. 2017).
Armour, J.C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs,” Diabetes 39(12):1519-1526, American Diabetes Association, United States (Dec. 1990).
Arnold, M. A., et al., “Selectivity Assessment of Noninvasive Glucose Measurements Based on Analysis of Multivariate Calibration Vectors”, Journal of Diabetes Science and Technology, vol. 1, No. 4, 2007pp. 454-462.
Aussedat, B., et al., “A User-friendly Method for Calibrating a Subcutaneous Glucose Sensor-based Hypoglycaemic Alarm,” Biosensors Bioelectronics 12(11):1061-1071, Elsevier Advanced Technology, United Kingdom (1997).
Bennion, N., et al., “Alternate Site Glucose Testing: a Crossover Design,” Diabetes Technology & Therapeutics 4(1):25-33, Mary Ann Liebert, United States (2002).
Bindra, D.S., et al., “Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring,” Analytical Chemistry 63(17):1692-1696, American Chemical Society, United States (Sep. 11, 991).
Bisdikian, C., “An Overview of the Bluetooth Wireless Technology,” IEEE Communications Magazine, pp. 86-94, (2001).
Blank, T.B., et al., “Clinical Results From a Noninvasive Blood Glucose Monitor,” Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE vol. 4624, 10 Pages, (May 2002).
Boyne, M.S., et al., “Timing of Changes in Interstitial and Venous Blood Glucose Measured With a Continuous Subcutaneous Glucose Sensor,” Diabetes 52(11):2790-2794, American Diabetes Association, United States (Nov. 2003).
Bremer, T.M., et al., “Benchmark Data From the Literature for Evaluation of New Glucose Sensing Technologies,” Diabetes Technology & Therapeutics 3(3):409-418, Mary Ann Liebert, Inc, United States (2001).
Brooks, S.L., et al., “Development of an On-line Glucose Sensor for Fermentation Monitoring,” Biosensors 3(1):45-56, (1987-1988).
Campbell et al., “Outcomes of Using Flash Glucose Monitory Technology by Children and Young People with Type 1 Diabetes in a Single Arm Study,” Pediatric Diabetes, 2018:19:1294-1301; Anlage TW 7, Taylor Wessing, Statement of Defence in Abbottv. Dexcom, Opposition to EP 3782539.
Cass, A.E., et al., “Ferrocene-mediated Enzyme Electrode for Amperometric Determination of Glucose,” Analytical Chemistry 56(4):667-671, American Chemical Society, United States (Apr. 1984).
Cheyne, E.H., et al., “Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers,” Diabetes Technology & Therapeutics 4(5):607-613, Mary Ann Liebert, United States (2002).
Choudhary, P., et al., “Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in Nocturnal Hypoglycemia in Those at Greatest Risk,” Diabetes Care 34(9):2023-2025, American Diabetes Association, United States (Sep. 2011).
Clarke, W.L. and Kovatchev, B., “Continuous Glucose Sensors: Continuing Questions about Clinical Accuracy,” Journal of Diabetes Science and Technology 1(5):669-675, Sage, United States (Sep. 2007).
Clarke, W.L. and Kovatchev, B., “Statistical Tools to Analyze Continuous Glucose Monitor Data,” Diabetes Technology & Therapeutics 11 Suppl 1(Suppl 1):S45-S54, Mary Ann Liebert, Inc., United States (Jun. 2009).
Cryer, P.E., “Preventing Hypoglycaemia: What is the Appropriate Glucose Alert Value?,” Diabetologia 52(1):35-37, Berlin Springer Verlag, Germany (Jan. 2009).
Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ”Wired“ Glucose Oxidase,” Analytical Chemistry 67(7):1240-1244, American Chemical Society, United States (Apr. 1995).
Deshmukh, H., et al., “Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit,” Diabetes Care 43(9):2153-2160, American Diabetes Association, United States (Sep. 2020), Anlage TW 5, Taylor Wessing, Statement of Defence in Abbottv. Dexcom, Opposition to EP 3782539.
Diabetes Control and Complications Trial Research Group, “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus”, New England J. Med., vol. 329, No. 13, 1993, pp. 977-986.
El-Khatib, F.H., et al., “Adaptive Closed-loop Control Provides Blood-glucose Regulation Using Dual Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine,” Journal of Diabetes Science and Technology 1(2):181-192, Sage, United States (Mar. 2007).
Eren-Oruklu, M., “Estimation of Future Glucose Concentrations With Subject-specific Recursive Linear Models,” Diabetes Technology & Therapeutics 11(4):243-253, Mary Ann Liebert, Inc., United States (Apr. 2009).
European Patent Application No. 08745803.0, Extended European Search Report mailed Sep. 27. 2012.
European Patent Application No. 08745805.5, Extended European Search Report mailed May 23, 2012.
European Patent Application No. 08745807.1, Extended European Search Report mailed October 8. 2012.
European Patent Application No. 08745809.7, Extended European Search Report mailed Jul. 2, 2012.
European Patent Application No. 08754499.5, Extended European Search Report mailed Sep. 20. 2012.
Exhibit CP-10, Second Expert Report of Dr. Cesar C. Palerm, Oct. 21, 2022, “Standards of Medical Care in Diabetes-2009” Position Statement, American Diabetes Association, 2009, Diabetes Care, 32(1):S13-S61.
Exhibit CP-4, Expert Report of Dr. Cesar C. Palerm, Sep. 20, 2022, “Animas VibeTM, the First Integrated Offering from Animas Corporation and Dexcom, Inc., Receives European CE Mark Approval”, Products & Operating Company, 2011, 4 pages.
Exhibit CP-6, Second Expert Report of Dr. Cesar C. Palerm, Oct. 21, 2022, Bailey, T.S et al., “Reduction in Hemoglobin Ale with Real-Time Continuous Glucose Monitoring: Results from a 12-Week Observational Study” Diabetes Technology & Therapeutics, 2007, 9(3):203-210.
Exhibit No. 13, to the Expert Report of Professor Nick Oliver, Sep. 20, 2022, Amiel, S et al., “Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial” BMJ, 2002, 325; 6 pages.
Exhibit No. 21, to the Expert Report of Professor Nick Oliver, Sep. 20, 2022, De Vries, J.H. “Glucose Sensing Issues For the Artificial Pancreas” Journal of Diabetes Science and Technology, 2008, 2(4):732-734.
Exhibit No. 3, to the Expert Report of Professor Nick Oliver, Sep. 20, 2022, “Defining and Reporting Hypoglycemia in Diabetes”, American Diabetes Association, Diabetes Care, 2005, 28(5):1245-1249.
Exhibit No. 4, to the Expert Report of Professor Nick Oliver, Sep. 20, 2022, Amiel, S. A., et al., “Hypoglycaemia in Type 2 diabetes”, Diabetic Medicine, 2008, 25:245-254.
Exhibit No. 8, to the Expert Report of Professor Nick Oliver, Sep. 20, 2022, Choudhary, p et al., “Hypoglycaemia in the treatment of diabetes mellitus” Oxford Textbook of Endocrinology and Diabetes, 2011 pp. 1849-1860.
Exhibit No. 9, to the Expert Report of Professor Nick Oliver, Sep. 20, 2022, “Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus” European Medicines Agency, May 14, 2012, 28 pages.
Facchinetti, Andrea, Ph.D et al., A new Index to Optimally Design and Compare Continuous Glucose Monitoring Glucose Prediction Algorithms, Diabetes Technology & Therapeutics, vol. 13, No. 2, 2011; 10 pages.
Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme Technology—Results From a 3-day Trial in Patients With Type 1 Diabetes,” Diabetes Technology & Therapeutics 5(5):769-779, Mary Ann Liebert, United States (2003).
Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change,” Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamnhlet, (2004).
Garg, S. and Jovanovic, L., “Relationship of Fasting and Hourly Blood Glucose Levels to HbAlc Values: Safety, Accuracy, and Improvements in Glucose Profiles Obtained Using a 7-day Continuous Glucose Sensor,” Diabetes Care 29(12):2644-2649, American Diabetes Association, United States (Dec. 2006).
Garg, S., et al., “Improvement in Glycemic Excursions With a Transcutaneous, Real-time Continuous Glucose Sensor: a Randomized Controlled Trial,” Diabetes Care 29(1):44-50, American Diabetes Association, United States (Jan. 2006).
Garg, S.K., et al., “Improved Glucose Excursions Using an Implantable Real-time Continuous Glucose Sensor in Adults With Type 1 Diabetes,” Diabetes Care 27(3):734-738, American Diabetes Association, United States (Mar. 2004).
Guerra, S., et al., A Dynamic Risk Measure from Continuous Glucose Monitoring Data, Diabetes Technology & Therapeutics, vol. 13, No. 8, pp. 843-852 (2011).
Haak, T., et al., “Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes,” Diabetes Therapy 8(3):573-586, Springer Healthcare, United States (Jun. 2017).
Hayter, P.G., et al., “Performance Standards for Continuous Glucose Monitors,” Diabetes Technology & Therapeutics 7(5):721-726, Mary Ann Liebert, Inc., United States (Oct. 2005).
Heller, et al., “Electrochemical Glucose Sensors and Their Applications in Diabetes Management”, Chemical Reviews, 108(7):2482-2505 (2008).
Hovorka, R., “Closing the loop”, Chapter 13.4.9.2, Oxford Textbook of Endocrinology and Diabetes, Wass et al., Eds., 2011, p. 1869.
Innovation Milestones et al., 2021, retrieved from https://www.medtronicdiabetes.com/about-medtronic-innovation/milestone-timeline, 37 pages.
International Hypoglycaemia Study Group, “Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes”, Diabetes Care, 2017, vol. 40, pp. 155-157.
International Preliminary Report on Patentability for Application No. PCT/US2011/055177, mailed on Apr. 18, 2013, 7 pages.
International Search Report and Written Opinion for Application No. PCT/US2011/055177, mailed on Feb. 23, 2012, 9 pages.
Isermann, R., and Balle, P., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes,” Control Engineering Practice 5(5):709-719, (May 1997).
Isermann, R., “Supervision, Fault-detection and Fault-diagnosis Methods—an Introduction,” Control Engineering Practice 5(5):639-652, (May 1997).
Johnson, P. C., “Peripheral Circulation,” John Wiley & Sons, pp. 198, (1978).
Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?,” pp. 250, (2002).
Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm,” Diabetes Care (24)7:1303-1306, American Diabetes Association, United States (Jul. 2001).
Kuure-Kinsey, M., et al., “A Dual-rate Kalman Filter for Continuous Glucose Monitoring,” Conference Proceedings 2006:63-66, IEEE Service Center (2006).
Li, Y., et al., “In Vivo Release From a Drug Delivery MEMS Device,” Journal of Controlled Release 100(2):211-219, Elsevier Science Publishers, Netherlands (Nov. 2004).
Lo, B., and Yang, G-Z., “Key Technical Challenges and Current Implementations of Body Sensor Networks,” Body Sensor Networks, pp. 1-5, (2005).
Lodwig, V., et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria,” Diabetes Technology & Theraneutics 5(4):572-586, Mary Ann Liebert, United States (2003).
Malin, S.F., et al., “Noninvasive Prediction of Glucose by Near-infrared Diffuse Reflectance Spectroscopy,” Clinical Chemistry 45(9):1651-1658, Oxford University Press, United Kingdom (Sep. 1999).
Marshall, J., “Defining hypoglycaemia: what level has clinical relevance?,” Diabetologia 52:31-34, (Nov. 2008).
Mcgarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing,” Diabetes Technology & Theraneutics 3(3):367-376, Mary Ann Liebert, United States (2001).
Mckean, B.D., and Gough, D.A., “A Telemetry-instrumentation System for Chronically Implanted Glucose and Oxygen Sensors,” IEEE Transactions on Bio-medical Engineering 35(7):526-532, Institute Of Electrical And Electronics Engineers, United States (Jul. 1988).
Mcmurry, Jr., J. F., “The Artificial Pancreas Today”, Henry Ford Hospital Medical Journal 31(2):77-83, Henry Ford Hospital, United States (1983).
Mgarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger,” TheraSense, Inc., 16 Pages, (2001).
Morbiducci, U., et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic Algorithms for Parameter Estimation,” Clinical Science 112(4):257-263, Portland Press on behalf of the Medical Research Society and the Biochemical Society, United Kingdom (Feb. 2007).
Mougiakakou, S., et al., “A Real Time Simulation Model of Glucose-insulin Metabolism for Type 1 Diabetes Patients,” Conference proceedings : Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2006:298-301, IEEE Service Center, United States (2005).
Mougiakakou, S. G., et al., “A Communication Platform for Tele-monitoring and Tele-management of Type 1 Diabetes”, Proceedings of the 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference, Shanghai, China, pp. 2207-2210.
Oliver, N.S., et al., “Glucose Sensors: a Review of Current and Emerging Technology,” Diabetic Medicine 26(3):197-210, Blackwell Science, United Kingdom (Mar. 2009).
Palerm, C.C., et al., “Hypoglycemia Detection and Prediction Using Continuous Glucose Monitoring-a Study on Hypoglycemic Clamp Data,” Journal of Diabetes Science and Technology 1(5):624-629, Sage, United States (Sep. 2007).
Panteleon, A.E., et al., “The Role of the Independent Variable to Glucose Sensor Calibration,” Diabetes Technology & Therapeutics 5(3):401-410, Mary Ann Liebert, Inc., United States (2003).
Parker, R., et al., “Robust Hoo Glucose Control in Diabetes Using a Physiological Model,” AIChE Journal 46(12):2537-2549, (Apr. 2000).
PCT/US2012/043012 Isr and Written Opinion dated Nov. 20, 2012.
Pickup, J. C., et al., “Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data”, British Medical Journal, 343:d3805, British Medical Association, England 14 pages (Jul. 2011).
Pickup, J.C., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy,” Biosensors 3(6):335-346, Elsevier Applied Science Publishers, United Kingdom (1987).
Pickup, J.C., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: an Implantable Glucose Sensor With Direct Electron Transfer,” Diabetologia 32(3):213-217, Berlin Springer Verlag, Germany (Mar. 1989).
Pishko, M.V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels,” Analytical Chemistry 63(20):2268-2272, American Chemical Society, United States (Oct. 1991).
Puhr, S., et al., “Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views”, Journal of Diabetes Science and Technology 14(1):83-86, Diabetes Technology Society, United States (Jan. 2020).
Quinn, C.P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured With 0.3-mm Amperometric Microsensors,” The American Journal of Physiology 269(1 Pt 1):E155-E161, American Physiological Society, United States (Jul. 1995).
Rilstone, S., et al., “The impact of CGM with a predictive hypoglycaemia alert function on hypoglycaemia in physical activity for people with type 1 diabetes: PACE study”, 58th Annual Meeting of the European Association for the Study of Diabetes, Stockholm, 2022, 2 pages.
Rodriguez, N., et al., “Flexible Communication and Control Protocol for Injectable Neuromuscular Interfaces, ” IEEE Transactions on Biomedical Circuits and Systems 1(1):19-27, IEEE, United States (Mar. 2007).
Roe, J.N., and Smoller, B.R., “Bloodless Glucose Measurements,” Critical Reviews in Therapeutic Drug Carrier Systems 15(3):199-241, Begell House, United States (1998).
Roussel, R., et al., “Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The Relief Study”, Diabetes Care 44(6):1368-1376, American Diabetes Association, United States (Jun. 2021).
Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations,” Artificial Organs Today 2(2):145-158, (1992).
Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane,” Sensors and Actuators B; Chemical 13(1-3):319-322, (May 1993).
Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors,” Analytical Letters 23(13):2289-2308, (Aug. 2006).
Sandham, W., et al., “Blood Glucose Prediction for Diabetes Therapy Using a Recurrent Artificial Neural Network”, 9th European Signal Processing Conference, 1998, Rhodes, Greece, pp. 1-4.
Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin, ” Proceedings of the National Academy of Sciences 95(1):294-299, National Academy of Sciences, United States (Jan. 1998).
Shaw, G.W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients,” Biosensors & Bioelectronics 6(5):401-406, Elsevier Advanced Technology, United Kingdom (1991).
Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs With a Wearable Artificial Endocrine Pancreas,” Diabetologia 24(3):179-184, Berlin Springer Verlag, Germany (Mar. 1983).
Shichiri, M., et al., “In Vivo Characteristics of Needle-type Glucose Sensor—measurements of Subcutaneous Glucose Concentrations in Human Volunteers,” Hormone and Metabolic Research. Supplement Series 20:17-20, Academic Press, Germany (1988).
Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor,” Diabetes Nutrition and Metabolism 2:309-313, (1989).
Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas,” Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, pp. 197-210, (1985).
Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-type Glucose Sensor: a Useful Tool for Blood Glucose Monitoring in Diabetic Individuals,” Diabetes Care 9(3):298-301, American Diabetes Association, United States (May-Jun. 1986).
Shichiri, M., et al., “Wearable Artificial Endocrine Pancrease With Needle-type Glucose Sensor,” Lancet 2(8308):1129-1131, Elsevier, United Kingdom (Nov. 1982).
Shiridhara., et al., “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes,” Journal of Diabetes Science and Technology 16(1):70-77, Diabetes Technology Society, United States (Jan. 2022).
Shults, M.C., et al., “A Telemetry-instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors,” IEEE Transactions on Bio-medical Engineering 41(10):937-942, Institute Of Electrical And Electronics Engineers, United States (Oct. 1994).
Sparacino, G., et al., “Glucose Concentration Can Be Predicted Ahead in Time from Continuous Glucose Monitoring Sensor Time-Series”, IEEE Transactions on Biomedical Engineering 54(5):931-937, Institute Of Electrical And Electronics Engineers, United States (May 2007).
Sternberg, R., et al., “Study and Development of Multilayer Needle-type Enzyme-based Glucose Microsensors,” Biosensors 4(1):27-40, Elsevier Applied Science Publishers, United Kingdom (1989).
Swinnen, S. G. H. A., et al., “Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia”, Diabetologia, 52(1):38-41 Berlin Springer Verlag, Germany (Jan. 2009).
Thompson, M., and Vandenberg, E.T., “In Vivo Probes: Problems and Perspectives,” Clinical Biochemistry 19(5):255-261, Elsevier Science, United States (Oct. 1986).
Tura, A., et al., “Non-invasive glucose monitoring: assessment of technologies and devices according to quantitative criteria.” Diabetes research and clinical practice 77(1):16-40 Elsevier Scientific Publishers, Ireland (Jul. 2007).
Turner, A.P., and Pickup, J.C., “Diabetes Mellitus: Biosensors for Research and Management,” Biosensors 1(1):85-115, Elsevier Applied Science Publishers, United Kingdom (1985).
“Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults”, National Collaborating Centre for Women's and Children's Health and the National Collaborating Centre for Chronic Conditions, Clinical Guideline 15, 2004, pp. 1-112.
“Type 1 Diabetes Research Roadmap”, JDRF, 2013, pp. 1-38.
Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC),” Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, pp. 117-137, (1997).
Urging FDA to Act Promptly to Approve Artificial Pancreas Technologies, Dan Burton, House of Representatives, Congressional Record, vol. 157, Pt. 13, Nov. 30, 2011; 3 pages.
Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor,” Biomedica Biochimica Acta 48(11-12):957-964, Akademie Verlag, Germany (1989).
Wilson, G.S., et al., “Progress Toward the Development of an Implantable Sensor for Glucose,” Clinical Chemistry 38(9):1613-1617, Oxford University Press, United Kingdom (Sep. 1992).
Related Publications (1)
Number Date Country
20230143496 A1 May 2023 US
Provisional Applications (1)
Number Date Country
61497821 Jun 2011 US
Divisions (1)
Number Date Country
Parent 13526394 Jun 2012 US
Child 15873464 US
Continuations (2)
Number Date Country
Parent 16525915 Jul 2019 US
Child 18152619 US
Parent 15873464 Jan 2018 US
Child 16525915 US